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ABSTRACT 
The existing scientific literature suggests that selenium can modify arsenite or cadmium 
toxicity in fish; however, our current understanding of the biochemical pathways involved in such 
interactions is obtained predominantly from mammalian experimental systems, and the literature 
on aquatic organisms is sparse. To address this knowledge gap, the modulatory effects of selenium 
on cadmium or arsenite toxicity was investigated using a model freshwater fish, rainbow trout 
(Oncorhynchus mykiss). Interactions at the cellular level were investigated using trout hepatocytes 
in primary culture. Selenite and selenomethionine were used as the inorganic and organic chemical 
forms of selenium to understand the chemical species-dependent effects. Interactions at the 
organismal level were studied by feeding the fish with Artemia based diets supplemented with 
selenomethionine in combination with cadmium or arsenite for 30 days. At the cellular level, 
cadmium and arsenite disrupted redox homeostasis which was alleviated by low-moderate doses 
of selenite and selenomethionine (< 25 µM). Further analysis revealed that selenite antagonized 
arsenite-induced oxidative stress by augmenting enzymatic antioxidants, whereas 
selenomethionine upregulated the GSH-dependent non-enzymatic antioxidative pathway. At the 
organismal level, supplementing the diet with only cadmium (40 µg/g diet) or arsenite (80 µg/g 
diet) increased the tissue level deposition of the respective elements and caused oxidative stress in 
the liver. However, medium dose (10 µg/g diet) of selenomethionine reduced cadmium 
accumulation in the liver and alleviated oxidative stress. In contrast, supplementation of diet with 
selenomethionine (both at low and high levels) in combination with arsenite resulted in higher 
degree of oxidative stress relative to the fish treated with arsenite alone. Furthermore, fish co-
treated with arsenite and selenomethionine accumulated significantly higher levels of arsenic in 
liver, kidney and muscle relative to fish treated with arsenite alone. Similarly, the synchrotron-
based X-ray fluorescence imaging also revealed a dose-dependent increase in the co-localization 
iii 
 
of arsenic and selenium in the brain of fish co-treated with dietary arsenite and selenomethionine, 
whereas no arsenic deposition in the brain was recorded in fish treated with dietary arsenite alone. 
Overall, the results indicated that selenium at moderate doses could antagonize cadmium-induced 
oxidative stress; however, selenomethionine can interact metabolically with arsenite at systemic 
level and increase its toxicity in fish.  
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CHAPTER 1: General Introduction 
1.1. Introduction 
Contamination of aquatic habitats from trace elements is a major issue in many parts of the 
world. Trace elements exist naturally in the geosphere, and due to various geological and 
anthropogenic activities may find their way into aquatic habitats. Contamination from metals like 
aluminum, copper, silver, and lead occurs mostly due to their targeted mining since they are the 
elements of human utility. However, the effluents that contaminate water bodies also consist of 
highly toxic metals and metalloids (henceforth referred to as metal), such as cadmium (Cd), arsenic 
(As), and selenium (Se), that are the by-products of mining and smelting processes of the ‘targeted’ 
elements.  
In a natural environment, with multiple biotic and abiotic components, organisms are 
exposed to more than one stressor which may cause additive, synergistic or antagonistic effects 
through crosstalk of cellular pathways (Schulte, 2007). This is also true for metal toxicity, as 
organisms are often exposed to multiple metals in the natural environment. Interactions among 
stressors make it more challenging to predict the ecotoxicological implications of biotic and abiotic 
stressors. Therefore, investigation of such interactions is essential and more ecologically relevant. 
Among various physiological mechanisms underpinning metal-induced toxicity, oxidative 
stress is of particular significance to aquatic toxicologists (Di Giulio et al., 1989), and an increasing 
body of literature emphasizes this concern (Wood, 2012). The term ‘oxidative stress’ is defined as 
a “disturbance in prooxidant-antioxidant balance in favor of the former, leading to damage” (Sies, 
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1991). A more practical definition of oxidative stress was given by Sies (2000) as “an increase in 
formation of pro-oxidants such as hydrogen peroxide, which is accompanied by a loss of 
glutathione and the formation of glutathione disulfide...”. Metals, in general, can disrupt oxidative 
homeostasis in two ways: (i) through production of reactive oxygen species (ROS) through redox 
recycling of metals or Fenton’s like reaction (Ercal et al., 2001; Jomova et al., 2012), and (ii) via 
depletion or impairment of cellular antioxidant defense system (e.g. glutathione) leading to increase 
in intracellular peroxide ions (Stohs and Bagchi, 1995). 
1.2. Selenium as an environmental pollutant 
Selenium is present globally in geological formations and is mobilized through a variety of 
natural and anthropogenic activities (Maher et al., 2010). Although natural weathering of 
seleniferous soil may add selenium to water, anthropogenic activities such as mining aggravate this 
process. Mining of coal, phosphate, and uranium are of particular concern (Lussier et al., 2003; 
Presser et al., 2004; Ramirez-Solis et al., 2004). Targeted refining of selenium for the industrial 
purpose also adds a significant amount of selenium to water bodies through the discharge 
electrolytic water. Other significant sources of aquatic selenium contamination are burning of coal 
in thermal plants, burning of fossil fuels, pharmaceutical industry waste, and application of 
selenium in agriculture. Selenium is a critical component in some quantum dots used in electronic 
products based on nanotechnology, and this source could be a major contributor to aquatic selenium 
contamination in coming future (Janz et al., 2010). 
The toxicity of selenium is influenced by its chemical speciation, which is quite complex 
and determined by various abiotic and biotic factors (Janz, 2012). Selenium in freshwater exists in 
four oxidation states (+6, +4, 0 and – 2). Due to its proclivity to form oxyanions in water, selenium 
mainly exists as inorganic salts of selenite (SeO3-2) and selenate (SeO4-2). Acute toxicity of 
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selenium to fish is usually caused by waterborne exposure to selenite or selenite, with the former 
being more toxic than the latter. Selenite was found to be 3-7 folds more toxic to fish in comparison 
to selenate (Hamilton and Buhl, 1990). The 96 h LC50 values for sodium selenite and sodium 
selenate in juvenile rainbow trout (Oncorhynchus mykiss) range from 4.2 to 9.0 mg Se L-1 and 32 
to 47 mg Se L-1, respectively (Buhl and Hamilton, 1991; Hodson et al., 1980). The organic forms 
of selenium (organoselenide) also exist and are formed as a result of biotransformation. The 
organoselenides form an important component of the fish diet (Maher et al., 2010). 
Selenomethionine (SeMet) is the most predominant form of organoselenide present in the 
freshwater food chain (Janz, 2012; Maher et al., 2010) and is responsible for chronic toxicity to 
fish through dietary exposure.  
Traditionally, the focus of selenium research was mainly on its nutritional and toxicological 
effects on mammals and other animals. However, more recently, selenium has been identified as 
one of the most hazardous aquatic pollutants after mercury (Janz, 2012; Luoma and Presser, 2009), 
and as a result, there has been a rise in the research concerning its toxic effects on the overall 
sustainability of the environment. Although selenium is a metalloid, because of highly persistent 
nature, and high bioaccumulation and biomagnification factor it behaves like a persistent organic 
pollutant (POP).  The primary producers can accumulate up to 1,000,000-fold higher selenium, 
relative to the water column (Stewart et al., 2010). The accumulated inorganic selenium is readily 
biotransformed to organoselenides and biomagnified with the increase in trophic level (Janz, 2012). 
Today, contamination of aquatic habitats with selenium is a global environmental safety issue 
which needs proper assessment and remediation  (Lemly, 2004). 
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1.3. Physiological effects of selenium exposure in fish 
1.3.1. Toxicity of selenium to fish 
Exposure to elevated concentrations of both organic and inorganic selenium in fish is 
known to cause deleterious effects in all the major organs such as kidney, liver, brain, heart, gonads 
(Berntssen et al., 2017; Lemly, 2002; Naderi et al., 2017). A survey of literature on dietary and 
waterborne selenium requirements of fish supports a whole-body threshold of 4 μg g-1 in fish and 
3 μg g-1 in diet beyond which selenosis occurs (Hamilton, 2004). Selenium and sulfur share many 
physical and chemical properties, because of which it was proposed that selenium can replace 
sulfur in methionine and cysteine to form selenomethionine and selenocysteine, respectively. Since 
the sulfurous residues form disulfide bonds and are responsible for maintenance of the tertiary 
structure of the proteins, their replacement could disrupt the structural and functional integrity of 
various proteins. Substitution of methionine with selenomethionine in yolk proteins was believed 
to cause teratogenesis (Lemly, 2002).  
More recently it has been argued that cysteine, and not methionine, is a major amino acid 
that contributes towards disulfide linkages (Hatahet et al., 2014; Reczek and Chandel, 2015). 
Moreover, the formation of selenocysteine and its incorporation into the protein chain is a highly 
regulated process and does not occur merely by substitution of the sulfur atom. Therefore, 
substitution of sulfur in the protein chain may not be the main reason behind selenosis. Instead, it 
is now proposed that the pro-oxidative nature of selenium at elevated concentrations could be the 
cause of its cytotoxicity and teratogenesis (Kupsco and Schlenk, 2014; Misra et al., 2010; Misra 
and Niyogi, 2009; Palace et al., 2004). 
As mentioned previously, the toxicity of selenium is governed by its chemical speciation. 
In fish, selenite and selenomethionine are metabolized differently, and thus generate oxidative 
 5 
 
stress through different biochemical pathways (Misra et al., 2010; Stewart et al., 1999). Painter, in 
1941, proposed for the first time that selenite produces its toxic effects by interacting with cellular 
thiols like GSH (Painter, 1941). Later, the metabolic relationship between GSH and selenite was 
elucidated, and it was proposed that the metabolic reduction of selenite not only reduces the cellular 
pool of GSH, but also produces superoxide radical (O2.- ) as a by-product (see Equation 1.1) (Seko 
et al., 1989).  
 
………. (1.1) 
 
 
On the other hand, selenomethionine, through the action of methionase enzyme, generates 
methylselenol which undergoes spontaneous redox recycling in the presence of GSH. It is during 
this redox recycling reaction that superoxide ion is formed (Palace et al., 2004) (Fig. 1.1). In 
addition, the pro-oxidative nature of inorganic selenium also leads to increased mitochondrial 
membrane permeability which activates a cascade of intrinsic apoptotic pathway assisted by 
mitochondrial cytochrome C. In summary, selenium in excess creates an oxidizing atmosphere 
within the cell which drives a cell towards apoptotic pathways (Kim et al., 2006). 
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Figure 1.1: Selenomethionine under the influence of enzyme methionase generates methylselenol 
which undergoes a spontaneous redox recycling in the presence of GSH to generate superoxide 
radical (Figure adapted from Palace et al., 2004). 
1.3.2. Essentiality of selenium 
The biochemical role of selenium in redox homeostasis was first demonstrated 
experimentally by Rotruck et al., (1972). A year later, in 1973, two independent research groups 
established that glutathione peroxidase (GPx), which is an antioxidant, was a selenoprotein and has 
selenium as its essential structural constituent (Flohe et al., 1973; Rotruck et al., 1973). Since then, 
a large number of scientific reports have subsequently shown that selenium is an integral part of 
many more proteins that help in the maintenance of cellular redox balance (Burk, 2002; Tapiero et 
al., 2003). The redox reactive properties of selenium are mediated by the selenolate moiety (SeCys-
Se-) of the selenoproteins which acts as a nucleophile and reduces the toxic free radicals (Reich 
and Hondal, 2016).  
Although main role of selenium is to maintain cellular redox homeostasis (Reich and Hondal, 
2016; Zwolak and Zaporowska, 2012), there are many selenoproteins with unknown biological 
roles. Approximately 30 seleno-compounds have been identified in mammals with known 
functions of about 12 (Arteel and Sies, 2001). After the discovery of specialized selenocysteinyl-
 7 
 
tRNA, which incorporates selenium into selenocysteine through recognition of UGA codon in 
selenocysteine insertion sequence (SECIS) of mRNA (Gonzalez-Flores et al., 2013), 
selenocysteine is now regarded as 21st amino acid (Böck et al., 1991). This discovery has further 
stimulated the research in selenium, and the SECIS has been discovered in many species of plants 
(Fajardo et al., 2014), mammals (Pietschmann et al., 2014), and fish (Kryukov and Gladyshev, 
2000). It is also known that selenocysteine is more catalytically redox reactive than cysteine, and 
probably this is why the SECIS was developed and retained during evolution of aerobes (H.-Y. 
Kim et al., 2006; Lobanov et al., 2009). A highly specialized genetic mechanism to incorporate 
selenium into proteins is a clear indication of the importance of this element in biology.  
1.3.2.1. Essentiality of selenium to fish 
Dietary deficiency of selenium in fish is known to result in reduced growth rate (Hu et al., 
2016), impaired immune function (Pacitti et al., 2016), and even mortality (Khan et al., 2017; Wang 
et al., 2013). The detrimental effects of selenium deficiency in fish have been associated with 
reduced antioxidant status (Bell et al., 1987; Hu et al., 2016; Khan et al., 2017; Wang et al., 2013). 
Unlike the recommended dietary allowance (RDA) of selenium for humans, the scientific literature 
do not have a consensus on dietary requirement of selenium for fish because the experimentally 
derived values can depend on three factors: (i) the chemical species of selenium, (ii) exposure 
period, and (iii) fish species. The optimum dietary requirement of selenium for fish can range from 
0.3 µg g-1 to 20 µg g-1 of diet (Hodson and Hilton, 1983; Janz, 2012; Le and Fotedar, 2014). 
However, an analysis of literature also suggests that the optimal dietary requirement of selenium 
for fish is between 5 to 25 µg Se Kg-1 body weight (Janz, 2012), which is significantly higher than 
the RDA for mammals. A dietary dose of 55 µg selenium per day is recommended for an adult 
human (Institute of Medicine, 2000). Considering 60 Kg to be the average weight of an adult 
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human, the daily dietary requirement of selenium is 0.92 µg Kg-1 body weight, which is 5 to 25 
folds less than the requirement for fish. Perhaps the higher dietary requirement of selenium for fish 
is to maintain their selenoproteome which is the largest amongst all the vertebrates (Lobanov et al., 
2009, 2008). 
The physiological roles of selenium in fish are similar to the roles observed in mammals; 
however, there are some selenoproteins that are specific to only fish. For example, fish specific 
selenoproteins have been identified in zebrafish and pufferfish that have a structural role in eye 
lens (Castellano et al., 2005, 2004). Oxidoreductases, especially the GPx, are the best-characterized 
selenoproteins in fish (Janz, 2012; Khan et al., 2017). The function of GPx is primarily to reduce 
hydroperoxides to corresponding alcohols at the expense of glutathione (GSH). There are five 
known GPx in vertebrates, and at least four have been identified in fish (Kryukov and Gladyshev, 
2000; Thisse et al., 2003).  Since GPx is involved in the metabolism of hydroperoxides and GSH, 
its activity in combination with measures of membrane lipid peroxidation, and thiol ratio is a 
sensitive biochemical marker of oxidative stress in ecotoxicological studies of fish (Branco et al., 
2012; Sattin et al., 2015; Wendel, 1980). Thioredoxin (Trx) and thioredoxin reductase (TrxR), 
which are the essential components of the intracellular redox system and important regulators of 
ROS accumulation, have also been characterized in fish (Pacitti et al., 2014). Vertebrate Trx is a 
selenoprotein with selenocysteine in its active site. New selenoproteins isoforms and their role in 
redox homeostasis, are being identified in fish every year. The overwhelming amount of evidence 
from scientific literature supports the antioxidative role of selenium in fish and cannot be 
overstated. 
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1.4. Cadmium 
1.4.1. Cadmium as an environmental pollutant 
Cadmium (Cd) is a ubiquitous toxic element with no known biological utility except as a 
zinc replacement at the catalytic site of a type of carbonic anhydrase in some marine diatoms (Maret 
and Moulis, 2013). Mean concentration of cadmium in Earth’s crust is very low (~0.2 mg Cd Kg-
1) and thus natural weathering of rocks or water run-off usually does not contribute much to aquatic 
contamination except in rare cases where soil may have unusually high cadmium (e.g., Jamaica 
and Devon Island in Canadian Arctic) (McGeer et al., 2012). Instead, cadmium contamination of 
the water bodies originates primarily from anthropogenic activities like mining and smelting, and 
its use in utility products like nickel-cadmium batteries, paints, phosphate fertilizers, stabilizers, 
and nanoparticles. 
Toxicity of cadmium to aquatic organisms depends on its bioavailability which, in turn, 
depends on its chemical speciation. The free cation (Cd+2) is the most bioavailable and most toxic 
form of cadmium (McGeer et al., 2012). In water, a wide variety of organic and inorganic ligands 
can reduce cadmium toxicity by forming complexes with it, and thereby reducing the availability 
of free Cd+2 (Soumya Niyogi and Wood, 2004; Playle et al., 1993). However, under most common 
conditions and at environmentally relevant pH, cadmium occurs primarily in its free cationic form 
(Cd+2) (McGeer et al., 2012).  
Cadmium through waterborne and dietary exposures is highly bioaccumulative, and liver 
and kidney are the main sites of accumulation in fish (Ciardullo et al., 2008; de Conto Cinier et al., 
1997; McGeer et al., 2012; Szebedinszky et al., 2001). Moreover, cadmium has very long 
depuration time which further contributes to its high body burden (Kondera et al., 2014).  
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1.4.2. Toxicity of cadmium to fish 
Cadmium is toxic to fish even at extremely low concentrations. Exposure to toxic 
concentrations of cadmium can result in reduced growth, teratogenesis, impaired immune and 
behavioral functions, reproductive failure, and mortality (Driessnack et al., 2017, 2016; Eissa et 
al., 2010; Groh et al., 2015; Ismail and Yusof, 2011; Jin et al., 2015). Acute toxicity of cadmium 
arises primarily from competitive inhibition of Ca+2 uptake at gills (Niyogi and Wood, 2004). 
Physiological mechanisms of chronic toxicity due to cadmium exposure are not well understood, 
but the deleterious effects of exposure may arise due to disruption of oxidative homeostasis (Fig. 
1.2) (Bertin and Averbeck, 2006; Nunes et al., 2014; Zhang et al., 2017; Zheng et al., 2016). 
Chronic toxic effects of cadmium exposure have been found to correlate with depletion of 
glutathione (Jin et al., 2015), binding of cadmium to the thiol groups of cellular proteins and 
enzymes (Bertin and Averbeck, 2006), or substitution of essential metals such as zinc in 
metalloenzymes  (Hartwig, 2001).  
1.4.2.1. Cadmium-induced oxidative stress 
One of the major reasons for cadmium-induced toxicity is disruption of oxidative 
homeostasis and induction of oxidative stress (Fig. 1.2) (Bertin and Averbeck, 2006; Nunes et al., 
2014; Zhang et al., 2017; Zheng et al., 2016). Mitochondria are the main site of cellular oxidative 
respiration and ROS generation. Accumulation of ROS in mitochondria is kept under check by an 
array of antioxidative enzymes such as catalase, glutathione reductase, superoxide dismutase, as 
well as by a variety of reducing agents like GSH, ascorbate, β-carotene, and α-tocopherol that 
sequester ROS (Orrenius et al., 2007; Sies, 1997). Cadmium can inhibit electron transport chain by 
binding with complex III located in the inner mitochondrial membrane (Wang et al., 2004). The 
electron transport chain, under normal circumstances, can efficiently handle the train of electrons 
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from one complex to the other. However, inhibition of complex III inhibits the transfer electrons 
to the next respiratory complex, and the electrons are released prematurely out of the system which 
reacts with molecular oxygen in an uncontrolled fashion to form various ROS (Orrenius et al., 
2007). Also, binding of cadmium to complex III may result in accumulation of semi-ubiquinones 
(Cannino et al., 2009; Wang et al., 2004), which is a radical anion generated within complex III 
due to an incomplete transfer of electrons. Generation of semi-ubiquinones may also generate ROS 
(Wang et al., 2004). Inhibition of complex III and uncoupling of mitochondrial electron transport 
chain was reported in rainbow trout (Oncorhynchus mykiss) hepatocytes after chronic water-borne 
exposure to a sublethal concentration of cadmium (Adiele et al., 2012, 2011). Generation of ROS 
under chronic cadmium exposure may also overwhelm the cellular machinery responsible for 
maintenance of redox homeostasis and various ROS scavengers, such as GSH, may be depleted 
(Rani et al., 2014; Wang et al., 2015). In addition, proteins involved in DNA repair are sensitive 
targets of cadmium toxicity (Ling et al., 2017). Over the past few decades, there have been 
extensive studies on cadmium bioaccumulation and toxicity in aquatic organisms, and cadmium 
ecotoxicology continues to receive further attention (Wang and Rainbow, 2006). 
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Figure 1.2: Effects of Cd on various cellular processes leading to cytotoxicity. Cadmium exposure 
causes oxidative stress by generating ROS and overwhelming the cellular anti-oxidative 
machinery. The ROS generated in response to Cd exposure damage biomolecules such as proteins, 
DNA, lipids in membranes of cell and mitochondria. Cd exposure also affects DNA repair system 
causing mutations and carcinogenicity. If the adaptive cellular response is not able to contain the 
damage induced by Cd exposure, then the cell proceeds towards apoptosis. Modified from Bertin 
and Averbeck (2006). 
 
1.5. Arsenic 
1.5.1. Arsenic as an environmental pollutant 
Arsenic (As) is a metalloid that occurs ubiquitously in Earth’s crust in various geological 
formations, usually in conjunction with sulfur and metals (Kumagai and Sumi, 2007). From such 
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depositions, arsenic may find its way into the atmosphere and then into the aquatic habitats that 
serve as the ultimate sink for pollutants. Natural events like volcanic activities and low-temperature 
volatilization from natural deposits contribute towards atmospheric arsenic, but anthropogenic 
activities constitute a significant source and contribute about 2/3rd of the total atmospheric arsenic 
flux (Chilvers and Peterson, 1987). Primary anthropogenic sources of arsenic are electronic 
industries (admixture in semiconductor production), ore production and processing, metal 
treatment, metal galvanizing, chemical industries (dyes and colors, wood preservatives, pesticides, 
pyrotechnics), and pharmaceutical products  (Matschullat, 2000). These are the sources that also 
contribute towards environmental selenium contamination. Thus, arsenic and selenium may coexist 
as aquatic contaminants and may influence each other’s toxicity.  In fresh water, arsenic primarily 
exists in inorganic forms as oxyanion of trivalent arsenite (As III) or pentavalent arsenate (As IV), 
and organically as monomethylarsonic acid (MMA) and dimethylarsenic acid (DMA) (Anawar, 
2012).  
1.5.2. Toxicity of arsenic 
The toxicity of arsenic is dependent on its chemical form and oxidation state with inorganic 
forms being more toxic than their organic counterparts. Also, among the inorganic forms of arsenic, 
the trivalent arsenites are more toxic than the pentavalent arsenates (Hughes, 2002). In comparison 
to many other toxic metals and metalloids , inorganic arsenic is less toxic, however its widespread 
distribution and persistent nature make it a priority pollutant (McIntyre and Linton, 2012; Smedley 
and Kinniburgh, 2002). Arsenic can bioaccumulate in fish, but can be influenced by its route of 
exposure, bioavailability, and chemical species in the water column (Ciardullo et al., 2010; Russell 
J. Erickson et al., 2011; Jankong et al., 2007). Exposure to toxic concentrations of inorganic arsenic 
to fish results in depression of growth, impaired immune system, poor cognitive and reproductive 
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function, detrimental effects on all organs, and mortality (Kumari et al., 2017; Olivares et al., 2016; 
Ray et al., 2017; Szymkowicz et al., 2017). Toxic to all multicellular organisms, arsenic has no 
known biological roles in higher organisms although some arsenate reductase possessing bacteria 
metabolize arsenic to derive energy (Green, 1918). Arsenic and phosphorus are both group 15 
elements and have chemical resemblance due to similar electron cloud and a same number of 
valence electrons, and because of this chemical resemblance, arsenite may uncouple the synthesis 
of ATP synthesis (Luz et al., 2016). Inorganic arsenic may also replace phosphorus on active sites 
of enzymes and impair metabolic reactions (McIntyre and Linton, 2012). Apart from these 
biological interferences, the most important deleterious effect of inorganic arsenic exposure is 
disturbance of cellular redox homeostasis which affects all macro biomolecules such as enzymes, 
membrane lipids and nucleic acids (Chitta et al., 2013). 
1.5.2.1. Arsenic-induced oxidative stress 
One of the most widely accepted and studied mechanisms of arsenic toxicity is its effect on 
cellular redox homeostasis by inducing ROS (Jomova et al., 2011; Kumagai and Sumi, 2007).  
Exposure to inorganic arsenicals is also known to induce ROS in fish (McIntyre and Linton, 2012; 
Sarkar et al., 2017; Selvaraj et al., 2013a); however, our understanding of the mechanisms of 
arsenic-mediated oxidative stress is derived primarily from work done on mammalian systems. 
Major species of ROS induced by exposure to inorganic arsenic are superoxide anion (O2•-), 
hydroxyl ion (•OH), singlet oxygen (1O2), hydrogen peroxide (H2O2) and peroxyl radicals (Flora, 
2011). 
Arsenite can generate ROS through NAD(P)H oxidase assisted process (Kumagai and 
Sumi, 2007) (Fig. 1.3). The NAD(P)H oxidase is a membrane-bound enzyme that transfers the 
electrons from intracellular NAD(P)H across the cell membrane to reduce molecular oxygen to 
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superoxide anion (see Eq. 1.2). It was demonstrated in mammalian endothelial cell culture that 
arsenite acts as an extracellular signal for the Ras proteins (cdc42) which activates NAD(P)H 
oxidase to generate ROS (Qian et al., 2005).  
NAD(P)H + 2O2  NADP+ + 2O2- + H+ …………………………………………………… (1.2) 
Arsenite also generates ROS by affecting nitric oxide (NO) synthase enzyme system (Fig. 
1.3). Nitric oxide synthase iso-enzymes are coupled to produce NO from L-arginine and molecular 
oxygen without generating superoxides. However, exposure to arsenic disrupts this coupling and 
ROS is generated (Kumagai and Pi, 2004; Kumagai and Sumi, 2007). The physiological effects of 
arsenic-induced oxidative stress in fish include increased tissue lipid peroxidation and Caspase-3 
induced apoptosis (Datta et al., 2009; Greani et al., 2017a; Sarkar et al., 2017; Selvaraj et al., 
2013a). 
The monomethylated (MMA III) and the demethylated (DMA III) metabolites of inorganic 
arsenic are known to be the potent inhibitors of antioxidative enzymes such as glutathione 
peroxidase, glutathione reductase, and thioredoxin reductase (Chouchane and Snow, 2001; Lin et 
al., 2001; Petrick et al., 2001; Rodriguez et al., 2005). Therefore, the metabolic methylation of 
inorganic arsenic, which was previously considered as a detoxification process, is now known to 
potentiate the toxicity of inorganic arsenicals by compromising the cellular antioxidative 
machinery. 
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Figure 1.3: Inorganic arsenite acts as an extracellular signal for small GTPase Rac family of 
proteins of which cdc42 is a part. Activation of Rac proteins triggers the downstream cascade of 
ROS mediated signaling via activation of NAD(P)H oxidases (Figure modified from Kumagai and 
Sumi, 2007). 
1.6. Interactions of selenium with arsenic and cadmium 
1.6.1. Interactions of selenium with arsenic 
Selenium is known to have both antagonistic and synergistic interactions with a large 
number of trace elements in fish; however, most of our understanding on the mechanistic basis of 
their interactions is derived mainly from mammalian studies (Alp et al., 2011; Janz, 2012; 
Ponomarenko, O., 2017; Selvaraj et al., 2012; Zwolak and Zaporowska, 2012).  Moxon in 1938, 
first discovered that arsenite could antagonize the toxicity of inorganic selenium in rats. Later, work 
by Moxon et al., (1945), and Levander and Baumann (1966) suggested that arsenic and selenium 
could interact metabolically and facilitated their excretion through biliary route. Currently, arsenic-
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selenium antagonism in mammals is an active field of research, and is even being used to prevent 
chronic arsenicosis through selenium fortified diets in human populations (Krohn et al., 2016; Sah 
et al., 2013). It has been proposed that the antioxidative properties of selenium (Banni et al., 2011; 
Ponton et al., 2016), and its modulatory effect on the tissue-level distribution of arsenic (Jamba et 
al., 1997) could be the reasons behind their antagonistic interactions in animals. The antioxidative 
properties of organic and inorganic forms of selenium against arsenic-induced oxidative stress are 
well characterized in mammals. In mammalian experiment models, selenium has been 
demonstrated to restore the redox-status of the tissues by upregulating the thiol balance and 
activities of anti-oxidative enzymes (Rossman and Uddin, 2004; Xu et al., 2013; Xue et al., 2010). 
Although the available literature mostly presents evidence and arguments in favor of arsenic-
selenium antagonism, some mammalian studies have also suggested that methylated selenium or 
the methylated metabolites of selenium can have synergistic toxic effects with arsenite (Kraus and 
Ganther, 1989; Levander, 1977). Inorganic selenium and its methylated forms may also potentiate 
arsenite toxicity by competitively inhibiting the complete methylation of arsenite, and thus increase 
the retention of more toxic monomethylated arsenicals in the tissues (Styblo and Thomas, 2001; 
Walton et al., 2003). 
In addition to the anti-oxidative properties of selenoproteins against arsenite, formation of 
a seleno-bis(S-glutathionyl) arsinium compound in liver has also been proposed as a potential 
mechanism by which selenium may antagonize arsenite toxicity (Gailer, 2007, 2009; Gailer et al., 
2000). It has been demonstrated in mammalian experimental models that arsenite and inorganic 
selenium are reduced in the presence of GSH to form bis(S-glutathionyl) arsinium and highly 
nucleophilic hydrogen selenide ions in the liver. Because of the reactive nature of hydrogen 
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selenide, it reacts with the bis(S-glutathionyl) arsinium ion to form a water soluble seleno-bis(S-
glutathionyl) arsinium complex, which is then methylated to replace glutathionyl and excreted as 
[(CH3)2AsSe-] via biliary route (Fig. 1.4) (Gailer, 2007, 2009; Gailer et al., 2000; Ponomarenko, 
O., 2017; Sun et al., 2014). However, it has also been proposed that under chronic exposure to 
arsenite, formation of a As-Se complex can deplete the flux of selenium to the liver and 
compromise the synthesis of anntioxidative selenoproteins such as GPx (Birringer et al., 2002). 
 
 
Figure 1.4: Structural basis of antagonism between arsenite and inorganic selenium. Figure 
modified from Sun et al., 2014. 
The interactions between selenium and arsenic have been studied sporadically in fish. To 
date, only a couple of in vitro studies have examined the arsenic-selenium interactions in piscine 
cells,  and both of these studies reported the antagonistic effects of selenium against arsenic toxicity 
(Alp et al., 2011; Selvaraj et al., 2012). For example, both selenate and selenite were able to reduce 
acute arsenite and arsenate induced cell mortalities in fin and gill cell culture derived from Bluegill 
(Lepomis macrochirus) (Babich et al., 1989). Selenite was also demonstrated to have a protective 
role against arsenite (As2O3) induced toxicity in fish hepatoma cell line through a reduction in ROS 
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generation, reduced DNA damage, increased GPx activity, reduction in apoptosis and prevention 
of mitochondrial membrane damage (Selvaraj et al., 2012). 
1.6.2. Interactions of selenium with cadmium 
Experiments conducted on mammalian and avian experimental models suggest that 
selenium can prevent cadmium-induced toxicity through the restoration of oxidative homeostasis, 
or escalation of the cellular stress response. For example, Liu et al., (2014) demonstrated through 
an in vitro experiment on chicken splenic lymphocytes that selenite augments the activity of anti-
oxidative enzymes and reduces ROS mediated apoptosis. Similarly, Chen et al. (2012) also 
demonstrated that selenite could augment cellular stress response against cadmium-induced 
toxicity by up-regulation of various proteins of HSP family in chicken splenic lymphocytes. 
Concurrent exposure to selenite with cadmium is known to restore cellular energetics in rat renal 
cells (El-Sharaky et al., 2007). Organic and inorganic selenium has also been found to alleviate 
cadmium-induced oxidative stress in fish (Banni et al., 2011; Orun et al., 2008; Talas et al., 2008; 
Xie et al., 2016), however all of these studies were carried out mainly by using non-toxic selenium 
exposure doses, as well as extremely high cadmium concentrations during waterborne exposure. 
Clearly, further studies are required on the interactive effects of selenium and cadmium in fish, 
specifically to enhance our understanding of how this interaction is modulated by the different 
exposure doses of selenium (non-toxic and toxic) as well as its chemical speciation (inorganic vs. 
organic) at both cellular and systemic levels. 
1.7. Research objectives 
Rationale: My research was designed to study the mechanistic underpinnings of interactive 
effects of selenium with arsenite or inorganic cadmium toxicity in a model freshwater fish, rainbow 
trout (Oncorhynchus mykiss). Interactions of selenium with arsenite or cadmium have been studied 
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sporadically, and most evidence on these interactions are derived from non-aquatic experimental 
systems, particularly from mammals and birds. Currently, there is complete lack of information on 
the biochemical pathways through which selenium modulates arsenite-induced oxidative stress in 
aquatic animals. Also, the in vivo investigations into selenium-arsenite interactions in aquatic 
animals and the effects of such interactions on the tissue-level distribution of metals is lacking. As 
mentioned previously, the scientific reports on selenium-cadmium interaction already exist for 
piscine experimental models. However, these studies have limited environmental relevance 
because these studies were carried out only with physiologically optimum doses of selenium. Also, 
the fish were exposed mainly to waterborne cadmium concentrations (0.4  2.0 mg L-1) that were 
well above the range of environmentally relevant cadmium exposure levels. It is essential to 
understand how selenium can influence cadmium toxicity at levels that exceed the physiological 
threshold and may cause toxicity to fish by itself. Since it is now known that diet is a significant 
route of exposure to cadmium (Harrison and Klaverkamp, 1989; Liu et al., 2015; Xu and Wang, 
2002), the studies investigating interactions of selenium with dietary cadmium are also warranted.  
Hypothesis: This research project is based on the principal hypothesis that “Selenium will 
modulate arsenite and cadmium-induced toxicity in freshwater fish but in a dose-specific manner, 
with antagonistic interactions at low to intermediate exposure levels and synergistic effects at 
higher doses”. 
Research objectives: My research has four main objectives which are as follows: 
i) To provide insights into the cellular pathways by which different chemical species 
[inorganic (selenite) vs. organic (selenomethionine)] and exposure concentration of 
selenium influences cadmium-induced oxidative stress at the cellular level (Chapter 2) 
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The interactions between selenium and cadmium were characterized in isolated hepatocytes of 
rainbow trout in primary culture. Modulatory effects of selenite and selenomethionine as inorganic 
and organic forms of selenium, respectively, on cadmium-induced oxidative stress were examined. 
The interactive effects on major anti-oxidative enzymes and cellular redox potential were 
investigated. Confocal microscopy was also used to analyze the generation of ROS within the 
hepatocytes under different experimental treatments. Pharmacological antioxidants, with 
biochemical activities similar to cellular enzymatic and non-enzymatic anti-oxidants, were also 
used to distinguish the anti-oxidative pathways involved in amelioration of cadmium-induced 
oxidative stress. 
ii) To characterize the hepatic pathways by which different chemical species [inorganic 
(selenite) vs. organic (selenomethionine)] and exposure concentration of selenium modulate 
arsenite-induced oxidative stress at the cellular level (Chapter 3) 
The biochemical pathways by which selenium modulates arsenite hepatotoxicity were 
characterized using isolated hepatocytes of rainbow trout in primary culture. Selenite and 
selenomethionine were used to investigate the modulatory effects of inorganic and organic forms 
of selenium, respectively. The influence of various exposure treatment on the activities of major 
anti-oxidative enzymes and cellular redox potential were studied. Effects of selenium on the 
arsenite-induced generation of ROS was visualized by confocal microscopy. Pharmacological 
antioxidants, with biochemical activities similar to cellular enzymatic and non-enzymatic anti-
oxidants, were also used to distinguish the anti-oxidative pathways involved in amelioration of 
arsenic-induced oxidative stress. 
iii) To understand the interactive effects of chronic exposure to dietary cadmium and 
selenomethionine on tissue-specific accumulation and toxicity of cadmium in rainbow trout 
(Oncorhynchus mykiss) (Chapter 4) 
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The fish were exposed to diets supplemented with cadmium in combination with three different 
doses (low, medium, and high) of selenomethionine for 30 days. Hepatosomatic index and 
condition factor were used as the general biomarkers of stress and energetic status of fish to dietary 
treatments. Lipid peroxidation, activities of hepatic anti-oxidative enzymes, and thiol ratio 
(GSH:GSSG) were used as biomarkers of oxidative stress. Redistribution of cadmium from 
critically important tissues such as liver, kidney, and muscle as one of the strategies for 
amelioration of cadmium-toxicity under the influence of selenomethionine was also investigated. 
iv) Characterization of the modulatory effects of selenomethionine on arsenite-induced hepato-
toxicity and tissue-specific accumulation of arsenic during chronic dietary exposure 
(Chapter 5) 
Juvenile rainbow trout were exposed to an environmentally relevant dietary dose of arsenite in 
combination with different levels of dietary selenium [control (low), moderate and high; as 
selenomethionine] for 30-days to examine the modulatory effects of selenium on the tissue-specific 
accumulation of arsenic and arsenite-induced hepatotoxicity. Hepatic lipid peroxidation, activities 
of anti-oxidative enzymes, and thiol ratio (GSH:GSSG) were used to understand the effects of 
selenomethionine on arsenite-toxicity. Modulation of arsenic accumulation in the critically 
important liver, kidney, and muscle were investigated as a strategy by which selenium may 
ameliorate arsenite toxicity. In addition, synchrotron-based X-ray absorption spectroscopy (see 
appendix for more information; Fig. C1 S1) was also used to understand how the interactions 
between selenium and arsenite may influence their distribution and localization pattern in fish 
brain.
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CHAPTER 2: An in vitro examination of selenium-cadmium antagonism using primary 
cultures of rainbow trout (Oncorhynchus mykiss) hepatocytes 
 
Preface 
The aim of this chapter is to address the 1st objective of my doctoral research work which 
is to provide insights into the cellular pathways by which different chemical species [inorganic 
(selenite) vs. organic (selenomethionine)] and exposure dose of selenium influences cadmium-
induced oxidative stress at the cellular level. The hepatocytes of rainbow trout in primary culture 
were used to determine the antagonistic effects of selenite and selenomethionine against cadmium 
hepatotoxicity without systemic interference. 
The content of Chapter 2 was reprinted (adapted) from Metallomics, (DOI: 
10.1039/C5MT00232J) A. Jamwal, M. Naderi, and S. Niyogi, “An in vitro examination of 
selenium–cadmium antagonism using primary cultures of rainbow trout (Oncorhynchus mykiss) 
hepatocytes”. Copyright 2016, with permission from Royal Society of Chemistry. 
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2.1. Introduction 
Cadmium (Cd) has been categorized as a global priority pollutant because of its ubiquitous 
presence, bio-accumulative nature and potential to induce toxic effects at relatively low 
concentrations (Campbell, 2006). Cadmium is a non-essential metal, and toxic to all life forms, 
including fish. Cadmium is a calcium antagonist, and known to cause toxicity in fish by disrupting 
branchial calcium uptake and homeostasis, especially during acute exposure (Niyogi and Wood, 
2004). The toxicity of Cd has also been attributed to the disruption of oxidative homeostasis 
(Faverney et al., 2004; Wang et al., 2004). Cellular oxidative homeostasis is primarily maintained 
by various enzymatic antioxidants such as catalase (CAT), glutathione peroxidase (GPx), 
superoxide dismutase (SOD), as well as by multiple non-enzymatic antioxidants such as 
glutathione, ascorbate and metallothionein (Lushchak, 2011). However, exposure to cadmium 
often leads to the disruption of antioxidative enzymes and/or depletion of the non-enzymatic 
antioxidant pool, resulting in a concomitant cellular accumulation of reactive oxygen species 
(ROS) and oxidative damage (Bertin and Averbeck, 2006; Waisberg et al., 2003).  
The intracellular handling of cadmium can be influenced by the crosstalk of cellular 
pathways involved in the metabolism and regulation of essential/nutrient elements, which may 
elicit additive, synergistic or antagonistic effects. Selenium (Se) is one such essential element that 
has been suggested to influence the toxicity of cadmium in different organisms, including mammals 
and fish (see Zwolak and Zaporowska, 2012 for review). Selenium is essential for the synthesis of 
selenoproteins, which have various critical adaptive and housekeeping functions in organisms, 
including the maintenance of cellular oxidative homeostasis (Zwolak and Zaporowska, 2012). 
Among all the living organisms, fish are known to have the highest requirement of selenium, as 
they possess the largest selenoproteome (Lobanov et al., 2009). For example, fish are known to 
have 30-37 selenoproteins, whereas mammals contain only 23-25 selenoproteins (Lobanov et al., 
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2009). Selenium exists in the environment in both organic and inorganic forms (Hodson et al., 
1983). Selenomethionine (SeMet) is the most common form of organic selenium found in fish diet, 
whereas selenite (SeO32-) is usually the most abundant soluble form of inorganic selenium found 
in natural waters under normal conditions (Maher et al., 2010). Since selenium, in the form of 
selenoproteins, is known to have antioxidative properties, it can be hypothesized that selenium may 
ameliorate cadmium-induced cellular oxidative stress, and thus provide protection against the 
toxicity of cadmium. However, it is also interesting to note here that selenium is also an important 
aquatic pollutant (Janz et al., 2010), and when present above the threshold level in biological 
systems, can rapidly turn into a pro-oxidant (Hodson et al., 1983). It has been demonstrated that 
exposure to high levels of both selenite and selenomethionine causes cellular oxidative stress in 
fish, essentially by disrupting thiol redox and inducing ROS generation (Misra et al., 2012a; Misra 
and Niyogi, 2009). Thus, the protective effects of selenium against cadmium-induced cytotoxicity 
might be influenced by selenium exposure dose, with antagonistic effect at low exposure levels 
and additive or synergistic effects at high exposure levels. 
Previous mammalian studies have demonstrated the protective effects of both selenite and 
selenomethionine against cadmium cytotoxicity (Messaoudi et al., 2010; Zhou et al., 2009; Zwolak 
and Zaporowska, 2012); however, the precise mechanistic underpinnings of this antagonism are 
not fully understood. The protective effects of selenium against the organismal toxicity of cadmium 
have also been reported in fish exposed to sub-lethal cadmium in the presence of selenium (Banni 
et al., 2011; Talas et al., 2008). However, all of these previous studies have investigated the 
ameliorative effects of relatively low exposure levels of selenium against cadmium toxicity, and 
how this effect is modulated by high selenium exposure level is yet to be characterized. Moreover, 
it is important to note that the chemical speciation of selenium may also influence cellular effects 
of cadmium exposure, since inorganic and organic selenium are known to be metabolized through 
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different cellular pathways (Misra et al., 2010; Palace et al., 2004; Seko et al., 1989). This is 
particularly important in fish since they acquire selenium primarily through their diet as 
selenomethionine (Maher et al., 2010). Although the antagonistic behavior of selenite and cadmium 
has been suggested to be mediated by the amelioration of oxidative stress (Newairy et al., 2007; 
Zhou et al., 2009), it is not known whether the cytoprotective effect of selenomethionine against 
cadmium cytotoxicity occurs through a similar mechanism.       
The main objectives of this study were twofold: (i) to examine how the chemical speciation 
[inorganic (selenite) vs. organic (selenomethionine)] and exposure dose of selenium influences 
cadmium induced cytotoxicity at the cellular level, and (ii) to provide a deeper insight into the 
cellular pathways underlying the antagonism of selenium and cadmium in fish. Rainbow trout 
(Oncorhynchus mykiss) hepatocytes in primary culture were used as the model in vitro 
experimental system in the present study, since hepatocytes are the functional units of liver and 
one of the main sites of selenium and cadmium metabolism (Okuno et al., 2001; Suzuki, 2005; 
Waalkes, 2000).  
2.2. Methods 
2.2.1. Chemicals 
High purity, cell culture tested sodium selenite (Na2SeO3, purity ~ 98%), seleno-L-
methionine (purity > 98 %), cadmium chloride (CdCl2, purity~99.99 %), cell dissociation solution 
non-enzymatic (catalogue# C1419), CelLytic MTTM solution, Dulbecco’s phosphate buffered 
saline and trichloroacetic acid (TCA) were purchased from Sigma Aldrich, USA. Antibiotic and 
antimicotic solution, and L-15 media were purchased from Invitrogen, Canada. AquacalmTM 
(Metomidate hydrochloride) was purchased from Syndel Laboratories Ltd, Canada. All other 
chemicals were purchased from VWR International, Canada. 
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2.2.2. Experimental animals 
Rainbow trout weighing 600-700 g were used for the experiments. Fertilised eggs from 
reference rainbow trout females were hatched in the department of biology, University of 
Saskatchewan. The spawn were reared until they reached 600-700 g in dechlorinated Saskatoon 
City water at a rate of 2 l min-1 under constant aeration. Fish were maintained at a photoperiod of 
16 h light: 8 h dark and a water temperature of 12 ± 1 oC. The fish were fed once daily with 
commercial diets at a ration of 2 % of body weight.  
2.2.3. Hepatocyte isolation and culture 
Trout hepatocytes were isolated using a two-step collagenase perfusion technique as 
described by Mommsen et al, (1994) with slight modifications (Misra and Niyogi, 2009; Moon et 
al., 1985). Briefly, fish were euthanized with an overdose of Aquacalm (0.5 g l-1) in dechlorinated 
water. The hepatic portal vein was cannulated with PE-50 tubing and perfused with ice-cold 
modified Hank’s Media (136.9 mM NaCl, 5.4 mM KCl, 0.8 mM MgSO4.7H2O, 0.33 mM 
Na2HPO4.7H2O, 0.44 mM KH2PO4, 5.0 mM HEPES, 5.0 mM Na-HEPES, pH 7.63). Perfusion 
with Hank’s media was continued until the liver was completely blanched, after that the perfusion 
line was switched to the medium containing 0.2 mg ml-1 collagenase in Hank’s Media. Perfusion 
with collagenase was performed until liver was fully digested. Digested liver was chopped into 
small pieces with a razor blade and the dissociated cells were filtered, first through 260 µm and 
then through 73 µm mesh size strainers. The cells obtained in the filtrate were centrifuged at 100 
x g for 5 minutes at 4 oC and washed twice in Hank’s media. This was followed by a single washing 
with the Hank’s media containing BSA (2 %) and CaCl2 (1.5 mM). The cells were then incubated 
for 30 min in L-15 media (pH 7.63) containing antimicrobial and antimicotic solution on an ice 
bath. The settled down cells were collected by aspirating out the media on top. The cells were then 
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re-suspended in 25 ml of L-15 media and their viability was determined by trypan blue exclusion 
test (Strober, 2001). The suspensions showing more than 85 % cell viability were used for the 
experiments. The cells were plated in 6-well Primaria plates (BD Falcon, USA) at a density of 0.3 
x 106 cells cm-2 and incubated, in dark at 15 oC for 24 h using a low temperature incubator (Fisher 
Scientific, Canada), to form monolayer before their use in the experiment. 
2.2.4. Exposure of hepatocytes to cadmium, alone or in combination with selenium 
At first, the hepatocytes were exposed only to an increasing range of cadmium 
concentrations (0  500 µM) in order to determine the dose-dependent effect of cadmium on cell 
viability. After 24 h of culture, following isolation, the media from culture plates was aspirated out 
and the hepatocytes were exposed to the media containing different concentrations of CdCl2. 
Cadmium exposures were conducted for 48 h with a change of exposure media at 24 h. A consistent 
30 % reduction in cell viability was observed at 100 µM cadmium exposure dose (n=4; data not 
shown). This concentration was therefore chosen for all of the subsequent experiments described 
below. 
To determine how selenium influences cadmium-induced cytotoxicity, hepatocytes were 
exposed to 100 µM cadmium, alone or in combination with different concentrations (25, 50, 100, 
250 and 500 µM) of selenite (SeO3-2) or selenomethionine (SeMet) for 48 h. Our preliminary work 
revealed that Se did not influence cadmium-induced loss of cell viability at concentrations below 
< 25 µM (selenite or selenomethionine) (data not shown). The hepatocytes in the control group 
were treated similarly with the media without any added cadmium or selenium. The exposure 
media was spiked with appropriate amounts of freshly prepared solutions of CdCl2, selenite or 
selenomethionine prior to each exposure. The exposure media was also changed after 24 h of 
exposure as described above. The osmolality of the exposure media was measured using a 5100C 
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vapour pressure osmometer (Wescor Inc., USA), and no change was recorded in any treatment due 
to the addition of CdCl2, SeO3-2 or SeMet. At the end of the exposure period, cells were collected 
from the culture plate using a non-enzymatic cell dissociation solution. Cell viability was measured 
immediately by the trypan blue exclusion test. The experiment was performed five times using 
hepatocytes isolated from an individual fish at each time. 
For the measurement of enzymatic activities, the harvested cells were centrifuged at 500 x 
g for 5 min and washed with Dulbecco’s Phosphate Buffer Saline three times and then lysed with 
500 µl of CelLytic-M reagent. The lysate was centrifuged at 25,000 x g for 20 min at 4 oC to pellet 
the cellular debris. The supernatant was collected and stored at -80 oC for the enzymatic analysis. 
For the measurement of oxidized and reduced glutathione, cells were treated as before, except that 
an ice-cold 5% TCA solution was used along with CelLytic-M reagent during the cell lysis. The 
cell lysate was split into two fractions (250 µl each). One fraction was stored as such at -80 oC for 
measurement of reduced glutathione (GSH). A 20 µl aliquot of 0.04 M of N-ethylmaleimide was 
added immediately to the other fraction in order to prevent the oxidation of GSH, and stored at -80 
oC for measurement of oxidised glutathione (GSSG). The Bradford method was used for estimation 
of protein content of the samples (Bradford, 1976).  
2.2.5. Exposure of hepatocytes to pharmacological antioxidants in the presence of cadmium 
Pharmacological antioxidants, (2,2,6,6-tetramethylpiperidin-1-yl)oxidanyl (TEMPO) and 
N-acetyl-L-cysteine (NAC), were used to compare with the antioxidative effects of selenium in 
trout hepatocytes. Hepatocytes were exposed to 100 µM cadmium, alone as well as with TEMPO 
or NAC (100 µM) for 48 h, as described previously for exposures with selenium. At the end of the 
exposure, cells were harvested and cell viability was assessed as mentioned above. 
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2.2.6. Measurement of cellular thiol redox balance (GSH:GSSG ratio) 
Cellular thiol redox balance is assessed traditionally by measuring GSH to GSSG ratio 
(Hwang et al., 1992; Jones, 2010; Mallikarjun et al., 2012). The concentration of the reduced (GSH) 
and oxidized (GSSG) glutathione in the cell lysates was measured using a fluorometric method 
(Hissin and Hilf, 1976), modified to a 96-well microplate based assay (Misra and Niyogi, 2009). 
In order to confirm the linearity of the reaction rate in the adopted method, commercially purified 
GSH and GSSG were used to calibrate the standard curve. The measurement of GSH was 
performed in a final reaction mixture volume of 200 µl, which contained 180 µl of phosphate–
EDTA buffer (0.1 M sodium phosphate–0.005 M EDTA, pH 8.0), 10 µl of o-Phthalaldehyde (OPT, 
100 µg per 100 µl methanol) and 10 µl of sample. The reaction mixture was incubated for 15 min 
at room temperature, and the fluorescence was measured in a multimode microplate reader 
(Varioskan Flash, Thermo Fisher Scientific, Finland) at excitation and emission wavelengths of 
350 nm and 450 nm, respectively. The GSH content was expressed as µg per mg of protein. GSSG 
was measured similarly, except the final reaction mixture volume (200 µl) contained 140 µl of 0.1 
N NaOH, 20 µl of o-Phthalaldehyde (OPT, 100 µg per 100 µl methanol) and 40 µl of sample. The 
GSSG content was also expressed as µg per mg of protein. Finally, GSH content of each replicate 
was divided by its corresponding GSSG content and expressed as a ratio. 
2.2.7. Measurement of antioxidant enzyme activities 
We measured the activities of three antioxidant enzymes, SOD, CAT, and GPx using 96-
well microplates and a multimode plate reader (Varioskan Flash, Thermo Fisher Scientific, 
Finland). Enzyme activities were measured in the hepatocytes exposed to 100 µM cadmium alone 
or in combination with 25 or 250 µM selenite or selenomethionine. The enzyme activities were 
measured using SOD (Catalogue #706002), CAT (Catalogue #707002), and GPx (Catalogue 
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#706002) activity kits as per the manufacturer’s (Cayman chemical company, USA) instructions. 
SOD activity was expressed as % of control. Activities of CAT and GPx were expressed as 
nmol/min/mg protein. One unit of CAT was defined as the amount of enzyme that will cause the 
formation of 1.0 nmol formaldehyde at 25 oC. One unit of GPx was defined as the amount of 
enzyme that will cause the oxidation of 1.0 nmol of NAD(P)H to NADP+ per minute at 25 oC.  
2.2.8. Measurement of intracellular reactive oxygen species (ROS) generation using 
Confocal Microscopy 
Confocal microscopy was used to investigate the effect of selenite and selenomethionine 
on ROS production in hepatocytes exposed to 100 µM cadmium. An ROS sensitive fluorescent 
dye, 50,6-chloromethyl-20,70-dichlorodihydro-fluorescein diacetate (CM-H2DCFDA) was used 
for this purpose. CM-H2DCFDA passively diffuses into cells, where its acetate groups are cleaved 
by intracellular esterases. Following the cleavage of acetate groups, the dye gets oxidized by 
intracellular ROS to yield a fluorescent adduct which can be evaluated under a confocal microscope 
with maximum excitation and emission spectra of 495 nm and 529 nm, respectively. Fluorescent 
intensity can be measured and quantified, thus, providing a measure of intracellular ROS 
generation. 
A 2 mM stock of CM-H2DCFDA was prepared in anhydrous dimethylformamide (DFO) 
which was diluted to 5 µM in L-15 media for use in the experiments. Final concentration of DFO 
in the exposure media was less than 1 %. For this experiment, hepatocytes were cultured on glass 
bottom dishes coated with poly-D-lysine (Mat Tek Corporation, USA) for 24 h. The 24 h culture 
was then exposed to 5 µM of CM-H2DCFDA for 45 min at 15 oC and washed three times with L-
15 media without phenol red. Subsequently, the hepatocytes were exposed to media containing 100 
µM cadmium, alone or in combination with a low concentration (25 µM) or a high concentration 
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(250 µM) of selenite or SeMet for 2 h. An exposure period of 2 h was employed instead of 24 h, 
primarily to capture the effects during the early exposure phase and also to prevent any leakage of 
the dye from the cells due to potential ROS induced membrane damage. At the end of the exposure 
period, intracellular ROS production in each treatment were measured at room temperature (21 oC) 
using the 488 nm excitation Argon laser beam and emission was collected using 505–530 nm band 
pass filter of the confocal microscope (Zeiss Axiovert LSM 510 Meta Confocal System, Carl Zeiss, 
Germany). Similar microscopic settings for the imaging were maintained throughout to allow 
conformity of the results.  
ImageJ software (National Institutes of Health, Bethesda, Maryland, USA) was used to 
quantify the fluorescence intensity of the cells. Integrated density of all the cells under the view of 
microscope was measured from which mean background intensity was subtracted. The final 
fluorescent intensity was expressed as corrected total cell fluorescence (CTCF) using the following 
formula: 
CTCF = Integrated Density - (Area of selected cell x Mean fluorescence of background readings) 
2.2.9. Statistical analysis 
All data are presented as mean ± standard error of mean (S.E.M.). Sample size ‘n’ indicates 
the number of true independent evaluations, each conducted with cells isolated from a different 
fish. The experiment involved manipulation of only Se as an independent variable therefore 
significant differences among the treatment groups were analyzed by one-way analysis of variance 
(1-WAY ANOVA) followed by Tukey’s multiple comparison test (SigmaPlot, version 11, Systat 
Software, Inc., USA). The assumptions of ANOVA, normality of distribution and homogeneity of 
variances, were verified using the Shapiro-Wilk and Levene’s tests, respectively.  A p-value of ≤ 
0.05 was considered to be significant while comparing different treatments. 
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2.3. Results 
2.3.1. Effects of selenite and selenomethionine on cadmium induced cytotoxicity 
Hepatocyte viability after 48 h of exposure to 100 µM cadmium, alone or in combination 
with selenite or selenomethionine (25, 50, 100, 250, and 500 µM) is illustrated in Fig. 2.1. There 
was a significant effect of cadmium exposure, independently or in combination with different 
concentrations of selenium, on cell viability (F11,48 = 13.29; p < 0.001) . Exposure to cadmium 
alone reduced hepatocyte survival by 30 % (p < 0.001). Co-exposure of hepatocytes to cadmium 
with selenite or selenomethionine reduced cadmium induced cytotoxicity. However, the protective 
effect of selenium against cadmium toxicity was observed only at 25 µM selenite or 
selenomethionine concentration, where the cell viability was restored and did not differ from the 
control group (p = 0.65). No such protective effect of selenium against the cytotoxicity of cadmium 
was observed at 50  250 µM of selenite or SeMet (p > 0.05). Co-exposure of 100 µM cadmium 
and 500 µM selenium (selenite or SeMet) was found to be more toxic than 100 µM cadmium alone, 
as the hepatocyte viability decreased significantly in the former treatment relative to the latter (p = 
0.025). 
2.3.2. Effects of pharmacological antioxidants on cadmium induced cytotoxicity 
The effects of pharmacological antioxidants on cadmium-induced cytotoxicity are 
presented in Fig. 2.2. Exposure of hepatocytes to cadmium, alone or in combination with 
pharmacological antioxidants, had a significant effect on cell viability (F3,16 = 13.92; p < 0.001). 
Co-exposure of hepatocytes to 100 µM cadmium and 100 µM TEMPO or NAC completely restored 
the cell viability (p < 0.001). Exposure to only 100 µM cadmium reduced cell viability by about 
30% (p < 0.001) in comparison to the control. However, there was no statistically significant 
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difference in cell viability between the control and the co-exposure of cadmium with TEMPO or 
NAC. 
2.3.3. Effects of selenite and selenomethionine on cadmium induced changes in cellular thiol 
redox balance 
Changes in GSH:GSSG ratio in hepatocytes exposed to 100 µM cadmium alone or in 
combination with selenite or selenomethionine are illustrated in Fig. 2.3. Cellular thiol redox 
balance was significantly influenced by cadmium exposure, alone or in combination with different 
concentrations of selenium (F11,36 = 8.65; p < 0.001). Exposure to cadmium alone resulted in a 
significant decrease in GSH:GSSG ratio (p < 0.001). Similar to the effect of selenium on cadmium 
induced loss in cell viability, 25 µM of selenium, either as selenite or selenomethionine, was able 
to fully restore the GSH:GSSG ratio as no difference relative to the control was observed. However, 
exposure of hepatocytes to ≥ 50 µM selenite or selenomethionine did not alter the cadmium induced 
decrease in cellular thiol redox (p > 0.05). 
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Figure 2.1: Changes in cell viability when rainbow trout hepatocytes were exposed to 100 µM 
cadmium (Cd), alone or in combination with different concentrations (25 – 500 µM) of selenite 
(A) or selenomethionine (B). Data are presented as mean ± S.E.M. (n = 5), where n represents the 
number of true independent measurements, each performed with cells isolated from a different fish. 
Mean values with different letters are statistically significant (p < 0.05). 
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Figure 2.2: Changes in cell viability when rainbow trout hepatocytes were exposed to 100 µM 
cadmium (Cd), alone or in combination with pharmacological antioxidants, TEMPO (100 µM) or 
NAC (100 µM). Data are presented as mean ± S.E.M. (n = 5), where n represents the number of 
true independent measurements, each performed with cells isolated from a different fish. Mean 
values with different letters are statistically significant (p < 0.05). 
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Figure 2.3: Changes in cellular thiol redox status, expressed as ratio of reduced (GSH) to oxidized 
(GSSG) glutathione in rainbow trout hepatocytes exposed to 100 µM cadmium (Cd), alone or in 
combination with different concentrations (25 – 500 µM) of selenite (SeO32-) or selenomethionine 
(SeMet). Data are presented as mean ± S.E.M. (n = 5), where n represents the number of true 
independent measurements, each performed with cells isolated from a different fish. Mean values 
with different letters are statistically significant (p < 0.05). 
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2.3.4. Effects of selenite and selenomethionine on cadmium induced changes in 
antioxidative enzyme activities 
Cadmium exposure, independently or in combination with selenium, had a significant effect 
on SOD activity (F5,22 = 42.0; p < 0.001). Exposure to 100 µM cadmium alone reduced SOD 
activity by 40 %, which was significantly different relative to the control (p < 0.001) (Fig. 2.4 A). 
A similar decrease in the activity was also observed when hepatocytes were co-exposed to 
cadmium and 250 µM selenium (p < 0.001). However, the SOD activity recovered back to the 
control level when hepatocytes were exposed to cadmium in the presence of 25 µM SeMet, whereas 
a treatment with 25 µM selenite resulted in a partial recovery of cadmium induced decrease in SOD 
activity. 
Cadmium exposure, independently or in combination with selenium, had a significant effect 
on CAT activity (F5,24 = 9.24; p < 0.001) Exposure of hepatocytes to 100 µM cadmium alone 
resulted in a > 50% decrease in the activity of CAT, which was significantly lower relative to the 
control (Fig. 2.4 B). The enzyme activity, however, was similar to the control in hepatocytes 
exposed to cadmium in combination with 25 µM selenite or selenomethionine. In contrast, co-
exposure to 100 µM cadmium and 250 µM of selenite or selenomethionine resulted in a similar 
decrease in CAT activity as caused by 100 µM cadmium alone.  
GPx activity exhibited a similar pattern as observed with CAT, when treated with 100 µM 
cadmium alone or together with 25 µM or 250 µM selenite or selenomethionine (F5,25 = 6.77; p < 
0.001) (Fig. 2.4 C). The GPx activity decreased significantly (~35%), in hepatocytes treated with 
cadmium alone or in combination with 250 µM selenite or selenomethionine, relative to the control. 
However, a partial recovery of GPx activity was recorded in hepatocytes exposed to 100 µM 
cadmium in combination with 25 µM selenite or selenomethionine. 
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Figure 2.4: Changes in the activities of antioxidant enzymes (A) superoxide dismutase (SOD), (B) 
catalase (CAT), and (C) glutathione peroxidase (GPx) in in rainbow trout hepatocytes exposed to 
100 µM cadmium (Cd), alone or in combination with a low (25 µM) or high (250 µM) 
concentration of selenite (SeO32-) or selenomethionine (SeMet). Data are presented as mean ± 
S.E.M. (n = 4  5), where n represents the number of true independent measurements, each 
performed with cells isolated from a different fish. Mean values with different letters are 
statistically significant (p < 0.05). 
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2.3.5. Effects of selenite and selenomethionine on cadmium-induced intracellular ROS 
generation 
The fluorescence intensity from ROS generation was measured as corrected total cell 
fluorescence (CTCF) and is illustrated in Fig. 2.5 A and B. There was a significant increase in 
intracellular ROS generation in hepatocytes exposed to 100 µM cadmium alone relative to the 
control (F5,18 = 13.72; p < 0.001) (Fig. 2.5 A i and ii, and B). However, co-exposure of hepatocytes 
to cadmium with 25 µM of selenite or selenomethionine resulted in a significant decrease in 
intracellular ROS level, and no difference in ROS generation was recorded in comparison to the 
control (Fig 2.5 A iii and iv, and B). In contrast, no difference in intracellular ROS generation was 
observed between the treatments of 100 µM Cd alone, and in combination with 250 µM selenite or 
selenomethionine (Fig. 2.5 A iv and vi, and B). Intracellular ROS level remained significantly high 
in hepatocytes exposed to cadmium, with or without 250 µM selenium, relative to the control (p = 
0.001). 
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Figure 2.5:  Representative confocal fluorescent images (A) and corrected total fluorescent 
intensity (B) of isolated rainbow trout hepatocytes exposed to 100µM cadmium (Cd), alone or in 
combination with low (25µM) or high (250µM) concentration of selenite (SeO32- ) or 
selenomethionine (SeMet) for a period of 2 h. The cells were loaded with CM-H2DCFDA for 45 
min followed by exposure to various treatments. The intensity of fluorescent signals was measured 
using ImageJ software (National Institutes of Health, Bethesda, Maryland, USA). Data are 
presented as mean ± S.E.M. of average fluorescence intensity of 15–20 cells from each replicate 
and the experiment was repeated four times using four different fish. Mean values with different 
letters are statistically significant (p < 0.05). 
 
B. 
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2.4. Discussion 
In the present study, we have examined the mechanistic underpinnings of selenium-
cadmium antagonism at the cellular level in rainbow trout hepatocytes in primary culture. Two 
different seleno-compounds, selenite (inorganic) and selenomethionine (organic), over a broad 
range of exposure dose (25  500 M), were used to understand the chemical species specific and 
dose dependent effects of selenium on cadmium cytotoxicity. In general, our findings supported 
our original hypothesis that selenium, irrespective of its chemical form, ameliorated cadmium 
induced oxidative stress by augmenting cellular antioxidative machinery, albeit the protective 
effect was evident only at the lowest selenium exposure dose (25 M) used in this study. 
Our results demonstrated that a low dose of selenium (25 µM) restored the cadmium 
induced loss in cell viability, however selenium at concentrations > 50 µM did not elicit any 
protective effect. Treatment with both selenite and selenomethionine produced similar protective 
effect against the cytotoxicity of cadmium. Similar protective effects of selenite and/or 
selenomethionine (10  50 M) against cadmium-induced loss in cell viability were reported 
previously in mammalian in vitro studies with human erythroleukemia K-562 cells (Frisk et al., 
2002), and porcine LLC-PK1 renal epithelial cells (Liu et al., 2007). The findings of the present 
study are also consistent with previous in vivo observations which suggested that supplementation 
of fish diet with low to moderate levels of selenium could reduce waterborne cadmium toxicity in 
fish (Abdel‐Tawwab and Wafeek, 2010; Banni et al., 2011). Interestingly however, our study also 
revealed that an exposure to 100 µM cadmium in conjunction with the highest dose of selenite or 
selenomethionine used (500 M) was more toxic to the trout hepatocytes than 100 µM cadmium 
alone. Although selenium is an essential element and has antioxidative functions (Hamilton, 2004; 
Reich and Hondal, 2016; Schwarz et al., 1957), it can rapidly turn into a pro-oxidant when its 
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concentration exceeds a certain threshold (Hodson et al., 1983; Janz et al., 2010; Maher et al., 
2010). Previous studies have demonstrated that both selenite and selenomethionine induce 
oxidative stress and markedly decrease viability of trout hepatocytes when their exposure 
concentrations exceed 200 µM (Misra et al., 2012a; Misra and Niyogi, 2009). Thus, the co-
exposure of cadmium with selenite or selenomethionine at high dose levels elicited an additive 
adverse effect on cell viability, likely because of the oxidative stress induced by both elements. 
Previous experimental evidences suggest that one of the primary mechanisms of cadmium 
cytotoxicity is the induction of oxidative stress, mediated mainly by the depletion of glutathione 
(Macías-Mayorga et al., 2015; Mohamed et al., 2008), and increased accumulation of intracellular 
of ROS (Faverney et al., 2004; Wang et al., 2004). In our study, a complete recovery in cell viability 
was observed when the hepatocytes were exposed to cadmium in the presence of pharmacological 
antioxidants, TEMPO or NAC (Fig. 2.2). This strongly suggests that the decrease in the viability 
of trout hepatocytes exposed only to cadmium occurred due to the induction of oxidative stress. 
TEMPO and NAC are both pharmacological antioxidants, but they act through different 
mechanisms. TEMPO is known to be a ROS scavenger (Sandhir et al., 2015), whereas NAC 
restores cellular thiol redox balance by facilitating GSH synthesis (Ramen, 2015). Since both 
TEMPO and NAC were able to ameliorate cadmium induced cytotoxicity, it is reasonable to 
suggest that selenium at a low dose level (25 M) was able restore the cadmium induced loss in 
cell viability via mechanisms similar to both of these two pharmacological antioxidants. 
Analysis of the GSH:GSSG ratio in the present study revealed that exposure to 100 µM 
cadmium alone caused a significant drop in cellular thiol redox potential (Fig. 2.3). Again, a 
complete recovery of GSH:GSSG ratio was observed when trout hepatocytes were exposed to 100 
µM cadmium in conjunction with 25 µM of selenite or selenomethionine. In contrast, no significant 
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improvement in thiol redox was noticed when cells were exposed to cadmium along with higher 
concentrations of selenium, especially >100 µM (Fig. 2.3). It has been reported previously that the 
exposure to toxic concentrations of cadmium causes a decline in cellular pool of GSH and thiol 
containing proteins in mollusk (Ivanina et al., 2008; Macías-Mayorga et al., 2015), and freshwater 
fish (Hermenean et al., 2015). A dose dependent decline in GSH:GSSG ratio in response to 
cadmium exposure was also observed in a mammalian renal cell line (Nair et al., 2015). Reduced 
glutathione can scavenge free ionic species of cadmium (Cd2+), which is the main driver for 
cadmium cytotoxicity (Waisberg et al., 2003). In addition to this, the thiol group of GSH in its 
reduced state is able to donate an electron to ROS and thereby neutralize it (Wu et al., 2004). During 
this process, GSH itself becomes oxidized and readily reacts with another oxidized glutathione to 
form GSSG. Cellular pool of GSH is replenished by two cellular processes: (i) de novo synthesis 
of GSH, catalysed by γ-glutamylcysteine ligase (Quintana-Cabrera et al., 2012), and (ii) reduction 
of GSSG to GSH by glutathione reductase enzyme (Wu et al., 2004). During continuous exposure 
to cadmium, de novo synthesis of GSH by γ-glutamylcysteine ligase and GSH regeneration from 
GSSG recycling could get overwhelmed, leading to the depletion of cellular pool of GSH and build-
up of GSSG, resulting in reduced cellular thiol redox potential (Liu et al., 1990). This might have 
occurred in the present study which resulted in the reduction of GSH:GSSG ratio in trout 
hepatocytes exposed to cadmium alone. A cell with reduced redox potential is more susceptible to 
cadmium toxicity because of its negative implications on several biochemical pathways that depend 
on reduced intracellular environment (Maracine and Segner, 1998; Waisberg et al., 2003).  
Selenium, at optimal concentrations is known to upregulate de novo synthesis of GSH 
(Chung and Maines, 1981; Richie et al., 2011). An increase in GSH:GSSG ratio was reported by 
Fontagné-Dicharry et al., when rainbow trout were fed with selenomethionine/selenite 
supplemented diet (Fontagné-Dicharry et al., 2015). Moreover, it has been demonstrated by Chung 
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and Maines (1981), that selenite could upregulate the activity of γ-glutamylcysteine ligase in rat 
liver, which can lead to increased GSH synthesis. This could be a likely mechanism by which 
selenium, at a low exposure dose (25 M), was able to augment cellular GSH:GSSG ratio observed 
in the present study. The improved cellular thiol ratio, in turn, probably played an important role 
in ameliorating cadmium induced oxidative stress and loss of cell viability. On the other hand, 
exposure to high doses of selenium (both selenite and selenomethionine) can lead to a reduced thiol 
ratio (Misra et al., 2012a; Misra and Niyogi, 2009). It has been suggested that the cellular 
metabolism of selenite, when present in excess, occurs via its reaction with GSH, which leads to 
the generation of superoxide anion (O2˙-) (Lin and Spallholz, 1993; Seko et al., 1989). This causes 
a depletion of cellular GSH pool, and thereby induce cytotoxicity. In contrast, selenomethionine, 
when present in abundance, is metabolised into methylselenol by the enzyme, L-methionine-γ-
lyase. Subsequently, methylselenol undergoes redox cycling, which requires GSH, and produce 
O2˙- in the process (Misra et al., 2010). Therefore, the decrease in GSH:GSSG ratio, observed in 
the present study when trout hepatocytes were exposed to high doses of selenite or SeMet, was 
likely mediated by the cellular metabolism of selenite and SeMet, which also resulted in increased 
intracellular ROS generation and oxidative stress. 
In the present study, we analysed the activities of three major enzymatic antioxidants, SOD, 
CAT, and GPx. These enzymes represent the first line of defence against ROS. SOD is responsible 
for dismutation of O2˙- into H2O and H2O2 (Fukai and Ushio-Fukai, 2011), whereas CAT or GPx 
reduce H2O2 to non-toxic H2O and O2 (Chelikani et al., 2004; Mills, 1957). These enzymes are also 
used as oxidative biomarkers because their activities are usually induced in response to mild 
oxidative stress as a compensatory mechanism. However, a rapid increase in intracellular ROS 
generation can overwhelm the antioxidative mechanisms, resulting in the suppression of 
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antioxidant enzymes (Petersen et al., 2014). In our study, a short-term (2 h) exposure to cadmium 
was found to cause a marked increase in intracellular ROS level, which could have overwhelmed 
the cellular antioxidative response capacities, leading to an apparent decline in the activity of these 
enzymes. The reduced activities of these key antioxidative enzymes, in turn, would reduce the 
capacity to neutralize ROS, leading to various cytotoxic effects. Therefore, the suppressed activity 
of enzymatic antioxidants could be one of the major cellular implications of cadmium toxicity. 
Furthermore, metalloenzymes such as SOD, CAT and GPx require an essential metal as cofactor 
to function, and cadmium is known to inhibit metalloenzymes by substituting metal cofactors 
(Casalino et al., 1997; Martelli et al., 2006). It is possible that cadmium at the dose used in our 
study might have been able to impair the functionality of these enzymes by replacing essential 
metals from their active sites. Reduced activity of enzymatic antioxidants following exposure to 
cadmium has been reported in several in vitro mammalian studies, using hamster ovarian cell line 
(Yang et al., 1996), and in cultures of rat pneumocytes (Tátrai et al., 2001), male gonadal cells 
(Yang et al., 2003), and hepatocytes (Müller, 1986). Similarly, in vivo studies conducted with 
different mammalian and piscine species also reported decreased activities of these antioxidant 
enzymes during exposure to cadmium (Banni et al., 2011; Cao et al., 2010; Jia et al., 2011; 
Manigandan et al., 2015; Qu et al., 2014; Waisberg et al., 2003).  
We have also demonstrated in this study that a low exposure dose of selenium (25 M of 
selenite or selenomethionine) was able to alleviate the activities of these antioxidant enzymes. Our 
results are in agreement with previous in vivo studies that reported upregulation of antioxidative 
enzymes, when fish were treated with low doses of selenite (Nazıroǧlu et al., 2004; Zafar et al., 
2003). This effect is probably attributable to the role of selenium in the maintenance of enzymes 
involved in redox reactions. Selenium causes this effect indirectly through GSH, which maintains 
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the redox status of the enzymes (Arteel and Sies, 2001). As discussed previously, low concentration 
of selenium was found to increase the cellular GSH:GSSG ratio in our study. It is perhaps this 
elevated cellular thiol status that facilitated the increase of antioxidative enzyme activities. We 
have also demonstrated in this study that when hepatocytes were exposed to cadmium along with 
high selenium (250 M), no induction of antioxidant enzymes was observed. This occurred likely 
because selenium, when present in excess, can interact with the thiol moieties of antioxidative 
enzymes and impair their functions. For example, selenium, when present in high concentrations, 
has been reported to inhibit GPx activity in mammals, by the formation of selenotrisulfide (S-Se-
S), selenenylsulfide (S-Se), and diselenide bonds (Se-Se), and also by the catalysis of disulfide 
bond (S-S) (Ganther, 1999). 
As discussed above, cadmium exposure can increase intracellular ROS generation 
indirectly by depleting thiol levels as well as suppressing enzymatic antioxidants. In addition, 
cadimum is known to inhibit and uncouple complex III of the mitochondrial electron transport 
chain (ETC) and cause proton leak, which ultimately leads to the generation of ROS (Faverney et 
al., 2004; Wang et al., 2004). Inorganic cadmium can also replace essential metals like Fe, Zn, or 
Cu from various intracellular sites that binds them and keep their cytosolic concentrations low 
(Banni et al., 2011; Martelli et al., 2006). Increased concentration of these pro-oxidative metals in 
the cytosol promote generation of ROS through Fenton’s reaction (Stohs and Bagchi, 1995). It has 
been demonstrated previously that increased ROS production is linked to reduced cell viability 
(Kelts et al., 2015; Laville et al., 2004). In the present study we also demonstrated that exposure to 
cadmium significantly increased intracellular ROS production, which corresponded with a 
reduction in cell viability. However, co-exposure of 100 µM cadmium with 25 µM selenite or 
selenomethionine was found to reduce ROS production back to the level observed in the control, 
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along with a full recovery of cell viability. It is apparent that the reduction in intracellular ROS 
generation during treatment with the lowest dose of selenium occurred due to increased ROS 
scavenging capacity, as a result of elevated cellular thiol redox and antioxidative enzyme activities. 
In contrast, we found that co-exposures of cadmium with 250 µM selenite or selenomethionine did 
not alter the intracellular ROS generation as well as cell viability, relative to that in the cells 
exposed to cadmium alone. This was to be expected since high selenium treatment did not produce 
any improvement in cellular thiol redox or antioxidative enzyme activities. 
In addition to the restoration of oxidative homeostasis, selenium may also alleviate 
cadmium induced toxicity by formation of metabolic complex. For example, Gasiewicz & Smith 
(1978) demonstrated formation of Cd-Se complex by gel filtration chromatography in rat plasma 
and erythrocytes through in vivo and in vitro experiments. Formation of chemically and 
biologically inert Cd-Se complex was also reported in yeast (Saccharomyces cerevisiae) (Dauplais 
et al., 2013). However, no interaction of selenium with cadmium was noted in the absence of 
erythrocytes in vitro (Gasiewicz & Smith, 1978). Similar interactions of selenium with cadmium 
may also influence their toxicity in fish and need further exploration. 
2.5. Conclusion 
The present study demonstrated that both selenite and selenomethionine could protect the 
hepatocytes of rainbow trout against toxicity of cadmium, but this cytoprotective effect of selenium 
occurs only at a low/non-toxic exposure dose (25 µM). Cadmium was found to decrease cell 
viability, which corresponded with increased intracellular ROS generation, and decreased cellular 
thiol redox and antioxidative enzyme activities.  Selenium at a low exposure concentration was 
found to alleviate cadmium-induced intracellular ROS generation by restoring the cellular thiol 
redox potential and capacity of enzymatic antioxidants. This indicates that selenium at low 
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exposure levels could act as an antidote for cadmium poisoning in fish and potentially in other 
organisms including humans. In contrast, selenium at a high exposure dose was not found to be 
protective against cadmium toxicity, as it did not induce any change in cellular thiol redox status 
or capacity of enzymatic antioxidants to overcome the oxidative stress caused by cadmium 
exposure. Overall, our study demonstrated that the antagonistic effects of selenium on cadmium-
induced cytotoxicity occur via both enzymatic and non-enzymatic antioxidative mechanisms.
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CHAPTER 3: Dose and chemical species-specific effects of selenium against arsenite toxicity 
in cultured hepatocytes of rainbow trout (Oncorhynchus mykiss) 
 
Preface 
The aim of this chapter is to address the 2st objective of my doctoral research work which 
is to characterize the hepatic pathways by which different chemical species [inorganic 
(selenite) vs. organic (selenomethionine)] and exposure dose of selenium modulate arsenite 
induced oxidative stress at the cellular level. The hepatocytes of rainbow trout in primary culture 
were used to determine the mechanistic basis of interactions between selenium and arsenite without 
systemic interference. 
The content of Chapter 3 was reprinted (adapted) from Metallomics, (DOI: 
10.1039/C7MT00006E) A. Jamwal, and S. Niyogi, “Dose and chemical species-specific effects of 
selenium against arsenite toxicity in cultured hepatocytes of rainbow trout (Oncorhynchus 
mykiss)”. Copyright 2017, with permission from Royal Society of Chemistry. 
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3.1. Introduction 
Arsenic (As) is a highly toxic element that occurs ubiquitously in Earth’s crust, usually in 
conjunction with sulphur and metals (Kumagai and Sumi, 2007). It ranks first on the Superfund list 
of hazardous substances (ATSDR, 2016) and is also listed as a group 1 carcinogen by the 
International Agency for Research on Cancer (IARC, 2016). Arsenicosis or arsenite poisoning 
usually occurs through contaminated water which is a serious environmental concern because of 
large number of contaminated sites present in many parts of the world (Smedley and Kinniburgh, 
2002). Toxicity of arsenic in humans and animals is usually exhibited through a variety of health 
effects including dysfunction of critical enzymes and cellular damage.  
It is generally believed that arsenic, especially in its trivalent form (arsenite; As-III), causes 
toxicity primarily by inducing reactive oxygen (ROS) reactive nitrogen species (RNS) generation, 
which eventually leads to the disruption cellular redox homeostasis (Flora, 2011; Shi et al., 2004). 
Although the reasons underlying the arsenic-mediated ROS and RNS production are not fully 
understood, it has been suggested that this occurs as a result of arsenic-induced changes in the 
structure of mitochondrial membrane and subsequent disruption of membrane redox potential 
(Valko et al., 2015). The cellular pathways regulated by flavin enzymes (e.g., NAD(P)H oxidase, 
and NO synthase isozymes) have also been suggested to generate ROS and RNS during arsenic 
exposure (Kumagai and Sumi, 2007; Shi et al., 2004). In addition to increased ROS and RNS 
generation, arsenic exposure results in impaired activities of redox active peptides and enzymes 
such as glutathione (GSH), superoxide dismutase (SOD), glutathione peroxidase (GPx), 
glutathione reductase (GR), glutathione–S-transferase (GST), and catalase (CAT), which can 
further add to the severity of oxidative stress (Flora, 2011). Arsenite is also known to inhibit the 
activity of redox active biomolecules by binding to the functional sulfhydryl groups (Shen et al., 
2013). 
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Similar to many other trace elements, toxicity of arsenite may also be influenced by the 
crosstalk of intra-cellular pathways involved in the metabolism and regulation of other essential 
and non-essential elements. These intracellular interactions, depending on the dose of interacting 
elements in the exposure, may either antagonize or accentuate the toxic effects of each other. 
Previous studies in mammalian systems suggest that selenium (Se) is one such important essential 
element, which can influence the metabolism and toxicity of arsenite (Davis et al., 2000; Levander, 
1977; McIntyre and Linton, 2012), although the mechanistic underpinnings of such interactions 
are yet to be fully understood. Moreover, the cellular and physiological implications of selenium-
arsenic interactions have been examined sporadically in non-mammalian organisms, particularly 
in aquatic organisms such as fish (Babich et al., 1989; Selvaraj et al., 2012). The significance of 
examining the cellular interactions of selenium and arsenite in fish can be emphasized by the fact 
that they possess the largest and most diverse selenoproteome (Lobanov et al., 2008). Lobanov et 
al. (2009) conducted a phylogenetic analysis of selenoproteins and suggested that  in the terrestrial 
animals some of the organoselenium moieties were substituted by cysteine-containing homologues 
in order to reduce the reliance on the trace elements (Lobanov et al., 2009). Fish is more dependent 
on selenoproteins than mammals to maintain redox balance in the body, and thus have a much 
greater physiological requirements of selenium (Lobanov et al., 2009; Mariotti et al., 2012). The 
physiological roles of many selenoproteins in fish are still unknown, nonetheless it has been 
established that selenium lends the peroxidase activity to the enzymes, which is why selenoproteins 
play a critical role in the maintenance of cellular redox balance (Reich and Hondal, 2016). 
Selenium exists in the environment in both organic and inorganic forms (Maher et al., 
2010). Selenite (SeO32-) is usually the most abundant water soluble inorganic form under normoxic 
conditions, whereas selenomethoinine (SeMet) comprises the most common organic form of 
selenium that is predominantly available to fish through diet (Maher et al., 2010). Although the 
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antioxidative properties of both inorganic and organic selenium have been demonstrated previously 
(Selvaraj et al., 2013b; Xu et al., 2013), the potential mechanisms by which selenium modulates 
the activities of key enzymatic and non-enzymatic antioxidants remain unclear. Furthermore, the 
anti-oxidative role of selenium is strictly dose dependent, and when present (both as selenite and 
SeMet) above the physiological threshold level, can itself turn into a pro-oxidant and induce 
oxidative stress (Jamwal et al., 2016; Misra et al., 2012a; Misra and Niyogi, 2009; Wallenberg et 
al., 2014). Moreover, the metabolism of organic and inorganic selenium, particularly when present 
in excess, occurs via different cellular pathways (Misra et al., 2010; Seko et al., 1989). Thus, it can 
be assumed that the interaction of selenium and arsenite can be influenced by both the dose and 
chemical speciation of selenium in the exposure. Although the dose and chemical species-specific 
ameliorative effects of selenium against arsenite cytotoxicity have been reported sporadically in 
mammalian systems (Alp et al., 2011; Rossman and Uddin, 2004), such investigations have not 
been performed in any non-mammalian models including fish. Given the greater physiological 
essentiality of selenium and its important role in maintaining redox homeostasis in fish, selenium 
and arsenite interactions in fish may elicit different cellular responses compared to the mammals, 
and thus requires an in-depth investigation.   
The present study was designed to carry out an in-depth examination of how the dose and 
chemical speciation of selenium affect the cytotoxicity of arsenite in a model freshwater fish, 
rainbow trout (Oncorhynchus mykiss). In particular, we focused on identifying the specific 
antioxidative pathways by which inorganic or organic selenium (selenite or SeMet, respectively) 
moderates arsenite cytotoxicity. Rainbow trout hepatocytes in primary culture were employed as 
the in vitro experimental system in the present study, because hepatocytes are the main functional 
units of the liver - the primary site of selenium and arsenite metabolism in animals (Sun et al., 
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2014). We hypothesized that selenium will influence arsenite cytotoxicity, but in a dose-specific 
manner with antagonistic interactions occurring only at low to intermediate exposure levels.  
3.2. Methods 
3.2.1. Chemicals 
High purity, cell culture tested sodium selenite (Na2SeO3, purity ~ 98%), seleno-L-
methionine (purity>98%), non-enzymatic cell dissociation solution (catalogue# C1419), CelLytic 
MTTM solution, Dulbecco’s phosphate buffered saline, L-15 medium (Leibovitz), 3-amino-1,2,4-
triazole (ATA), buthionine sulfoximine (BSO), diethyldithiocarbamic acid sodium salt trihydrate 
(DETC), mercaptosuccinic acid (MS), and trichloroacetic acid (TCA) were purchased from Sigma 
Aldrich, USA. Antibiotic and antimycotic solution, were purchased from Invitrogen, Canada. 
AquacalmTM (Metomidate hydrochloride) was purchased from Syndel Laboratories Ltd, Canada. 
All other chemicals, including sodium arsenite (NaAsO2), were purchased from VWR 
International, Canada. 
3.2.2. Experimental animals 
Rainbow trout (Oncorhynchus mykiss), weighing 600  700 g were used for the 
experiments. Fertilised eggs from reference rainbow trout females were hatched in the Department 
of Biology, University of Saskatchewan. The juveniles were reared on a ration of 2 % body weight 
until they attained 600  700 g. Dechlorinated Saskatoon City water with a flow rate of 2 l min-1 
under constant aeration was used for husbandry. A photoperiod of 16 h light: 8 h dark and a water 
temperature of 12 ± 1 oC was maintained during the rearing period. 
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3.2.3. Hepatocyte culture and experimental treatments 
Trout hepatocytes were isolated using a two-step collagenase perfusion technique as 
described elsewhere (Jamwal et al., 2016). Following isolation, the cells were plated in a 6-well 
Primaria plates (BD Falcon, USA) at a density of 0.3 x 106 cells per cm2 and incubated in the dark 
at 15 oC for 24 h using a low temperature incubator (Fisher Scientific, Canada), to form a monolayer 
before their use in the experiment.  
Initially, to determine the dose-dependent effect of arsenite on cell viability, the hepatocytes 
were exposed only to an increasing concentration range of arsenite (0  500µM). Following 24 h 
of culture, the media from the culture plates was aspirated out and the hepatocytes were exposed 
to fresh media spiked with different concentrations of arsenite (as sodium arsenite) for 24 h. A 
consistent 40 % reduction in cell viability (61 % ± 6.08) was observed at the concentration of 100 
µM arsenite (n = 5; supplementary data, Fig. C3.S1). This concentration was therefore chosen for 
all the subsequent experiments described below. 
To determine the influence of selenium on arsenite-induced cytotoxicity, hepatocytes were 
exposed to freshly prepared solutions of 100 µM arsenite, independently or in combination with 
different concentrations (5, 10, 20, and 40 µM) of selenite (SeO32-) or selenomethionine (SeMet) 
for 24 h. The hepatocytes were also exposed to the exposure media spiked solely with 5 – 40 µM 
of selenite or selenomethinine for 24 h to evaluate the independent effects of selenium on the 
hepatocyte viability. The hepatocytes in the control group were treated with a similar change in 
media without any added arsenic or selenium. The exposure dose levels of selenium (5 – 40 µM) 
was selected on the basis of our preliminary experiments which demonstrated that the combination 
of 100 µM arsenite and >40 µM selenite or selenomethionine either did not affect arsenite 
cytotoxicity or was more toxic to the hepatocytes than 100 µM arsenite alone (see supplementary 
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data, Fig. C3.S2 A & B). The osmolality of the exposure media was measured using a 5100C 
vapour pressure osmometer (Wescor Inc., USA), and no significant change was recorded in any 
treatment due to the addition of NaAsO2, selenite or selenomethionine. At the end of the exposure 
period, cells were gently harvested from the culture plate using a non-enzymatic cell dissociation 
solution. Cell viability was measured immediately by the trypan blue exclusion test using the 
Countess Automated Cell Counter (Invitrogen, Canada). The experiment was performed five times 
using hepatocytes isolated from an individual fish at each time. 
3.2.4. Processing of treated hepatocytes for bio-chemical measurements 
For the measurement of biochemical end-points, the harvested cells were centrifuged at 500 
x g for 5 min and washed three times with Dulbecco’s Phosphate Buffer Saline and then lysed with 
1000 µl of CelLytic-M reagent. The lysate was centrifuged at 25,000 x g for 20 min at 4 oC to pellet 
the cellular debris. The supernatant was collected and stored at -80 oC for the enzymatic analysis. 
For the measurements of oxidized (GSSG) and reduced glutathione (GSH), the cells were also 
lysed as mentioned before. From the cell lysate 20 µl was taken for estimation of protein content 
by the Bradford method (Bradford, 1976). The remaining cell lysate was immediately deproteinised 
with 100 µl of 5% TCA. The deproteinised solution was then centrifuged at 12,000 x g at 4 oC for 
25 min to pellet cellular debris. The supernatant was collected and split into two fractions (500 µl 
each). One fraction was stored as such at -80 oC for the measurement of reduced glutathione (GSH). 
A 20 µL aliquot of 0.04 M of N-ethylmaleimide was added immediately to the other fraction to 
prevent the oxidation of GSH, and stored at -80 oC for the measurement of oxidised glutathione 
(GSSG). 
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3.2.5. Measurement of cellular thiol redox balance (GSH:GSSG ratio) 
The concentration of the reduced (GSH) and oxidized (GSSG) glutathione, as an estimate 
of cellular redox balance, was measured using a fluorometric method (Hissin and Hilf, 1976), 
modified to a 96-well microplate based assay. A calibration standard curve was prepared from 
commercially purified GSH and GSSG and used to confirm the linearity of the reaction rate in the 
adopted method. The final reaction mixture (200 µl) for the measurement of GSH contained 180 
µl of phosphate–EDTA buffer (0.1 M sodium phosphate–0.005 M EDTA, pH 8.0), 10 µl of o-
Phthalaldehyde (OPT, 100 µg per 100 µl methanol) and 10 µl of sample. The reaction mixture was 
incubated at room temperature for 15 min before measuring the fluorescence at excitation and 
emission wavelengths of 350 nm and 450 nm, respectively in a multimode microplate reader 
(Varioskan Flash, Thermo Fisher Scientific, Finland). The GSH content was expressed as µg per 
mg of protein. GSSG was measured in the same way except that the final reaction mixture volume 
contained 140 µl of 0.1 N NaOH, 20 µl of o-Phthalaldehyde (OPT, 100 µg per 100 µl methanol) 
and 40 µl of sample. The GSSG content was also expressed as µg per mg of protein. Finally, the 
GSH:GSSG ratio was obtained by dividing GSH concentration with its corresponding GSSG 
content. 
3.2.6. Measurement of antioxidant enzyme activities 
We measured the activities of three antioxidant enzymes, superoxide dismutase (SOD, 
catalase (CAT), and glutathione peroxidase (GPx), in 96-well microplates using a multi-well plate 
reader (Varioskan Flash, Thermo Electron Corporation,Finland). The enzyme activities were 
measured using SOD (Catalogue #706002), CAT (Catalogue #707002), and GPx (Catalogue 
#706002) activity kits as per the manufacturer’s (Cayman chemical company, USA) instructions. 
SOD activity was expressed as U/mg protein. One unit (U) of SOD is defined as the amount of 
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enzyme needed to exhibit 50% dismutation of the superoxide radical. Activities of CAT and GPx 
were expressed as nmol min-1 mg protein-1. 
3.2.7. Measurement of intracellular reactive oxygen species (ROS) generation using 
Confocal Microscopy 
The effect of selenite and selenomethionine on ROS production in hepatocytes exposed to 
100 µM arsenite was examined as described in Jamwal et al., (2016) using 50,6-chloromethyl-
20,70-dichlorodihydro-fluorescein diacetate (CM-H2DCFDA) as an ROS sensitive probe (Jamwal 
et al., 2016). A 2mM stock solution of the ROS sensitive dye was prepared by dissolving CM-
H2DCFDA in anhydrous dimethylformamide (DFO). The dye was protected from direct light 
during all the stages of preparation and exposure. From the stock, 5 µM working solution was 
prepared in L-15 media for use in the experiments. Final concentration of DFO in the exposure 
media was less than 1% (v/v). For this experiment, hepatocytes were cultured on glass bottom 
dishes coated with poly-D-lysine (Mat Tek Corporation, USA) for 24 h to form a monolayer. The 
24 h culture was then pre-incubated with 5 µM of CM-H2DCFDA for 45 min at 15 oC and washed 
three times with L-15 media that did not contain phenol red. This step was performed to remove 
the background fluorescence from phenol red and unabsorbed dye. Subsequently, the hepatocytes 
were exposed to media containing 100 µM arsenite, alone or in combination with a low 
concentration (20 µM selenite or 10 µM selenomethionine) or a high concentration (40 µM) of 
selenite or selenomethionine for 2 h. An exposure period of 2 h was employed instead of 24 h, to 
capture the early effects of treatments when most hepatocytes were under oxidative stress but still 
viable. At the end of the exposure period, the intensity of fluorescence due to intracellular ROS 
production was measured at room temperature (21 oC) using the 488 nm excitation Argon laser 
beam, and the emission was collected using 505 – 530 nm band pass filter of the confocal 
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microscope (Zeiss Axiovert LSM 510 Meta Confocal System, Carl Zeiss, Germany). Similar 
microscopic settings for the imaging were maintained throughout the experiment to allow for 
conformity of the results.  
ImageJ software (National Institutes of Health, Bethesda, Maryland, USA) was used to 
quantify the fluorescence intensity of the cells. Integrated density of all the cells under the view of 
microscope was measured from which mean background intensity was subtracted. The final 
fluorescent intensity was expressed as corrected total cell fluorescence (CTCF) using the following 
formula: 
CTCF = Integrated Density - (Area of selected cell X Mean fluorescence of background readings) 
3.2.8. Pharmacological treatments 
Pharmacological antioxidants, (2,2,6,6-tetramethylpiperidin-1-yl) oxidanyl (TEMPO) and 
N-acetyl-L-cysteine (NAC), were used to compare with the antioxidative effects of Se in trout 
hepatocytes. Hepatocytes were exposed to 100 µM arsenite, alone or in combination with isomolar 
concentrations of TEMPO or NAC for 24 h, as described previously for exposures with selenium. 
At the end of the exposure, cells were harvested and cell viability was assessed as described before. 
We also examined the effects of specific enzyme inhibitors to understand the role of GSH 
and antioxidative enzymes (CAT, SOD, and GPx) in mediating the antagonistic effects of selenium 
against arsenite-induced oxidative stress. Since we observed that 20 µM selenite or 10 µM 
selenomethionine were most protective against the cytotoxicity of 100 µM arsenite (see Fig. 1. B, 
C.), only these two concentrations were used in these assays. Trout hepatocytes were pre-exposed 
to 1000 µl of media containing 1 mM concentration of one of the following inhibitors: BSO (GSH 
inhibitor), ATA (Catalase inhibitor), DETC (SOD inhibitor), or MS (GPx inhibitor). Pre-incubation 
ensured the loading of cells with inhibitors before the main treatment, and thus prevented the 
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interference from housekeeping concentrations of the target enzymes. After 2 h of incubation in 
dark, 1000 µl of media was added that contained 200 µM arsenite and 40 µM selenite or 20 µM 
selenomethionine. Therefore, the composition of final incubation media was 0.5 mM inhibitor, 100 
µM arsenite, and 20 µM selenite or 10 µM SeMet. The hepatocytes were then incubated for 24 h 
in the final incubation media. At the end of the exposure period, the hepatocyte viability was 
assessed as described previously. A positive control experiment was also conducted to examine the 
efficacy of the anti-oxidative enzymes inhibitors. The hepatocytes were incubated with 0.5 mM 
ATA, DETC or MS for 24 h, after which the hepatocytes were processed and the activities of the 
enzymes were measured using the procedures mentioned previously. 
3.2.9. Statistical analysis 
All statistical analyses were performed using the IBM SPSS statistical software package 
(Version 20.0.0) and graphs were plotted with SigmaPlot (version 12, Systat Software, Inc., USA). 
The data are presented as mean ± standard error of mean (S.E.M.). Sample size ‘n’ indicates the 
number of true independent evaluations, each conducted with cells isolated from a different fish. 
Interactive effects of selenium and arsenite on hepatocyte viability were analysed by two-factor 
analysis of variance (2-WAY ANOVA). Interactive effects of selenium, arsenite and enzyme 
inhibitors were analysed by three-way analysis of variance (3-WAY ANOVA). Estimation of the 
effects of treatments on enzyme activities, GSH:GSSG ratio, and CTCF involved manipulation of 
only selenium as an independent variable, therefore significant differences among the treatment 
groups were analyzed by one-way analysis of variance (1-WAY ANOVA) followed by Tukey’s 
multiple comparison test (SigmaPlot, version 11, Systat Software, Inc., USA). The positive 
controls (inhibitors of anti-oxidative enzymes) were compared to the true controls (without the 
inhibitors) by t-test. The assumptions of ANOVA, normality of distribution and homogeneity of 
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variances, were verified using the Shapiro-Wilk and Levene’s tests, respectively.  A p-value of ≤ 
0.05 was considered to be significant while comparing different treatments. 
3.3. Results 
3.3.1. Effects of selenite and selenomethionine on arsenite-induced cytotoxicity 
There was no significant effect of independent Se treatments (5-40 µM selenite or SeMet) 
on cell viability (p > 0.05; Fig. 3.1 A). However, there was a statistically significant interaction 
between arsenite and selenite (but not with selenomethionine) on hepatocyte viability (2-way 
ANOVA; F4,40 = 3.43; p = 0.02). Exposure to only 100 µM arsenite significantly reduced (36%) 
cell viability in comparison to the control (p<0.001). Co-treatment with arsenite and selenium 
(selenite or selenomethionine) ameliorated arsenite cytotoxicity, but only at moderate selenium 
concentrations used in this study, with no effect at low or high Se exposure levels (Fig. 3.1 B and 
C). For example, an exposure to 10 and 20 µM selenite in conjunction with 100 µM arsenite 
significantly improved cell viability [14% (p = 0.02) and 23% (p < 0.001), respectively] relative to 
that in the 100 µM arsenite only treatment, however no such effect was observed during co-
treatment with 5 or 40 µM selenite (Fig. 3.1 B). Similarly, a combined treatment of 10 µM 
selenomethionine and 100 µM arsenite significantly improved cell viability (14%) in comparison 
to that in the 100 µM arsenite only treatment (p = 0.03), but no protective effect against arsenite 
cytotoxicity occurred during co-treatment with 5, 20 or 40 µM selenomethionine (Fig. 3.1 C).
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Figure 3.1: Changes in the viability of rainbow trout hepatocytes when exposed to (A) only 5µM – 40µM selenite or selenomethionine 
(SeMet); (B) 100µM arsenite (As), alone or in combination with different concentrations (5µM – 40µM) of selenite, or (C) 100µM 
arsenite, alone or in combination with different concentrations (5µM – 40µM) of selenomethionine. Data are presented as mean ± S.E.M. 
(n = 5), where n represents the number of true independent measurements, each performed with cells isolated from a different fish. 
Different alphabetical notations on the bars indicate statistical differences between groups of means (p < 0.05) as determined by ANOVA 
and post-hoc test. 
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3.3.2. Effects of selenite and selenomethionine on arsenite-induced intracellular ROS 
generation 
Intensity of green fluorescence from CM-H2DCFDA, which is proportional to the extent of 
intracellular ROS generation, was measured as the corrected total cell fluorescence (CTCF), and is 
presented in Fig. 3.2 A and 3.2 B. There was an overall significant effect of treatments on 
intracellular ROS generation in the hepatocytes (F5,24 = 13.7; p < 0.001). An exposure to 100 µM 
arsenite resulted in a significant increase in CTCF relative to the control (p < 0.001). However, the 
co-exposure of hepatocytes to 100 µM arsenite and 20 µM selenite or 10 µM selenomethionine 
resulted in a significant decrease in the intracellular ROS production in comparison to that in the 
100 µM arsenite only treatment (Fig. 3.2 A iii and v, and 3.2 B). In contrast, no significant decrease 
in intracellular ROS production was recorded in trout hepatocytes during co-exposure with 40 µM 
selenite or SeMet (Fig. 3.2A iv and vi, and 3.2 B). 
3.3.3. Effects of pharmacological antioxidants on arsenite-induced cytotoxicity 
The effect of pharmacological antioxidants on arsenite-induced cytotoxicity are illustrated 
in Fig. 3.3. Exposure of hepatocytes to 100 µM arsenite, independently or with equimolar 
concentration of pharmacological antioxidants had a significant influence on their viability (F3,16 = 
46.4; p <0.001). An independent exposure to 100 µM arsenite reduced cell viability by 40 % (p < 
0.001) relative to the control. Pharmacological anti-oxidants, however, significantly decreased the 
toxicity of arsenite in trout hepatocytes. Co-treatment of hepatocytes to 100 µM TEMPO with an 
equimolar concentration of arsenite significantly improved the cell viability relative to the 
hepatocytes treated exclusively with 100 µM arsenite (p < 0.001). NAC was also found to 
significantly increase the viability of arsenite-exposed cells (p = 0.01), although the effect was not 
as strong as that of TEMPO. 
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Figure 3.2: Representative confocal fluorescent images (A) and corrected total fluorescent 
intensity (B) of isolated rainbow trout hepatocytes exposed to 100µM arsenite (As), alone or in 
combination with low (10-20µM) or high (40µM) concentration of selenite (SeO32-) or low 
selenomethionine (SeMet) for a period of 2 h. The cells were loaded with CM-H2DCFDA for 45 
min followed by exposure to various treatments. The intensity of fluorescent signals (green colour) 
was measured using ImageJ software (National Institutes of Health, Bethesda, Maryland, USA). 
Data are presented as mean ± S.E.M. of average fluorescence intensity of 15–20 cells from each 
replicate and the experiment was repeated four times using four different fish. Different 
alphabetical notations on the bars indicate statistical differences between groups of means (p < 
0.05) as determined by ANOVA and post-hoc test. 
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Figure 3.3: Changes in cell viability when rainbow trout hepatocytes were exposed to 100μM As, 
alone or in combination with pharmacological antioxidants, TEMPO (100μM) or NAC (100μM). 
Data are presented as mean ± S.E.M. (n = 5), where n represents the number of true independent 
measurements, each performed with cells isolated from a different fish. Different alphabetical 
notations on the bars indicate statistical differences between groups of means (p < 0.05) as 
determined by ANOVA and post-hoc test. 
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3.3.4. Effects of selenite and selenomethionine on arsenite-induced changes in cellular thiol 
redox balance 
Exposure to arsenite, alone or in combination with selenium, significantly influenced 
intracellular thiol content and ratio in the trout hepatocytes (p<0.001; Fig. 3.4 A, and 3.4 B). 
Exposure to arsenite only caused 83% reduction in GSH content, in comparison to the control (Fig. 
3.4 A). However, co-exposure to 10 and 40 µM selenite with 100 µM arsenite resulted in a 
significant increase in the intracellular GSH concentration in comparison to 100 µM arsenite only 
treatment (p<0.001; Fig. 3.4 A). A consistent increase in intracellular GSH content was also 
observed when hepatocytes were co-treated with 5  40 µM selenomethionine and 100 µM arsenite 
(p < 0.001. Fig. 3.4 A). The hepatic GSSG content was very low in comparison to the GSH and 
ranged from 1.8 to 8.1 µg mg protein-1. The intracellular GSSG concentration was almost 50 % 
lower in the hepatocytes treated with only 100 µM arsenite, in comparison to the control (Fig. 3.4 
A). Nevertheless, due to high variation in the GSSG content of the control hepatocytes, this change 
was not statistically significant (p = 0.93; Fig. 3.4 A). The GSSG content in the hepatocytes treated 
with 20 and 40 µM selenite, in combination with 100 µM arsenite, increased by up to 10 folds than 
the cells treated with 100 µM arsenite alone (p < 0.005). Similarly, in comparison to the 100 µM 
arsenite only treatment, the GSSG content was significantly elevated in the hepatocytes co-treated 
with 10  40 µM selenomethionine and 100 µM arsenite (p < 0.02). With respect to the GSH to 
GSSG ratio, exposure to arsenite alone caused a 70 % reduction in the ratio, in comparison to the 
control (p < 0.001; Fig. 3.4 B). Co-exposure to 5 and 10 μM selenite with 100 μM arsenite elevated 
thiol ratio by 30 % and 40 % respectively, in comparison to 100 μM arsenite only treatment (p < 
0.03). Similarly, co-exposure to 5 μM selenomethionine and 100 μM arsenite increased thiol ratio 
by 40 % in comparison to 100 μM arsenite alone treatment (p < 0.03). However, selenite at 
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concentrations ≥ 20 μM as well as selenomethionine at concentrations ≥ 10 μM did not alter the 
arsenite-induced decrease in thiol ratio (p > 0.05).
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Figure 3.4: Changes in cellular thiol content (A), and thiol redox status, expressed as a ratio of reduced (GSH) to oxidized (GSSG) 
glutathione (B), in rainbow trout hepatocytes exposed to 100μM arsenite (As), alone or in combination with different concentrations 
(5μM – 40μM) of selenite (SeO32-) or selenomethionine (SeMet). Data are presented as mean ± S.E.M. (n = 5), where n represents the 
number of true independent measurements, each performed with cells isolated from a different fish. Different alphabetical notations on 
the bars indicate statistical differences between groups of means (p < 0.05) as determined by ANOVA and post-hoc test.
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3.3.5. Effects of selenite and selenomethionine on arsenite-induced changes in antioxidative 
enzyme activities 
Arsenite exposure, independently or in combination with selenite, significantly influenced 
the activity of SOD enzyme (F5,24 = 6.6; p = 0.001; Fig. 3.5 A). Exposure to arsenite alone inhibited 
the activity of SOD by 39 % in comparison to the control (p < 0.001). A complete recovery in the 
activity of SOD was recorded when the hepatocytes were exposed to 100 µM arsenite in 
combination with 10 µM selenite, however this effect of selenite against arsenite was not observed 
at concentrations above or below 10 µM (Fig. 3.5 A). We did not observe any significant effect of 
selenomethionine, at any concentration tested, on arsenite-induced inhibition of SOD activity 
(p>0.05; Fig. 3.5 B). 
Exposure of hepatocytes to 100 µM arsenite alone resulted in a significant reduction (25 
%) in the activity of GPx enzyme in comparison to the control (F5,24 = 5.6; p = 0.001; Fig. 3.6). Co-
exposure of 100 µM arsenite and 5-10 µM selenite did not have any effect on GPx activity relative 
to that in 100 µM arsenite alone (p < 0.38; Fig. 3.6 A). However, the GPx activity was restored 
back to the control level when the cells were co-exposed to arsenite with 20-40 µM selenite (Fig. 
3.6 A). SeMet also ameliorated the reduction in GPx activity caused by arsenite exposure (F5,24 = 
5.9; p = 0.001; Fig. 3.6 B). A complete restoration of GPx activity was observed when the cells 
were exposed to 5 µM selenomethionine in combination with 100 µM arsenite (Fig. 3.6 B), 
however this protective effect was not particularly evident at concentrations of 10 µM 
selenomethionine (Fig. 3.6 B). 
Both selenite and selenomethionine had similar effects on the arsenite-induced changes in 
CAT activity. Arsenite exposure, independently or in combination with selenium, had a significant 
effect on the activity of CAT enzyme (F5,24 = 26.3; p < 0.001; Fig. 3.7). A significant upregulation 
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in the activity of CAT, in comparison to the control, was observed when the hepatocytes were 
exposed exclusively to 100 µM arsenite (p < 0.001). However, exposure to selenite or 
selenomethionine, irrespective of their exposure concentrations (5  40 µM), resulted in a 
consistently significant suppression of arsenite-induced increase in CAT activity, although it was 
still relatively higher than the control (Fig. 3.7 A and 3.7 B).  
3.3.6. Effects of the pharmacological inhibitors of the antioxidative enzymes (CAT, SOD, 
and GPX) and GSH on the viability of hepatocytes and the activities of the enzymes 
Effects of the anti-oxidative enzymes and GSH inhibitors on the viability of trout 
hepatocytes exposed to arsenite in combination with the most protective levels of selenite (20 µM) 
and selenomethionine (10 µM) are presented in Fig. 3.8. Exposure to the pharmacological 
inhibitors of the anti-oxidative enzymes alone led to a marginal (10-20%) decrease in the viability 
of hepatocytes, in comparison to the control (p<0.001; supplementary data, Fig C3.S3). Although 
all the pharmacological inhibitors used in this study eliminated the protective effect of 20 µM 
selenite against the toxicity of 100 µM arsenite (p < 0.05), the effect of DETC (SOD inhibitor) was 
most pronounced since the cell viability decreased further than that in the arsenite only exposure 
(Fig. 3.8). In contrast, the protective effect of selenomethionine against the arsenite-induced loss 
of cell viability was eliminated by BSO, DETC and MS (p < 0.05), but was not influenced by ATA 
at all (p > 0.05; Fig. 3.8). The GPx inhibitor MS elicited the maximum response as the loss in cell 
viability was even greater than that observed with exposure to 100 µM arsenite alone. The 
pharmacological inhibitors also reduced the activities of their respective enzymes (p<0.001; 
supplementary data, Table C3.A1). The activity of CAT was reduced by 37 %, in comparison to 
the control, by 0.5 mM ATA (p < 0.05). Similarly, DETC, and MS also reduced the activities of 
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SOD and GPx by 47.3 % and 42.7 %, respectively, relative to the control (p<0.001; supplementary 
data, Table C3.A1).
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Figure 3.5: Changes in activities of superoxide dismutase (SOD) in rainbow trout hepatocytes upon exposure to 100μM arsenite (As), 
alone or in combination with different concentrations (5μM – 40μM) of A. Selenite (SeO32-), or B. Selenomethionine (SeMet). Data are 
presented as mean ± S.E.M. (n = 5), where n represents the number of true independent measurements, each performed with cells isolated 
from a different fish. Different alphabetical notations on the bars indicate statistical differences between groups of means (p < 0.05) as 
determined by ANOVA and post-hoc test. 
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Figure 3.6: Changes in activities of glutathione peroxidase (GPx) in rainbow trout hepatocytes upon exposure to 100μM arsenite (As), 
alone or in combination with different concentrations (5μM – 40μM) of A. Selenite (SeO32-), or B. Selenomethionine (SeMet). Data are 
presented as mean ± S.E.M. (n = 5), where n represents the number of true independent measurements, each performed with cells isolated 
from a different fish. Different alphabetical notations on the bars indicate statistical differences between groups of means (p < 0.05) as 
determined by ANOVA and post-hoc test. 
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Figure 3.7: Changes in activities of catalase (CAT) in rainbow trout hepatocytes upon exposure to 100μM arsenite (As), alone or in 
combination with different concentrations (5μM – 40μM) of A. Selenite (SeO32-), or B. Selenomethionine (SeMet). Data are presented as 
mean ± S.E.M. (n = 5), where n represents the number of true independent measurements, each performed with cells isolated from a different 
fish. Different alphabetical notations on the bars indicate statistical differences between groups of means (p < 0.05) as determined by ANOVA 
and post-hoc test.
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Figure 3.8: Changes in cell viability when rainbow trout hepatocytes were exposed to 100μM 
arsenite (As), alone or in combination with 20 μM selenite (SeO32-) or 10 μM selenomethionine 
(SeMet), and inhibitors of anti-oxidative enzymes. Data are presented as mean ± S.E.M. (n = 5), 
where n represents the number of true independent measurements, each performed with cells 
isolated from a different fish. Different alphabetical notations on the bars indicate statistical 
differences between groups of means (p < 0.05) as determined by ANOVA and post-hoc test. 
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3.4. Discussion 
To the best of our knowledge, the current study is first to examine how arsenite cytotoxicity 
is modulated not just by the dose but by the chemical speciation of selenium as well in a non-
mammalian model experimental system. The main objective of our study was to unravel the 
cellular pathways involved in the ameliorative effects of selenium against arsenite-induced 
cytotoxicity using the primary cultures of rainbow trout hepatocytes as the experimental model. 
Both inorganic (selenite) and organic (selenomethionine) selenium were used at 5  40 µM 
concentrations to evaluate the dose and chemical species dependent effects of selenium. Our study 
revealed that both selenite and selenomethionine were able to ameliorate the toxicity of arsenite 
(100 µM) in trout hepatocytes. Interestingly, though, the protective effects of selenite and 
selenomethionine were observed only at specific exposure concentrations. For example, selenite at 
concentrations <10 µM and > 20 µM did not provide any protective effects against arsenite 
cytotoxicity, whereas selenomethionine did not elicit any ameliorative effects at concentrations 
over 10 µM. Similar to the observations in the current study, both selenite and selenomethionine 
were also found to ameliorate cadmium toxicity in rainbow trout hepatocytes in a dose-specific 
manner, with no protective effects at >25 µM Se concentrations (Jamwal et al., 2016). It is to be 
noted though that treatment with selenite and selenomethionine resulted in a partial recovery of 
arsenite-induced cell viability in the current study, whereas it produced a complete recovery of cell 
viability in trout hepatocytes exposed to 100 µM cadmium for 48 h. This suggests that arsenite 
may cause cytotoxicity not just by inducing oxidative stress, but other pathway(s) likely contributes 
to its toxicity as well.   
Protective effects of selenium against arsenite cytotoxicity have also been reported 
previously in different in vitro mammalian experimental models. Antagonistic effects of selenium 
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on arsenite toxicity were demonstrated in human malignant skin and renal cells (Chitta et al., 2013; 
Wang and Guo, 2011). Similar observations were also reported in rat kidney cells where selenium 
ameliorated the toxic effects of arsenic (Berry and Galle, 1994). A couple of previous studies have 
also provided evidence of antagonism between selenium (only as selenite) and arsenite in piscine 
experimental models. Babich et al. (1989) examined selenium-arsenite interactions in fibroblastic 
cell line of a Bluegill (Lepomis macrochirus), where partial protective effects of selenite against 
arsenite cytotoxicity were observed over an exposure period of 24 h. Similar in vitro protective 
effects of selenite (1, and 5 µM) against 100 µM arsenite cytotoxcity were also reported in teleost 
hepatocellular carcinoma line 1 during an exposure period of 20 h (PLHC-1) (Selvaraj et al., 2012). 
However, the present study provides the first evidence of similar ameliorative effect of 
selenomethionine, which is the predominant form in which fish acquire selenium (Janz, 2012; 
Maher et al., 2010), against arsenite cytotoxicity in fish. In the present study, we demonstrated that 
selenite was more protective than selenomethionine against arsenite cytotoxicity in trout 
hepatocytes (Fig. 3.1 B and 3.1 C). Rossman and Udin (2004) also examined the protective effects 
of selenite and selenomethionine, at comparable exposure dose levels as used in the present study 
over an expoure period of 6 weeks, and found that selenite was more protective than 
selenomethionine against arsenite cytotoxicity in human osteosarcoma cells (Rossman and Uddin, 
2004). Thus, our findings on the chemical species-specific effects of selenium against arsenite 
cytotoxicity in trout hepatocytes are in agreement with previous observations in mammalian cells. 
It is to be noted though that contradictory evidence also exists in the mammalian literature on the 
ameliorative effects of inorganic and organic selenium against arsenite toxicity. For example, Alp 
et al. (2011) reported that only selenomethionine, not selenite, reduced arsenite cytotoxicity in 
human kidney cells over an exposure period of 24 h, although the exposure doses of selenite and 
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selenomethionine (30  100 µM) were relatively higher than that used in the present study (5  40 
µM). 
Multiple studies, both in vitro and in vivo, indicate that arsenite can generate ROS by 
involving flavin enzymes such as NAD(P)H oxidase, and NO synthase isozymes (Flora, 2011; 
Kumagai and Sumi, 2007; Selvaraj et al., 2012). Metabolic intermediates of inorganic arsenic such 
as dimethylarsinic acid (DMA) can also react with molecular oxygen to generate superoxide (O2•−) 
and peroxyl radicals that cause oxidative damage, including breaks in DNA strands, and ultimately 
lead to apoptosis (Yamanaka et al., 1990, 1989). In the present study, we have also demonstrated 
that exposure to 100 µM arsenite alone significantly increased intracellular ROS production (Fig. 
3.2). However, co-exposure of trout hepatocytes to 100 µM arsenite and 20 µM selenite or 10 µM 
selenomethionine significantly reduced the intracellular ROS level (Fig. 3.2 A iii and v, and B), 
which also coincided with a significant recovery in the cell viability relative to that in the 100 µM 
arsenite only treatment (Fig 3.1 B and C). This observation indicated that selenium at low exposure 
levels ameliorates arsenite cytotoxicity likely by augmenting cellular ROS scavenging activity. To 
counter the effects of deleterious ROS, cells have evolved both enzymatic and non-enzymatic anti-
oxidative machineries (Sies, 1997). One of the major components of the non-enzymatic machinery 
is the ROS scavenger, glutathione (GSH) (Sies, 1999, 1997). On the other hand, the enzymatic 
machinery involves three major anti-oxidative enzymes - superoxide dismutase (SOD), catalase 
(CAT), and glutathione peroxidase (GPx) (Sies, 1997). Pharmacological or exogenous anti-
oxidants, such as the ones used in this study, either mimic the activity of natural anti-oxidative 
agents in the cells or stimulate their activity. In our study, we observed that the treatment of 
hepatocytes with 100 µM TEMPO and NAC in conjunction with isomolar concentration of arsenite 
increased the cell viability relative to that in arsenite treatment alone (Fig. 3.3). Both, TEMPO and 
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NAC, are pharmacological anti-oxidants, but differ in their mechanisms of action. TEMPO mimics 
the activity of SOD enzyme and scavenges ROS (Samuni et al., 1990; Sandhir et al., 2015), whereas 
NAC facilitates GSH synthesis and therefore acts via non-enzymatic pathway (Ramen, 2015). Our 
results suggest that selenite and selenomethionine may ameliorate arsenite-induced oxidative stress 
by facilitating ROS scavenging, which could involve both enzymatic and non-enzymatic pathways. 
To further investigate the precise pathways involved in selenite and selenomethionine mediated 
amelioration of arsenite-toxicity, we analyzed the cellular GSH:GSSG ratio and the activity of anti-
oxidative enzymes. 
Reduced glutathione (GSH) is a redox buffer that can readily donate its electron to reduce 
ROS. During this process, GSH itself becomes oxidized and reacts with another oxidized 
glutathione to form glutathione disulphide (GSSG) (Sies, 1999). Since the formation of 
intracellular GSSG is coupled with the oxidation of GSH, a decrease in their ratio (GSH:GSSG) 
indicates the loss of cellular redox potential, and the onset of cellular oxidative stress (Jamwal et 
al., 2016; Zitka et al., 2012). Analysis of GSH:GSSG ratio in the present study revealed that the 
exposure of trout hepatocytes to 100 µM arsenite independently caused a sharp decline in the 
cellular redox potential (Fig. 3.4), further indicating arsenite-induced oxidative stress. These results 
are consistent with previous studies that demonstrated a reduction in GSH:GSSG ratio associated 
with the exposure to arsenite (Bhattacharya and Bhattacharya, 2007; Flora et al., 2009). Arsenic 
has a strong affinity to bind with the sulfhydryl groups (Shi et al., 2004). The functional capacity 
of GSH depends on the presence of sulfhydryl groups at its active sites, which can be inhibited due 
to the binding of arsenic to sulfhydryl groups (Miller et al., 2002). In addition, it has now been 
established that the metabolic reduction of inorganic arsenic occurs only in the presence of thiol 
compounds such as GSH (Watanabe and Hirano, 2013). Consequently, an exposure to sodium 
arsenite is expected to rapidly deplete the cellular pools of GSH, as it will be required for both the 
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mitigation of oxidative stress and metabolism of arsenic. It is therefore reasonable to argue that 
these factors likely contributed to the arsenite-induced decrease in cellular GSH:GSSG ratio 
observed in the present study.  
Interestingly, we also observed that GSH:GSSG ratio recovered, at least partially, when 
arsenite-exposed hepatocytes were co-treated with low concentrations of selenite (5 and 10 µM) 
and selenomethionine (5 µM) (Fig. 3.4). Previous studies suggest that selenium helps in the 
maintenance of cellular thiol redox balance through a combination of 3 processes: (i) de novo 
synthesis of GSH, catalyzed by γ-glutamyl-cysteine ligase (Chung and Maines, 1981; Richie et al., 
2011), (ii) reduction of GSSG to GSH by glutathione reductase (GR) enzyme (Chung and Maines, 
1981), and/or (iii) alleviation of oxidative stress by other biochemical mechanisms so that GSH is 
spared. The alleviation of arsenite-induced reduction in cellular thiol redox potential at low 
concentrations of Se (selenite and selenomethionine) observed in the present study was likely 
mediated by a combination of these processes (Fig. 3.4 B). Although we did not estimate the 
activity of γ-glutamyl-cysteine ligase, an elevated GSH content in the hepatocytes, when treated 
only with 10  20 µM selenite or 5  40 µM SeMet, suggests an upregulation of de novo GSH 
synthesis (Fig. 3.4 A).  No significant improvement in the cellular thiol redox potential was 
recorded when the cells were co-treated with 100 µM arsenite and >10 µM selenite, or >5 µM 
selenomethionine (Fig. 3.4 B). The metabolism of selenite, when present in concentrations excess 
of physiological requirements, occurs via cellular pathways that require GSH and  generate O2•− as 
a metabolic by-product (Lin and Spallholz, 1993; Seko et al., 1989). Similarly, selenomethionine, 
when present in excess, is metabolized into methylselenol (a redox active compound), which 
subsequently utilizes GSH to undergo redox cycling and produce O2•− in the process (Misra et al., 
2010; Okuno et al., 2001). Therefore, the lack of recovery of GSH:GSSG ratio in arsenite-exposed 
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cells co-treated with higher concentration of selenium observed in the present study (Fig. 3.4 B) 
occurred likely because of the cellular metabolism of excess selenite and selenomethionine, 
resulting in conversion of cellular GSH pool to GSSG. 
In addition to the non-enzymatic antioxidant pathway (thiol ratio), we also evaluated the 
response of key enzymatic anti-oxidants in trout hepatocytes treated with arsenite and/or selenium 
(Fig. 3.5  3.7). An exposure to 100 µM arsenite alone inhibited the activities of SOD (Fig. 3.5) 
and GPx (Fig. 3.6) enzymes, whereas it upregulated the activity of CAT (Fig. 3.7). Arsenic-induced 
inhibition of SOD and GPx has been reported previously in mammalian systems (Ramanathan et 
al., 2002; Shila et al., 2005). The most common forms of SOD in eukaryotic cells require copper, 
zinc and manganese as co-factors to carry out their functions (Fukai and Ushio-Fukai, 2011). 
Arsenite has been known to induce alterations in redox-active metals associated with proteins and 
cause intoxication (Valko et al., 2015). It has also been demonstrated in human fibroblast cells that 
generation of excessive superoxide/lipid peroxide ions in response to high concentration of arsenite 
can inhibit SOD activity (Yang et al., 2007). Thus, it is possible that arsenite-induced inhibition of 
SOD activity observed in our study might have occurred via similar mechanisms. Furthermore, 
arsenite is known to be an inhibitor of selenoprotein synthesis (Ganyc et al., 2007; Rodríguez-sosa 
and García-montalvo, 2013), which could be the probable mechanism of arsenite-induced 
reduction in activity of GPx, which is a selenoprotein. Upregulation of the activity of anti-oxidative 
enzymes in response to oxidative stress is a compensatory cellular mechanism for maintaining 
redox homeostasis. The elevated activity of CAT observed in our study might have occurred as a 
compensatory response to arsenite-induced increase in cellular ROS production (Shi et al., 2004), 
especially when the activities of other two important enzymatic anti-oxidants (SOD and GPx) were 
downregulated.  
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We have also observed in this study that treatment with both selenite and SeMet ameliorated 
the arsenite-induced alterations in the activities of antioxidative enzymes, except for the SOD 
activity in cells treated with selenomethionine (Fig. 3.5  3.7). It has been demonstrated previously 
that selenomethionine can ameliorate arsenite toxicity by influencing the activities of enzymatic 
antioxidants (Zwolak and Zaporowska, 2012), however we have demonstrated for the first time 
that this effect is dependent on the chemical speciation of selenium. We demonstrated that only 
selenite was able to upregulate SOD activity, which was inhibited by arsenite exposure (Fig. 3.5). 
In addition, we also found that the inhibition of SOD activity with a pharmacological blocker, 
DETC, resulted in a complete elimination of the protective effect of selenite against arsenite 
cytotoxicity (Fig. 3.8). Inhibition of other enzymatic (CAT and GPx) as well as non-enzymatic 
(GSH) antioxidants also reduced the protective effect of selenite, although the magnitude of 
reduction was modest and not as pronounced as observed with the inhibition of SOD activity (Fig. 
3.8). This indicated that selenite protects against the adverse effects of arsenite-induced production 
of ROS mainly by augmenting SOD activity. Interestingly, the cellular anti-oxidant response to 
selenite cytotoxicity also involves selective upregulation of SOD, whereas other anti-oxidants, such 
as CAT and GPx, are not upregulated at the same magnitude (Weekley et al., 2014). On the other 
hand, treatment with selenomethionine alleviated arsenite-induced decrease in the GPx activity, 
but not the SOD (Fig. 3.6). This suggested that unlike selenite, selenomethionine provides its 
antagonistic effects against arsenite cytotoxicity primarily by augmenting the activity of GPx. This 
was further substantiated by the observation that pharmacological blocking of GPx activity 
completely eliminated the protective effect of selenomethionine against arsenite cytotoxicity (Fig. 
3.8). Furthermore, the pharmacological blocking of other enzymatic (SOD and CAT) as well as 
non-enzymatic (GSH) anti-oxidants either did not influence at all or marginally reduced the 
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protective effects of selenomethionine against arsenite cytotoxicity (Fig. 3.8). The anti-oxidant 
enzyme GPx ameliorates oxidative stress by catalyzing the reactions by which GSH neutralizes 
ROS (Arteel and Sies, 2001), and thus the upregulation of GPx activity is merely a facilitation of 
the non-enzymatic pathway for maintaining redox homeostasis.  
It is evident from our findings that both selenite and selenomethionine elicited antagonistic 
effects against arsenite-induced oxidative stress by both enzymatic and non-enzymatic pathways, 
which ultimately lead to a decrease in the intracellular ROS accumulation (Fig. 3.2 A iii and v, and 
3.2 B). Mammalian studies have previously reported that selenite at low exposure concentrations 
can augment the activity of SOD (Messarah et al., 2012; Zwolak and Zaporowska, 2012), which 
can be attributed to the upregulation of redox active selenoproteins which maintain the cellular 
redox status and may therefore prevent redox injury to anti-oxidative enzymes (Reich and Hondal, 
2016). On the other hand, GPx activity is highly dependent on cellular thiol status, since GPx is 
extremely specific for GSH as its substrate (Messarah et al., 2012; Shila et al., 2005; Wendel, 
1980). It is also to be noted here that selenomethionine has been suggested to have GPx-like activity 
(Arteel and Sies, 2001; Walter and Roy, 1971). In the present study, it was observed that co-
treatment of 100 µM arsenite and 5 µM selenomethionine led to the recovery of arsenite-induced 
decrease in cellular thiol status, which also coincided with a concurrent increase in the GPx activity. 
This indicates that selenomethionine ameliorated arsenite-induced oxidative stress by improving 
cellular thiol status, which also subsequently contributed to the recovery of GPx activity.  
3.5. Conclusion 
The present study demonstrated that both, selenite and selenomethionine, at low exposure 
levels can ameliorate arsenite toxicity in rainbow trout hepatocytes. Exposure to arsenite (100 µM) 
was found to decrease the cell viability, which corresponded with an increased accumulation of 
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intracellular ROS, decreased thiol status, and reduced activity of enzymatic antioxidants (SOD and 
GPx). Co-exposure of hepatocytes to low-intermediate levels of selenomethionine (10  20 µM 
selenite and 10 µM selenomethionine) and 100 µM arsenite resulted in a significant (although 
partial) recovery of cell viability. Improvement in cell viability corresponded with decreased 
accumulation of intracellular ROS, indicating the antioxidative properties of selnomethionine. 
Interestingly however, our investigation into the cellular mechanisms underlying the antagonistic 
interactions of selenium and arsenite revealed that inorganic (selenite) and organic 
(selenomethionine) forms of selenium elicit their protective response through different anti-
oxidative pathways. Selenite alleviates arsenite-induced oxidative stress essentially by 
upregulating the SOD activity, whereas selenomethionine provides similar protective response 
predominantly via non-enzymatic anti-oxidative pathway that involves GSH. The characterization 
of chemical species-specific responses of selenomethionine against arsenite toxicity is novel, and 
has important toxicological implications since selenium and arsenic often co-occur in contaminated 
aquatic ecosystems. Our study indicates that selenium can be an effective antidote to arsenic 
poisoning in fish and potentially in other organisms as well, but only at a specific exposure levels 
(low-moderate) as the protective effects were not evident at high exposure levels of selenium. 
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CHAPTER 4: Interactive effects of chronic exposure to dietary cadmium and 
selenomethionine on tissue-specific accumulation and toxicity of cadmium in rainbow trout 
(Oncorhynchus mykiss) 
 
Preface 
The aim of this chapter is to address the 3rd objective of my doctoral research work which is to 
understand the interactive effects of chronic exposure to dietary cadmium and 
selenomethionine on tissue-specific accumulation and toxicity of cadmium in rainbow trout 
(Oncorhynchus mykiss). The findings of this chapter complement the findings of Chapter 2 and 
further our understanding on the mechanistic basis of how selenomethionine influences the toxic 
effects of cadmium at the organismal level (under the influence of systemic interference). 
4.1. Introduction 
Cadmium (Cd) is a non-essential element and known to induce toxic effects in all biological 
forms at relatively low exposure levels (Benavides et al., 2005; Trevors et al., 1986). Although it 
is a rare and a naturally occurring element, the anthropogenic activities have dominated the 
cadmium biogeochemical cycle, which has elevated its concentrations in many aquatic ecosystems 
(Cullen and Maldonado, 2013). In natural waters, cadmium is highly persistent and can biomagnify 
along the food chain (Croteau et al.,. 2005). Thus, diet is an important source of Cd in aquatic 
organisms in addition to the water, and several studies have suggested that dietary Cd is more 
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bioaccumulative than waterborne Cd in fish (Guo et al., 2017; Harrison and Klaverkamp, 1989; 
Maunder et al., 2011; Ranaldi and Gagnon, 2009). Therefore, the carnivorous fish, such as rainbow 
trout (Oncorhynchus mykiss), that occupy higher trophic levels in the food chain can be more 
susceptible than the herbivorous fish to Cd toxicity through diet in metal contaminated aquatic 
habitats (Croteau et al., 2005). 
The toxicity of chronic cadmium exposure in fish are often associated with the disruption 
of cellular redox balance due to the increased production and accumulation of reactive oxygen 
species (ROS) (Baldisserotto et al., 2005; Cuypers et al., 2010; Verbost et al., 1989; Wood et al., 
2006). Cadmium has very low standard reduction potential and cannot generate ROS via direct 
redox reactions under normal physiological conditions (Cuypers et al., 2010). However, cadmium 
can increase the cytoplasmic concentration of free redox-reactive metals, such as iron, by replacing 
them in various metalloproteins. The free redox-reactive metals (e.g., iron) in cytoplasm can 
generate ROS via Fenton reaction (Cuypers et al., 2010). Cadmium can also cause leaks in 
mitochondrial membrane, and induce NADPH-oxidases that generate superoxide anions (O2) 
(Cuypers et al., 2010; Onukwufor et al., 2017). In addition, cadmium can also induce oxidative 
stress by disrupting the activities of enzymatic antioxidants (e.g., catalase, superoxide dismutase) 
and/or depleting the non-enzymatic antioxidant pool (e.g., glutathione), which can ultimately lead 
to the accumulation of intracellular ROS (Bertin and Averbeck, 2006; Cuypers et al., 2010; 
Waisberg et al., 2003). 
In natural waters that receive effluents from mining and smelting industries, cadmium often co-
exists with other metals and metalloids (Barwick and Maher, 2003; Ponton et al., 2016; Yuan, 
2017). These elements, depending on their concentration and chemical speciation, can interact with 
each other, and antagonize or exacerbate their toxicity in exposed organisms. Selenium (Se) is one 
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such element that has been reported to have an antagonistic relationship with cadmium (Messaoudi 
et al., 2010; Zwolak and Zaporowska, 2012; Jamwal et al., 2016). Selenium is essential for the 
synthesis of various selenoproteins that have vital adaptive and housekeeping functions, including 
the maintenance of cellular redox homeostasis (Reich and Hondal, 2016). On the other hand, 
selenium can also be extremely toxic to fish, when its concentration in the body exceeds the 
physiological threshold (Janz, 2012). Recent studies have indicated that exposure to elevated 
organic and inorganic forms of selenium causes toxicity in fish by inducing ROS production and 
oxidative stress (J.-H. Kim and Kang, 2015; Kupsco and Schlenk, 2014; Thomas and Janz, 2016). 
Although fish can accumulate selenium via both water and diet, the predominant source of 
selenium exposure to fish is the diet, especially in its organic form (selenomethionine) (Janz, 2012).  
The ameliorative effects of both inorganic and organic forms of selenium against chronic 
cadmium toxicity in fish have been reported in a few previous studies (Banni et al., 2011; Talas et 
al., 2008; Xie et al., 2016). Talas et al. (2008) and Banni et al. (2011) suggested that selenite, via 
water and diet, respectively, alleviates oxidative stress in fish during chronic exposure to 
waterborne cadmium. More recently, Xie et al. (2016) also demonstrated that pre-exposure to 
selenium-supplemented diet (both in the form of selenite and selenomethionine) led to lower 
oxidative stress and whole body cadmium burden in fish during short-term exposure to waterborne 
cadmium. Although these studies provided useful insights into the interaction of cadmium and 
selenium in fish, their environmental implications are limited. This is mainly because all of these 
studies were carried out using physiologically optimum or non-toxic exposure levels of selenium, 
and also at waterborne cadmium concentrations (0.4  2.0 mg L-1) that were well above the range 
of environmentally relevant cadmium exposure levels. To date, it is not yet understood how the 
interactions of selenium and cadmium are influenced by different selenium exposure levels, 
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particularly at levels that exceed the physiological threshold and may cause toxicity to fish by itself. 
Moreover,  no previous studies have investigated how the interaction of cadmium and selenium 
modulates the accumulation pattern of both elements in critical body organs (e.g., liver, kidney, 
muscle) in fish. Interestingly, it has been reported in a recent field study that higher selenium levels 
in the liver were correlated with lower hepatic oxidative stress in fish naturally exposed to metals 
including cadmium (Ponton et al., 2016). This indicates that the physiological response in fish 
during chronic exposure to cadmium and selenium may be directly linked with the tissue-specific 
burden of each element, and thus worthy of further investigation.            
The present study was designed to conduct an in-depth investigation of the interactive effects 
of dietary cadmium and selenium exposure in fish, and also to elucidate how these effects are 
influenced by selenium exposure levels. Juvenile rainbow trout were chronically exposed to an 
environmentally relevant dietary cadmium concentration, concurrently with different levels of 
dietary selenium (control (low), moderate and high; as selenomethionine). The specific objectives 
of this study were to examine: (i) how selenomethionine (SeMet) affects cadmium-induced 
alteration in morphophysiological indices (condition factor, hepato-somatic index) of fish, (ii) how 
cadmium-induced changes in hepatic anti-oxidative responses and oxidative stress markers are 
modulated by dietary SeMet exposure, and also (iii) how the interaction of cadmium and SeMet 
alters the tissue-specific burden of each element in fish. We hypothesized that SeMet would 
ameliorate cadmium toxicity by augmenting the cellular redox potential as well as by reducing 
cadmium accumulation in critically important tissues such as liver and kidney, but these protective 
effects would be evident only at the moderate selenium exposure level, with no protection or 
potential exacerbation of toxicity at the high selenium exposure level.            
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4.2. Materials and Methods 
4.2.1. Chemicals 
L(+)-Selenomethionine ( >99% purity) was procured from Fisher Scientific, Canada. High 
purity Cadmium chloride (>99.99 % trace metal basis) was purchased from Sigma Aldrich, USA. 
AquacalmTM (Metomidate hydrochloride) was purchased from Syndel Laboratories Ltd., Canada. 
The reference standards and reagents for graphite-furnace atomic absorption spectroscopy were 
purchased from PerkinElmer, Canada. All other chemicals and reagents were procured from VWR, 
Canada, unless stated otherwise.  
4.2.2. Experimental Fish 
Rainbow trout juveniles weighing 30  35 g were used in the study. Fertilized eggs from 
adult rainbow trout females were hatched in the Aquatic Toxicology Research Facility (ATRF) at 
the University of Saskatchewan, Canada. Fish were raised on commercial dried pellet feed, fed at 
2 % body weight (wet weight) ratio throughout the husbandry period. Fish were reared in 
dechlorinated, aerated water [hardness 159 mg L-1, alkalinity 105 mg L-1 (both as CaCO3), 
dissolved organic carbon (DOC) 2.1 mg L-1, pH 7.5 – 7.8, Se 5.2 µg L-1, Cd < 0.1 µg L-1] in a flow-
through system (1 L min-1). The photoperiod was set at 14:10 h light to dark cycle and water 
temperature was maintained at 12 oC. 
4.2.3. Diet preparation  
 Brine shrimp (Artemia franciscana) containing 5.8 % crude protein, 0.6 % crude fat, 0.25 
% crude fiber (all on a wet wt. basis) was used to prepare the experimental diets. First, the shrimps 
were rinsed several times with deionized water and then ground in a commercial blender with a 
known amount of selenomethionine and/or cadmium (as CdCl2) solution, which was prepared with 
deionized water. The mixture was blended for about 10 min to ensure homogenous mixing. 
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Carboxymethylcellulose (2 %, in dry wt.) was also included as a feed binder during the blending 
process. The mix was frozen at −20 oC and subsequently freeze-dried (Labconco Freezone, USA). 
The feed was cut into small pellets (∼0.3 cm) and stored at -20 oC until its use in the experiment. 
The control diet was prepared similarly without the addition of selenomethionine or CdCl2. The 
concentrations of selenium and cadmium in each of the experimental diets were verified in an 
atomic absorption spectrometer, prior to their use in the experimental exposure (see below for 
details). 
4.2.4. Experimental treatments and sampling 
Using a fully factorial experimental design, fish were treated with six different dietary 
treatments (see Table 4.1). Fish in each treatment were fed once daily at 2 % of their body weight 
for 30 days. A total of 60 fish were divided equally into twelve 180 L tanks (5 fish in each tank, 2 
replicates per treatment). The six different diets used in the present study were identified as: Control 
(no added cadmium or selenium), cadmium only (40 g g-1 dry wt.), medium SeMet only (10 g 
g-1 dry wt.), high SeMet only (40 g g-1 dry wt.), cadmium + medium SeMet (40 and 10 g g-1 dry 
wt., respectively), and cadmium + high SeMet (40 g g-1 dry wt. for each). The concentrations of 
cadmium and selenium in the diets mentioned here are nominal concentrations, and the measured 
concentration of cadmium and selenium are presented in Table 4.1. Typically, fish in each 
treatment consumed the diet within 3 minutes of its presentation. Each tank received continuous 
aeration, and the water flow-through rate was maintained at 8 L min-1 to ensure rapid flushing of 
selenomethionine or cadmium, that could have potentially leached out of the diet. Nonetheless, 
water samples were collected from each treatment tank once a week 1 h post feeding. Fish were 
starved for 24 h before sampling on day 30th, and 4 fish from each replicate treatment were 
randomly sampled to obtain a sample size (n) of 8. Fish were euthanized with an overdose of 
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AquacalmTM. Length and weight of each fish were recorded. Subsequently, the muscle, liver, and 
kidney were dissected out, weighed to the nearest 0.01 mg, and then frozen immediately in liquid 
nitrogen and stored at -80 oC until their analysis. 
4.2.5. Measurement of hepatic thiol content 
The hepatic concentration of reduced (GSH) and oxidized (GSSG) glutathione were 
measured as an estimate of cellular redox balance using a fluorometric method (Hissin and Hilf, 
1976), modified to a 96-microwell plate based assay as described in Jamwal and Niyogi (2017). 
The liver samples were homogenized in HEPES-EGTA sample buffer, with 1:5 sample to buffer 
ratio (w/v). A 20 µl homogenate was taken for the estimation of protein. The remaining 
homogenate was immediately deproteinized with 100 µl of 5 % TCA and centrifuged at 12,000 x 
g at 4 oC for 25 min. The supernatant was collected and split into two fractions of 500 µl each. One 
fraction was immediately stored in -80 oC for the estimation of GSH. The second fraction was used 
for the estimation of GSSG, and mixed immediately with a 20 µl aliquot of 0.04 M of N-
ethylmaleimide to prevent the spontaneous oxidation of GSH to GSSG. For the estimation of GSH, 
a 200 µl final reaction mixture was prepared, which contained 180 µl of phosphate-EDTA buffer 
(0.1 M sodium phosphate, 0.005 M EDTA, pH 8.0), 10 µl of o-phthalaldehyde (OPT, 100 µg per 
100 µl methanol), and 10 µl of sample. The reaction mixture was incubated for 15 min and read 
fluorometrically at excitation and emission wavelengths of 350 nm and 450 nm, respectively, in a 
multimode microplate reader (Varioskan Flash, thermos Fisher Scientific, Finland). The 
concentration of GSSG was measured in the same way except that the final reaction mixture 
volume (200 µl) contained 140 µl of 0.1 N NaOH, 20 µl of o-phthalaldehyde (OPT, 100 µg per 
100 µl methanol) and 40 µl of sample. The GSH and GSSG content was expressed as µg per mg 
of protein. Finally, the GSH : GSSG ratio was obtained by dividing GSH concentration with its 
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corresponding GSSG content. Bradford method, modified for 96-well microplate based assay, was 
used to determine the protein content in the samples (Bradford, 1976). 
4.2.6. Measurement of hepatic antioxidant enzyme activities 
Frozen liver samples were thawed and then homogenized in 5 volumes (w/v) of chilled 
HEPES-EGTA sample buffer (1 mM EGTA, 210 mM mannitol, 70 mM sucrose, and 20 mM 
HEPES, pH 7.2) using a hand-held homogenizer. The homogenate was centrifuged at 25,000 x g 
for 20 min at 4 oC and the supernatant was collected. A 50 µl of the supernatant was used to estimate 
the protein content, as described previously. The activities of three antioxidant enzymes, catalase 
(CAT), superoxide dismutase (SOD) and glutathione peroxidase (GPx), were measured using 
commercially available SOD (Catalogue #706002), CAT (Catalogue #707002), and GPx 
(Catalogue #703102) activity kits, following the manufacturer’s instructions (Cayman chemical 
company, USA). The activities of CAT, SOD, and GPx were expressed as nmol/ mg protein, U mg 
protein-1, and nmol min-1 mg protein-1, respectively. One unit of SOD was defined as the amount 
of enzyme needed to achieve the dismutation of 50 % superoxide anions.  
4.2.7. Estimation of hepatic lipid peroxidation (LPO) 
A 96 micro-well plate based thiobarbituric acid reactive substance (TBARS) assay kit 
(Catalogue # 10009055; Cayman chemical company, USA) was used for the estimation of lipid 
peroxidation (LPO) in the livers. For the estimation of LPO, liver samples were homogenized in 
1:10 volume (w/v) of chilled TBARS-kit buffer. The homogenate was centrifuged at 1,600 x g for 
10 min at 4 oC to collect the supernatant. A 20 µl of the supernatant was taken to estimate the 
protein content, as mentioned before. The hepatic LPO was measured as per the instruction manual 
of the kit at excitation and emission wavelengths of 530 nm and 550 nm, respectively, in a 
multimode microplate reader. The LPO was expressed as nmol MDA mg tissue protein-1.   
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4.2.8. Measurement of selenium and cadmium in water, diet and fish tissue 
 Experimental water samples were acidified (1% HNO3) and analyzed for selenium and 
cadmium concentrations using a graphite-furnace atomic absorption spectrometer (Analyst 800, 
PerkinElmer, USA). The experimental diets and fish tissues were digested in 5 volumes of 2 N 
HNO3 at 60 oC for 48 h and then centrifuged at 1,000 x g for 20 min. The supernatant was collected 
and diluted appropriately in 0.1 % HNO3 prior to their analysis. Appropriate method blanks and 
certified standards for both cadmium and selenium were used to maintain the quality control and 
quality assurance of total selenium and cadmium analysis (PerkinElmer, USA). A certified 
reference material (DOLT-3; National Research Council, Canada) was also analyzed similarly to 
validate the efficiency of the applied method, and the recovery of Cd and Se was found to be 105 
% and 93 %, respectively. 
4.2.9. Calculations and statistical analysis 
Hepato-somatic index [HSI = weight of liver (g) weight of the fish (g) -1] and condition 
factor [K = 100 x weight of the fish (g) length (cm)-3] were calculated for individual fish. All 
statistical analysis and the graphs were plotted using SigmaPlot (version 12, Systat Software, Inc., 
USA). The data are presented as mean ± standard error of mean (S.E.M.). Interactive effects of 
selenomethionine and cadmium were analyzed by a two-way analysis of variance (2-WAY 
ANOVA). Pairwise multiple comparisons (post hoc) with Holm-Sidak correction was performed 
to determine the effect of different treatments. The assumptions of ANOVA (normality of 
distribution and heteroscedasticity) were verified using Shapiro-Wilk and Brown-Forsythe test, 
respectively. Data were subjected to logarithmic transformation when the assumption of normality 
was not met. A p-value of ≤ 0.05 was considered to be significant while comparing different 
treatments.  
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Table 4.1. Measured selenium and cadmium concentrations in different diets (µg g-1 feed dry 
weight).  
Treatments Se (µg g-1) Cd (µg/g-1) 
Control 1.2 ± 0.7a 0.8 ± 0.2A 
Cadmium only 1.3 ± 0.9a 42.4 ± 1.7B 
Medium SeMet 12.2 ± 1.9b 1.2 ± 0.7A 
High SeMet 46.1 ± 3.1c 1.6 ± 0.5A 
Cadmium + Med SeMet 13.7 ± 1.2b 47.5 ± 1.7B 
Cadmium + High SeMet 47.8 ± 2.1c 51.2 ± 1.3B 
Values are mean ± SEM, n = 3 for the selenium and cadmium in the diets. Values with different 
alphabetic superscripts represent statistical difference in the concentration of a particular element 
between different treatments (p < 0.001). Similar superscripts represent no statistical difference 
(p > 0.05), as determined by 1-WAY ANOVA and post hoc analysis. 
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4.3. Results 
4.3.1. Fish morphometrics [Hepato-somatic index (HSI) and condition factor (K-factor)] 
No mortality was recorded in any treatment over 30 days of experimental exposure. The 
interaction between dietary cadmium and selenomethionine significantly influenced the HSI (F2,37 
= 4.2; p = 0.023; Table 4.2). There was a significant reduction (~30 %) of HSI in fish treated with 
cadmium only diet, relative to the control group (p < 0.001), whereas HSI in fish treated with 
medium SeMet only diet was ~36 % higher than the control group (p < 0.001). Fish treated with 
high SeMet diet, alone or in combination with cadmium, also exhibited a significantly lower HSI 
values, which were similar to that observed in fish treated with cadmium only diet (p > 0.05; Table 
4.2). Interestingly, however, fish fed with cadmium + medium SeMet diet did not show any 
significant difference in HSI value relative to the control fish (p = 0.80; Table 4.2). No statistically 
significant interaction between cadmium and selenomethionine was recorded for K-factor (F2,37 = 
0.67; p = 0.52; Table 4.2), and a significant decrease, relative to the control, was observed only in 
fish treated cadmium only diet (Table 4.2). 
Table 4.2. Physiological indicators of health of juvenile rainbow trout exposed to different 
treatments. 
Treatments HSI Condition factor (K) 
Control 0.022 ± 0.0008a 1.29 ± 0.041A 
Cadmium only 0.014 ± 0.0002b 1.10 ± 0.025B 
Medium SeMet 0.029 ± 0.0005c 1.35 ± 0.030C 
High SeMet 0.016 ± 0.0002b 1.29 ± 0.028A 
Cadmium + Med SeMet 0.022 ± 0.0004a 1.33 ± 0.031A 
Cadmium + High SeMet 0.015 ± 0.0004b 1.24 ± 0.03A 
Values are mean ± SEM, n = 5 - 8. HSI = hepatosomatic index. Values with different alphabetic 
superscripts represent statistical difference among the treatments for a particular parameter (p < 
0.001). Similar superscripts represent no statistical difference (p > 0.05), as determined by 2-
WAY ANOVA and post hoc analysis. 
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4.3.2. Hepatic thiol redox balance 
Two-Way ANOVA did not reveal any significant interactive effect of cadmium and 
selenomethionine on GSH, GSSG, or the thiol ratio (GSH:GSSG). However, there was a significant 
simple-main effect of the treatments on the thiol redox balance (Fig. 4.1). Exposure to cadmium 
only diet led to a significant decrease and increase (both ~50%) in the hepatic GSH and GSSG 
contents, respectively, which ultimately resulted in a markedly significant reduction in the hepatic 
GSH:GSSG ratio relative to the control (p < 0.001; Fig. 4.1). The concentrations of GSH, GSSG, 
and the thiol ratio were not significantly different among fish treated with SeMet only diets 
(medium and high) as well as cadmium + medium SeMet diet, relative to the control (Fig. 4.1). 
However, the hepatic GSH level and GSH:GSSG ratio were significantly reduced (26 % and 60 %, 
respectively) in fish treated with cadmium + high SeMet diet in comparison to the control (p < 
0.001; Fig. 4.1). The magnitude of reduction in hepatic GSH content and thiol ratio in fish treated 
with cadmium + high SeMet diet was similar to that observed in fish treated with cadmium only 
diet (Fig. 4.1). 
4.3.3. Hepatic antioxidative enzyme activities 
The effects of different dietary treatments on the activities of hepatic antioxidative enzymes 
(CAT, SOD, and GPx) are illustrated in Fig. 4.2. Dietary exposure to selenomethionine and 
cadmium had a significant interactive effect on CAT activity (F2,33 = 9.2; p < 0.001). Dietary 
exposure to cadmium, alone and in combination with high SeMet, resulted in a significant increase 
(~40% in both treatments) in CAT activity relative to the control (p < 0.001; Fig. 4.2 A). In contrast, 
no significant change in CAT activity was recorded following treatments with medium and high 
SeMet only diets as well as cadmium + medium SeMet diet (p > 0.05; Fig. 4.2 A).  
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Similar to CAT, the hepatic SOD activity was also significantly affected by the interaction 
of cadmium and selenomethionine (F2,39 = 8.1; p < 0.001). Exposure to dietary cadmium alone 
resulted in a significant increase (2.5 fold) in SOD activity relative to the control (p < 0.001), 
however no change in SOD activity was recorded following treatment with cadmium + medium 
SeMet diet (Fig 4.2 B). The SOD activity in SeMet only (medium and high) and cadmium + high 
SeMet dietary treatments was also somewhat elevated, and not significantly different relative to 
that observed in the cadmium only dietary treatment.    
No significant interaction between dietary cadmium and selenomethionine was found for 
hepatic GPx activity (F2,24 = 2.6; p = 0.1). Exposure to dietary cadmium, alone and in combination 
with medium or high SeMet, resulted in significant increases (35  70%) in GPx activity relative 
to the control (p < 0.001), however, the magnitude of increase was more modest (~35%) and 
significantly lower in the cadmium + medium SeMet treatment relative to the other two cadmium 
treatments (Fig. 4.2 C). The GPx activity in both medium and high SeMet alone dietary treatments 
was similar to that in control (p = 0.008; Fig. 4.2 C). 
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Figure 4.1: Concentration of reduced (GSH) and oxidized (GSSG) glutathione, and their ratio 
(GSH:GSSG) in the livers of rainbow trout exposed to various treatments. Data are presented as 
mean ± SEM (n = 6 - 8). For GSH and GSSG the statistical significance is denoted with capital 
letters, and small letters respectively. The bars with different letters are statistically different (p < 
0.05). For GSH:GSSG, an asterisk (*) represents statistically significant difference in comparison 
to the control group and the data-points without an asterisk are statistically similar to each other (p 
< 0.05).
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Figure 4.2: Changes in the activities of (A.) catalase (CAT), (B.) superoxide dismutase (SOD), and (C.) glutathione peroxidase 
(GPx) upon exposure to various treatments. Data are presented as mean ± SEM (n = 5 – 8).  In each figure panel (A, B, or C), 
experimental treatments with different alphabetical notations are significantly different (p < 0.005) from each other, while the 
treatments with common alphabetical notations have no significant difference among them, as determined by 2-WAY ANOVA 
and post hoc analysis.
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4.3.4. Hepatic lipid peroxidation (LPO) 
There was a significant interaction between dietary cadmium and selenomethionine on the 
hepatic lipid peroxidation (F2,29 = 4.3; p = 0.02). Hepatic MDA level increased by more than 2-
folds following treatment with dietary cadmium, alone and in combination with high SeMet, 
relative to the control (p < 0.001 and p < 0.001, respectively; Fig. 4.3). However, no change in 
hepatic MDA level was observed between the control and cadmium + medium SeMet treatments. 
Similarly, the hepatic MDA level in both medium and high SeMet only treatments was not 
significantly different relative to the control (Fig. 4.3).   
4.3.5. Tissue specific selenium and cadmium accumulation 
 A significant interaction between cadmium and selenomethionine was recorded for the 
accumulation of cadmium in liver (F2,40 = 3.44; p = 0.042), kidney (F2,37 = 13.4; p < 0.001), and 
muscle (F2,35 = 8.2; p = 0.001). The cadmium burden in all of these tissues in fish fed with SeMet 
only diets (medium and high) was similar to that in control (p > 0.005; Fig. 4.4). Treatment of fish 
with cadmium only diet resulted in significantly increased cadmium accumulation in all of the 
tissues. The hepatic cadmium concentration increased by ~50-fold in fish exposed to dietary 
cadmium alone, relative to the control (p < 0.001; Fig. 4.4 A). A marked increase in cadmium 
burden in the kidney (~115-fold) and muscle (~160-fold) was also observed following treatment 
with cadmium only diet (p <0.001; Fig 4.4 B and C). Interestingly, however, the supplementation 
of dietary cadmium with medium and high levels of SeMet significantly reduced cadmium 
accumulation in the liver and kidney (p < 0.05), although cadmium levels in both tissues remained 
significantly higher than the control (Fig 4.4 A and B). The ameliorative effect of selenomethionine 
on cadmium accumulation was more pronounced in the kidney than the liver, as the magnitude of 
decrease in cadmium accumulation was much greater (1.4  2.7 fold) in the kidney relative to that 
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in the liver (1.2  1.6 fold). In contrast, supplementing dietary cadmium with either medium or 
high level of SeMet did not reduce the cadmium burden in the muscle. No significant change in 
muscle cadmium accumulation was observed between cadmium only and cadmium + medium 
SeMet dietary treatments (p = 0.09), whereas a significant increase in muscle cadmium 
accumulation was recorded following treatment with cadmium + high SeMet diet, in comparison 
to the cadmium only dietary treatment (p < 0.001; Fig 4.4 C).  
Accumulation of selenium in the liver, kidney and muscle was also significantly affected 
by the interaction between cadmium and SeMet (F2,38 = 11.6; p < 0.001, F2,38 = 8.9; p <0.001; F2,39 
= 33.2; p <0.001, respectively). Selenium accumulation in both liver and kidney increased 
significantly following treatment with cadmium only diet (not supplemented with 
selenomethionine) relative to the control, whereas a significant decrease of selenium accumulation 
was observed in the muscle (p < 0.001; Fig 4.5). There was a significant dose dependent increase 
in Se accumulation in liver, kidney and muscle following treatment with medium and high SeMet 
only diets, in comparison to the control (p < 0.001; Fig. 4.5). The presence of cadmium in the diet 
supplemented with medium level SeMet did not significantly alter the selenium concentration in 
any of tissues examined relative to that in the medium SeMet only treatment. However, a 
significant decrease in selenium accumulation was observed in all of the tissues following 
treatment with cadmium + high SeMet diet in comparison to high SeMet only diet. The magnitude 
of this effect was more pronounced in the muscle (a 2-fold reduction; p < 0.001; Fig. 4.5 C), than 
in the liver (p = 0.002; Fig. 4.5 A) and kidney (p <0.001; Fig. 4.5 B), where the decrease in selenium 
accumulation was modest (1.3  1.5 fold). 
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Figure 4.3: Concentration of hepatic malondialdehyde (MDA) measured as a biomarker of lipid 
peroxidation (LPO) due to different treatments to which the rainbow trout were exposed. Data are 
presented as mean ± SEM (n = 6 – 8). The experimental treatments with different alphabetical 
notations are significantly different (p < 0.005) from each other, while the treatments with common 
alphabetical notations have no significant difference among them, as determined by 2-WAY 
ANOVA and post hoc analysis.
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Figure 4.4: Concentration of Cd in liver (A.) kidney (B.), and muscle (C) in rainbow trout exposed to various treatments. Values are 
mean ± SEM (n = 6-8). In each figure panel (A, B, or C), experimental treatments with different alphabetical notations are significantly 
different (p < 0.005) from each other, while the treatments with common alphabetical notations have no significant difference among 
them, as determined by 2-WAY ANOVA and post hoc analysis.  
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Figure 4.5: Concentration of Se in liver (A.) kidney (B.), and muscle (C) in rainbow trout exposed to various treatments. Values are 
mean ± SEM (n = 6-8). In each figure panel (A, B, or C), experimental treatments with different alphabetical notations are significantly 
different (p < 0.005) from each other, while the treatments with common alphabetical notations have no significant difference among 
them, as determined by 2-WAY ANOVA and post hoc analysis. 
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4.4. Discussion 
To the best of our knowledge, the current study is the first to examine the interactive effects 
of chronic exposure to cadmium and SeMet via diet in fish. We used exposure concentrations of 
cadmium and SeMet that fish might experience in the metal-contaminated natural environments, 
and thus are environmentally relevant. The measured concentration of  cadmium in cadmium-
supplemented diets used in the present study varied between 42 – 48 µg g-1 dry wt. (Table 4.1), 
which was comparable to the cadmium levels reported in fish prey species collected from the metal-
contaminated natural waters (Farag et al., 1999).  On the other hand, the selenium concentration 
(1.2 ± 0.7 µg g-1) recorded in the control diet was within the range of physiologically optimum 
dietary selenium requirement (0.1  4.7 µg g-1 dry wt.) in rainbow trout (Hodson and Hilton, 1983). 
The measured selenium concentrations in diets supplemented with  medium and high levels of 
SeMet used in our study were in the range of 12  14 and 46  48 µg g-1 dry wt., respectively (Table 
4.1).  Similar range of selenium level has also been reported in the aquatic food chain in several  
Se-impacted North American sites (Hamilton, 2004).  
The HSI and K-factor are the most common indirect measures for estimating the energetic 
status in fish (Chellappa et al., 1995). Fish, like other vertebrates, under normal physiological 
condition convert the excess dietary energy into glycogen and fat, which are then stored mainly in 
the liver and adipose tissues (Enes et al., 2009). However, under chronic stress such as exposure to 
elevated levels of metals, the energy requirement for maintaining the homeostatic processes (e.g., 
synthesis of detoxifying proteins, and antioxidative enzymes) may exceed the energy assimilated 
from the diet. As a consequence, the hepatic glycogen reserves are used to compensate the energy 
deficiency, which reduces the overall mass of the liver. The reduced liver mass, in proportion to 
the body mass of the fish, is reflected by a decrease in the HSI. In addition, the increased energetic 
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cost of homeostasis may also reduce the fat reserves, muscular development and growth of fish, 
which can result in a decreased K-factor. Our observations in the present study suggest that chronic 
exposure to dietary cadmium alone was energetically costly to the fish, as indicated by the reduced 
HSI and K-factor (Table 4.2). Interestingly, however, both HSI and K-factor values recovered back 
to the control levels when fish were treated with dietary cadmium supplemented with medium, but 
not high, level of SeMet. It is important to note here that we recorded a decrease in HSI when fish 
were treated with the diet supplemented exclusively with high, not medium, SeMet level, indicating 
that the high SeMet only diet used in our study increased the metabolic cost as well, and thus was 
somewhat toxic to the fish.  
Cadmium is known to elicit its toxic effects by disrupting the cellular redox homeostasis, 
mainly via the depletion of glutathione (GSH) (Rani et al., 2014; Sandbichler and Höckner, 2016; 
Wang et al., 2008). In the present study, we examined the biochemical effects of interaction 
between cadmium and SeMet in the liver, which is the primary site of their metabolism (Nordberg, 
1984). In addition, the deleterious effects of dietary cadmium exposure are usually observed first 
in the hepatic tissue (Godt et al., 2006). Analysis of the reduced and oxidized thiol content in the 
liver revealed that exposure to elevated dietary cadmium alone markedly reduced the GSH:GSSG 
ratio (Fig. 4.1). This is consistent with our previous findings in the primary cultures of rainbow 
trout hepatocytes, where the acute exposure to a toxic cadmium concentration was found to sharply 
decrease the thiol ratio (Jamwal et al., 2016). Cadmium-induced depletion of GSH and an 
associated increase in GSSG content has also been reported previously in several in vivo studies in 
fish (Jin et al., 2015; Karaytug et al., 2014; Pereira et al., 2016). The tripeptide GSH acts as a non-
enzymatic redox buffer and the first line of defense against cadmium intoxication (Sandbichler and 
Höckner, 2016; Singhal et al., 1987). It prevents cadmium toxicity by scavenging the free cationic 
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Cd+2, which is the most toxic form of cadmium (Waisberg et al., 2003). In addition, GSH also 
mitigates cadmium-induced oxidative stress by transferring its electron to ROS, thereby 
neutralizing it (Wu et al., 2004). During this process, the reduced form of glutathione (GSH) is 
oxidized to GSSG, and the overall thiol redox potential (GSH:GSSG) decreases, compromising the 
cellular redox homeostasis.  
The cellular pool of GSH can be maintained by a combination of 3 different processes 
(Chung and Maines, 1981; Jamwal and Niyogi, 2017; Richie et al., 2011): (i) de novo synthesis of 
GSH, catalyzed by γ-glutamyl-cysteine ligase, (ii) recycling of GSSG to GSH by glutathione 
reductase, and/or (iii) alleviation of oxidative stress by other biochemical mechanisms so that GSH 
is spared. Under chronic cadmium-exposure, the GSH:GSSG ratio can decrease if the rate of GSH 
oxidation exceeds GSSG recycling or when the de novo GSH synthesis is compromised. In the 
present study, the decrease in hepatic GSH:GSSG ratio following treatment with elevated dietary 
cadmium alone suggested the occurrence of oxidative stress. Reduced thiol ratio makes tissues 
more susceptible to various other stressors besides oxidative damage because many other 
homeostatic and housekeeping cellular processes depend on a reduced intracellular environment 
(Waisberg et al., 2003). Interestingly, we observed that the decrease in thiol ratio recorded during 
exposure to elevated dietary cadmium was completely alleviated, when the diet was supplemented 
with medium level of SeMet, but not with high SeMet level (Fig. 4.1). Selenium, when present at 
an optimum dose, is known to upregulate the activity of γ-glutamylcysteine ligase and increase the 
de novo GSH synthesis (Chung and Maines, 1981). In our previous in vitro study with trout 
hepatocytes, a low dose of SeMet (25 µM) was also found to completely restore cadmium-induced 
(100 µM) reduction in thiol ratio (Jamwal et al., 2016). The recovery of thiol ratio in fish treated 
with cadmium + medium SeMet diet was probably contributed, in part, by the upregulation of de 
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novo GSH synthesis, which is evident from a significant increase in the hepatic GSH content 
relative to that in fish treated with cadmium only diet. The restoration of thiol redox balance might 
have ameliorated cadmium-induced oxidative stress, which also corresponded with the improved 
morphometrics (HSI and K-factor) of fish treated with cadmium + medium SeMet diet (Table 4.2). 
In addition to GSH, the enzymatic antioxidants such as SOD, CAT and GPx are also 
responsible for the maintenance of cellular redox homeostasis. These enzymes play a crucial role 
in neutralizing the toxic ROS, and therefore their activities are commonly used as markers of 
oxidative stress. SOD converts toxic O2 into H2O and H2O2, whereas CAT and GPx reduce H2O2 
into non-toxic H2O and O2 (Chelikani et al., 2004; Fukai and Ushio-Fukai, 2011; Mills, 1957). On 
the other hand, LPO is an index of oxidative damage of cellular lipid structures, since ROS (e.g., 
such as O2 ) can react with fatty acid molecules and produce MDA as one of the end products 
(Yagi, 1998). In the current study, we observed that exposure to elevated dietary cadmium alone 
upregulated the activities of all 3 antioxidative enzymes examined (SOD, CAT, and GPx; Fig. 4.2), 
which might have occurred as a defensive response in order to cope with cadmium-induced 
oxidative stress, as suggested in several previous studies (Almeida et al., 2002; Basha and Rani, 
2003; Cuypers et al., 2010; Nair et al., 2015). This is also consistent with our concurrent 
observation of decreased hepatic thiol ratio as well as increased hepatic lipid peroxidation in fish 
treated with cadmium only diet (Fig. 4.1 and 4.3), as both of these responses indicate increased 
accumulation of intracellular ROS. Similar to Cd, exposure to elevated levels of SeMet is also 
known to cause oxidative stress in fish (Hao et al., 2014; J.-H. Kim and Kang, 2015; Kupsco and 
Schlenk, 2014; Thomas and Janz, 2016). However, we did not observe any significant change in 
any of the hepatic oxidative stress parameters in fish treated with the diet supplemented exclusively 
with high SeMet. Our findings are in agreement with Decker (2015), who also reported no change 
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in hepatic thiol balance and lipid peroxidation in rainbow trout chronically exposed to the same 
high SeMet level in the diet (Decker, 2015). It should, however, be noted that we recorded a 
significant reduction in the HSI of fish treated exclusively with high SeMet diet, as discussed 
previously. This suggests that despite the increased the metabolic cost, high SeMet in the diet did 
not impair the anti-oxidative balance in rainbow trout.  
Although the cellular compensatory responses may enable an organism to survive a chronic 
stress, it is energetically expensive and unsustainable over long term. In the present study, a high 
energetic burden of such compensatory response might have contributed to reduced morphometrics 
in fish exposed to elevated dietary cadmium alone. Interestingly again, no significant increase in 
the activity of any of the antioxidative enzymes or hepatic lipid peroxidation were recorded in fish 
treated with cadmium + medium SeMet diet (Fig. 4.2 and 4.3). Consistent with our observations, 
Talas et al. (2008) and Banni et al. (2011) also reported protective effects, albeit partial, of low 
levels of selenium (as selenite, via water or diet) against the alterations in hepatic antioxidative 
enzymes and/or increased lipid peroxidation in rainbow trout and zebrafish (Danio rerio), 
respectively,  during chronic exposure to waterborne cadmium. Recently, Xie et al. (2016) also 
demonstrated that pre-exposure to low levels of selenite and SeMet via diet ameliorates the adverse 
effects of short-term (5 days) waterborne cadmium exposure on whole-body CAT activity and lipid 
peroxidation in killifish (Heterandria formosa). It is important to note here that although high 
SeMet on its own did not elicit an oxidative stress response, its combination with cadmium resulted 
in increased lipid peroxidation and antioxidative enzyme activities in the liver. This indicates that 
high SeMet in combination with cadmium overwhelmed the capacity of maintaining redox 
homeostasis in rainbow trout. Collectively, our observations suggest that SeMet protects against 
the cadmium-induced oxidative stress in fish essentially by restoring cellular redox balance, but 
only at a moderate dose level.  
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In the present study, we also observed that chronic exposure to elevated dietary cadmium 
increased the tissue-specific cadmium accumulation in rainbow trout, primarily in the kidney 
followed by liver and muscle. Similar tissue-specific pattern of cadmium accumulation was also 
reported in previous studies where trout were chronically exposed to dietary cadmium (Kwong et 
al., 2011; Ng et al., 2009; Szebedinszky et al., 2001). However, co-exposure to cadmium and SeMet 
(medium and high levels) via diet was found to significantly reduce cadmium burden in the liver 
and kidney, but not in the muscle (Fig. 4.4). In contrast to our findings, Banni et al. (2011) did not 
record any significant decrease in cadmium accumulation in the liver and ovary in zebrafish 
exposed to waterborne cadmium (0.4 mg L-1) and fed with a selenium-supplemented diet (2 g g-1 
dry wt., as selenite) for 21 days. This might have occurred because of the low dietary selenium 
exposure level used by Banni et al. (2011) relative to the present study (10  50 g g-1 dry wt.), 
and/or differences in the chemical speciation of selenium (selenite vs. SeMet) and route of 
cadmium exposure (waterborne vs. dietary). Nevertheless, our findings are consistent with previous 
mammalian studies, which also demonstrated that selenium reduces the cadmium accumulation in 
the liver and kidney (Chen et al., 1975; Whanger et al., 1980). These mammalian studies suggested 
that the selenium-induced reduction in hepatic and renal cadmium was correlated with increased 
affinity of cadmium for high molecular weight proteins instead of low molecular weight proteins 
(e.g., metallothioneins) (Chen et al., 1975; Whanger et al., 1980). Since cadmium in the body is 
known to be primarily complexed by metallothioneins in hepatic and renal tissues for long-term 
storage (Nordberg, 1984; Rani et al., 2014), any reduction in their affinity for binding to each other 
may reduce cadmium accumulation in these tissues. However, unlike in the liver and kidney, an 
increase in cadmium accumulation in the muscle was observed in the present study during co-
exposure to dietary cadmium in combination with high SeMet level. Selenium has been found to 
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increase cadmium concentration in the blood (Chen et al., 1975; Magos and Webb, 1980), which 
might have led to increased cadmium uptake in the muscle. In addition, redistribution of cadmium 
from low-molecular weight proteins to high molecular weight proteins could have also contributed 
to increased cadmium burden in the muscle, because the muscular tissue is enriched with high 
molecular weight proteins containing actin and myosin monomers which contain cadmium-binding 
thiol domains (Bailey and Perry, 1947; Cuypers et al., 2010; Jiang et al., 2017; Otterbein et al., 
2001) It is important to note here that although both medium and high level of dietary SeMet 
decreased hepatic and renal cadmium burden, cadmium toxicity (increased hepatic oxidative stress 
and reduced morphometrics) was ameliorated only by the medium SeMet level in the diet. This 
suggests that SeMet-induced reduction in tissue cadmium burden was likely not the predominant 
factor behind the reduction of cadmium toxicity in fish.   
In the present study, dietary exposure to SeMet alone increased tissue-specific selenium 
accumulation in rainbow trout in a dose-dependent manner except in the muscle. A similar pattern 
of tissue-specific selenium accumulation was previously reported in rainbow trout chronically 
exposed to dietary SeMet (40 g selenium g-1 dry wt.)(Misra et al., 2012b). More importantly 
though, we also observed that the presence of admium in the diet supplemented with high, not 
medium, level of SeMet resulted in a significant decrease in selenium accumulation in all three 
tissues examined relative to that in the treatment with only high SeMet diet (Fig. 4.5). This indicates 
that the antagonistic effect of dietary cadmium on tissue-specific selenium accumulation occurs 
when cadmium and selenium exist in 1:1 molar ratio in the diet. The influence of cadmium on 
tissue-specific selenium accumulation has not been investigated previously in any species, and the 
precise mechanisms by which cadmium reduces selenium accumulation, and vice versa, are 
presently unknown.  
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Selenium has also been reported to form chemical complex with cadmium in mammals and 
may therefore influence the distribution of both elements in tissues. For example, Gasiewicz & 
Smith (1978) demonstrated formation of Cd-Se complex by gel filtration chromatography in rat 
plasma and erythrocytes through in vivo and in vitro experiments. Formation of chemically and 
biologically inert Cd-Se complex was also reported in yeast (Saccharomyces cerevisiae) (Dauplais 
et al., 2013). It is possible that formation of similar Cd-Se complex could have also influenced the 
tissue-level distribution of both cadmium and selenium in the present study. However, such 
metabolic interactions between cadmium and SeMet have not been studied in any aquatic animal 
so far and only further investigations into this can reveal their inter-relationship in fish.   
4.5. Conclusion 
We demonstrated in the current study that dietary supplementation of SeMet ameliorated 
the toxicity of chronic dietary cadmium exposure in rainbow trout. However, this protective effect 
was evident only at the moderate SeMet exposure level (~ 10 g Se g-1 dry wt.), with no reduction 
in cadmium toxicity at the high dietary SeMet exposure level (~ 45 µg Se g-1 dry wt.). Chronic 
exposure to dietary cadmium caused increased hepatic lipid peroxidation and loss of thiol redox 
balance, and reduced morphometrics in fish, which were completely alleviated during co-exposure 
to the moderate level of dietary selenomethionine. Dietary supplementation of s SeMet, both at the 
moderate and high level, was also found to reduce cadmium accumulation in the liver and kidney 
during chronic dietary exposure to cadmium. Overall, our study suggests that SeMet essentially 
protects fish against the chronic toxicity of dietary cadmium exposure via its anti-oxidative 
functions. 
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CHAPTER 5: Characterization of the modulatory effects of selenomethionine on arsenite 
induced hepato-toxicity and tissue-specific accumulation of arsenic during chronic dietary 
exposure in rainbow trout (Oncorhynchus mykiss) 
Preface 
The aim of this chapter is to address the 4th objective of my doctoral research work which is to 
characterize the modulatory effects of selenomethionine on arsenite-induced hepatotoxicity and 
tissue-specific accumulation of arsenic during chronic dietary exposure. The findings of this 
chapter complement the findings of Chapter 3 and further our understanding on the mechanistic 
basis of how selenomethionine influence the toxic effects of arsenite at the organismal level (under 
the influence of systemic regulation). 
5.1. Introduction 
Arsenic is a well-known environmental toxin and a priority water pollutant that is mobilized 
from its geological deposits by both natural and anthropogenic activities (Shen et al., 2013; Winter, 
2017). In the water bodies, arsenic is highly persistent and can easily accumulate to toxic 
concentrations. Currently, millions of people worldwide are at the risk of chronic exposure to toxic 
forms of arsenic through contaminated water with consequences that affects immune system, and 
all major organs systems to cause carcinogenic and noncarcinogenic pathologies (Shakoor et al., 
2017). Consistent with the studies on humans and other mammals, exposure to inorganic arsenic 
also affects multiple vital organs of fish, and is also associated with reduced growth, poor 
reproductive performance, weak immune response, and impaired behavioral and cognitive 
functions (de Castro et al., 2009; Kumari et al., 2017; Szymkowicz et al., 2017). 
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The toxic effects of arsenic have been attributed to the generation of reactive oxygen species 
(ROS) and reactive nitrogen species (RNS), which eventually cause oxidative stress (Flora, 2011; 
Watanabe and Hirano, 2013). Although the precise mechanisms underlying arsenic mediated 
oxidative stress are not fully understood, it has been suggested that arsenite can disrupt redox 
potential by inducing changes in the mitochondrial membrane (Flora, 2011; Selvaraj et al., 2013a). 
In addition to the role of mitochondria, arsenite induced upregulation of flavin enzymes, such as 
NAD(P)H oxidase, is also known to generate ROS (Kumagai and Sumi, 2007). Inorganic arsenic 
is also known to disrupt cellular redox homeostasis indirectly by inhibiting antioxidative enzymes 
such as catalase (CAT), superoxide dismutase (SOD), and glutathione peroxidase (GPx) (Flora, 
2011; Jamwal and Niyogi, 2017). Arsenic-induced oxidative stress can alter the integrity of cellular 
biomolecules and signaling pathways, which is linked to carcinogenic as well as non-carcinogenic 
disorders (Shi et al., 2004). 
In aquatic ecosystem, arsenic can occur in four different oxidation states; however, the 
pentavalent arsenate [As(V)], and trivalent arsenite [As(III)] are the most environmentally and 
toxicologically relevant (Carlin et al., 2016; Zhu et al., 2014). Under normoxic conditions, As(V) 
is usually the dominant oxidation state, whereas As(III) is more abundant in hypoxic and acidic 
waters (Zhu et al., 2014). However, following the uptake by the living organisms, most of the 
absorbed As(V) is reduced to more toxic As(III) (Russell J. Erickson et al., 2011; McIntyre and 
Linton, 2012; Zhu et al., 2014). Most toxicological assessments of inorganic forms of arsenic in 
aquatic animals are conducted through waterborne exposures, and dietary exposure has received 
very little attention to date. It has been demonstrated that aquatic invertebrates can bioaccumulate 
arsenic to toxic concentrations and intoxicate the fish that feed on them even when the arsenic in 
water is below lowest-observed-effect-concentration (LOEC) (CCME, 2001; R. J. Erickson et al., 
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2011; US-EPA, 2015). Therefore, dietary exposure of arsenic is a more sensitive marker of 
environmental arsenic contamination to aquatic animals, including fish. 
The toxicity of arsenite is also confounded by its interactions with other metals, non-metals, 
and metalloids. Selenium (Se) is one such element that is known to interact with As (Zeng et al., 
2005; Zwolak and Zaporowska, 2012). Unlike arsenic, selenium is essential for the synthesis of 
selenoproteins that have various adaptive and housekeeping functions, especially in the 
maintenance of cellular redox homeostasis (Reich and Hondal, 2016). However, selenium is also 
a freshwater priority aquatic pollutant, and can induce ROS production and oxidative stress when 
its concentration in the body exceeds the physiological threshold (J.-H. Kim and Kang, 2015; 
Kupsco and Schlenk, 2014; Thomas and Janz, 2016; USEPA, 2014). Although a fish can be 
exposed to selenium via both water and diet, the latter is a predominant route of exposure, 
especially in its organic form (selenomethionine) (Janz, 2012). Therefore, it is important to 
investigate how dietary selenomethionine modulates arsenite toxicity in a dose dependent manner. 
The interaction between selenium and inorganic arsenic was first reported by Moxon and 
DuBois, (1939) in rats. Later, the ameliorative effect of selenium against arsenic (as arsenate and 
arsenite) toxicity was also demonstrated in the fish epithelial cell lines (Babich et al., 1989). More 
recently, selenium was shown to partially antagonize arsenite toxicity in fish hepatocytes by 
restoring cellular redox homeostasis (Jamwal and Niyogi, 2017; Selvaraj et al., 2012); although, 
the ameliorative effects of selenium were seen only at relatively low concentration (10 – 20 µM) 
(Jamwal and Niyogi, 2017). These in vitro studies provide a prima facie evidence that selenium 
can antagonize arsenite-induced oxidative stress in fish. However, there is a complete lack of 
information on how these two metalloids interact in any aquatic animal in vivo, and our 
understanding on this subject is derived solely from mammalian literature. In addition to the 
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antioxidative effects, mammalian literature also suggests that selenium can form complexes with 
arsenite, which is either biologically inert or less toxic (Burns et al., 2008; Gailer, 2007; Korbas et 
al., 2008). It has also been suggested that selenium can reduce tissue accumulation of arsenic by 
increasing its depuration rate (Hilmy et al., 1991; Krohn et al., 2016; Sah et al., 2013). However, 
some reports have also indicated that inorganic arsenic can have synergistic toxic effects with 
methylated selenium or methylated metabolites of selenium (Kraus and Ganther, 1989; Levander, 
1977). More recently, it was suggested that selenium can prevent complete methylation of 
inorganic arsenic, and thus increase retention of monomethylated arsenicals in the tissues, which 
are more toxic than their inorganic counterparts (Styblo and Thomas, 2001; Walton et al., 2003). 
These studies indicate that there is no general consensus on how arsenic and selenium may interact 
even within the mammalian system. Since both arsenic and selenium are important aquatic 
pollutants, a cohesive scientific enquiry on aquatic animals is also warranted linking their 
interaction with oxidative stress and tissue-level distribution.   
The present study is the first in-depth investigation on how the interactions between arsenite 
and selenium in the fish diet are influenced by different selenium exposure concentrations. The 
juvenile rainbow trout were exposed to an environmentally relevant dietary dose of arsenite in 
combination with diferent doses of dietary selenium [control (low), moderate and high; as 
selenomethionine]. The specific objectives of this study were to examine: (i) how the interaction 
between dietary selenomethionine and arsenite affect the morphophysiological indices (condition 
factor, hepatosomatic index) of fish, (ii) the modulatory effects of selenomethionine on the 
arsenite-induced hepatic oxidative stress, and (iii) how the interactions between arsenite and 
selenomethionine influence the tissue-level deposition of each element. Furthermore, arsenic can 
cross blood-brain barrier and have deleterious effects on neurological development and congnitive 
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functions, in both mammals and fish (Au and Kwong, 2008; de Castro et al., 2009; Palaniappan 
and Vijayasundaram, 2009; Prakash et al., 2016), we used synchrotron based X-ray fluorescence 
imaging to map the depostion of arsenic and selenium in the telencephalic region of the fish brain. 
Telencephalon is a highly specialized region of the fish cerebellum that is involved in critical 
behavioural and learning functions such as breeding, parental care, learning, and foraging (Gómez 
et al., 2011; Rodriguez et al., 2005). We hypothesized that selenium would influence arsenite 
toxicity in a dose-specific manner by modulating hepatic redox potential, and accumulation of 
arsenic in critically important tissues such as kidney, liver, muscle and brain. 
5.2. Materials and methods 
5.2.1. Experimental Fish 
Rainbow trout eggs were hatched in the Aquatic Toxicology Research Facility (ATRF), at 
the University of Saskatchewan. The fish were raised in dechlorinated, aerated water [alkalinity 
105 mg L-1 (both as CaCO3), hardness 159 mg L-1, dissolved organic carbon (DOC) 2.1 mg L-1, pH 
7.5 – 7.8, Se 5.2 µg L-1, Cd < 0.1 µg L-1] in a flow-through system (1 L min-1). The photoperiod 
was set at 14:10 h light to dark cycle and water temperature was maintained at 12 oC. The fish were 
fed at 2 % body weight ratio (wet wt.) with commercial feed during the husbandry period. The 
juveniles, weighing 30  35 g, were used for the experiment.  
5.2.2. Diet preparation  
 The diets were prepared using frozen brine shrimp (Artemia franciscana). Nominal 
concentrations of Se (10 and 40 µg g-1 dw) and As (80 µg g-1 dw), in the form of selenomethionine 
and sodium arsenite (NaAsO2), respectively were dissolved in de-ionized distilled water, added to 
frozen Artemia, and blended in commercial blender for 10 min. Carboxymethyl cellulose (2 % 
w/w. dw basis) was used as a feed binder. The mix was frozen at −20 oC and freeze-dried (Labconco 
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Freezone, USA). The freeze-dried feed was cut into small pieces (~0.5 cm), and stored in air-tight 
containers in -20 oC until used. The control diet (normal selenium and normal arsenite levels) was 
prepared similarly, without the addition of selenomethionine or NaAsO2. The final concentration 
of selenium and arsenic in the diets was analyzed by atomic absorption spectroscopy (AAS), as 
described later. 
5.2.3. Experimental treatments and sampling 
The fish were divided into six different treatment groups which are identified as: control 
(normal selenium and arsenic), arsenite only (normal selenium and 80 µg arsenic g-1 diet), medium 
SeMet only (10 µg selenium g-1 diet), High SeMet only (40 µg selenium g-1 diet), arsenite + 
medium SeMet (10 µg selenium + 80 µg arsenite g-1 diet), arsenite + high SeMet (40 µg selenium 
+ 80 µg arsenite g-1 diet). Each treatment was run in duplicate, with five fish in each replicate. Five 
fish from each treatment group were weighed randomly every week to maintain the feeding ration 
at 2 % body weight. The fish consumed the diet within 3 minutes of feeding. Each tank received 
continuous aeration and the water flow-through rate was maintained at 8 L min-1 to ensure rapid 
flushing of metabolites, excreta, selenomethionine or arsenic that could have potentially leached 
out of the diet. Fish were starved for 24 h before the final take down of the experiment. On the 30th 
day, fish from each treatment were euthanized with an overdose of AquacalmTM (metomidate 
hydrochloride; Syndel, USA). Four fish from each replicate treatment were randomly sampled to 
obtain a sample size (n) of 8. Length and weight of each fish was measured. Liver, kidney, brain 
and muscle were dissected from each fish. Liver from each was also weighed for the estimation of 
hepatosomatic index (HSI). Liver, kidney, and muscle were immediately frozen in liquid nitrogen 
and stored in -80 oC until used. Fish brains were embedded in optimal cutting temperature (OCT) 
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compound and frozen in liquid nitrogen. The frozen brain samples were sectioned to 12 µm thick 
sections using a cryotome and mounted on Thermanox plastic coverslips (Gibco BRL).  
5.2.4. Estimation of hepatic lipid peroxidation (LPO) 
The extent of lipid peroxidation (LPO) in fish livers was estimated by thiobarbituric acid 
reactive substance (TBARS) assay. A 96 micro-well plate based commercial TBARS kit 
(Catalogue # 10009055; Cayman chemical company, USA) was used for the estimation of LPO. 
The hepatic LPO was expressed as nmol MDA mg-1 tissue protein.   
5.2.5. Measurement of hepatic thiol content 
The hepatic concentration of reduced (GSH) and oxidized (GSSG) glutathione were 
measured using fluorometric method (Hissin and Hilf, 1976), modified to a 96-well microplate 
based assay as described in Jamwal and Niyogi (2007). The GSH and GSSG contents were 
expressed as µg mg protein-1. The hepatic GSH content was divided by GSSG concentration to 
obtain thiol ratio (GSH:GSSG).  
5.2.6. Measurement of antioxidant enzyme activities 
The thawed livers were homogenized in 5 times its volume (w/v) of chilled HEPES-EGTA 
sample buffer (1mM EGTA, 210 mM mannitol, 70 mM sucrose, and 20mM HEPES, pH 7.2) using 
a hand-held homogenizer. The homogenate was centrifuged at 25,000 x g for 20 min at 4 oC to 
obtain supernatant with enzyme fraction. The activities of three antioxidant enzymes, catalase 
(CAT), superoxide dismutase (SOD) and glutathione peroxidase (GPx) were estimated using SOD 
(Catalogue #706002), CAT (Catalogue #707002), and GPx (Catalogue #703102) kits as per the 
manufacturer’s instructions (Cayman chemical company, USA). The activities of CAT, SOD, and 
GPx were expressed as nmol mg protein-1, U mg protein-1 and nmol min-1 mg protein-1, 
 122 
 
respectively. One unit of SOD is defined as the amount of enzyme needed to exhibit dismutation 
of the superoxide radical by 50%.  
5.2.7. Measurement of selenium and cadmium in water, diet and tissue 
 The concentration of selenium and arsenic in water, diet and tissues was measured using a 
graphite-furnace atomic absorption spectroscopy (Analyst 800, PerkinElmer, USA). The water 
samples were acidified with 1% HNO3, and filtered through 0.45 µm filter before analysis. The 
experimental diets and tissues were digested in 5 volumes of 2 N HNO3 at 60oC for 48 h, and then 
was centrifuged at 10,000 RCF for 20 min. The supernatant was extracted and diluted with 0.2 % 
HNO3, to analyze for total selenium and arsenic concentrations using a graphite-furnace atomic 
absorption spectrometer (AAnalyst 800, Perkin Elmer, USA). Appropriate method blanks and 
certified standards for both metals were used to maintain the quality control and assurance of 
selenium and arsenic analysis (PerkinElmer, USA). Certified reference materials (DOLT-3; 
National Research Council, Canada) were also used to validate the results. The recovery of 
selenium and arsenic were 97 % and 93 %, respectively. 
5.2.8. X-ray fluorescence imaging (XFI) 
The pallium region of the telencephalon was scanned for the imaging. Due to limited 
beamtime, only two to three representative brain sections from each treatment were scanned.  The 
XFI data was collected at the 20-ID-B,C beamline of the Advanced Photon Source in Argonne 
National Laboratory, Illinois following the protocol and experimental set-up as described by 
McDonald et al., (2015). The Rh-coated Kirkpatrick-Baez mirrors were used to obtain X-ray beams 
of size 2.5 µm vertical and 2.7 µm horizontal, and incident at 45o on the samples. The X-ray beam 
was monochromated by diffraction from silica crystals. The incident X-ray energy for the imaging 
was selected at 13.45 keV which was above both selenium K-edge and the arsenic K-edge, but 
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below bromine K-edge to avoid bromine fluorescence from plastic components of the setup. 
Initially, fluorescence signals from the larger area of the telencephalon were collected in “fly scan” 
mode with 15 µm beam size and 0.2 s dwell time to detect the regions of arsenic and selenium 
localization. Later, smaller regions of interest were scanned for higher resolution with 5 µm step 
size and 0.6 s dwell time.  The integrated fluorescence spectra of smaller regions of interest were 
extracted to determine the average elemental concentration in µg cm-2 and quantification was 
performed by comparison to the spectra from CdSe and GaAs elemental standards with known 
concentration (15.6 µg cm-2 and 16.3 µg cm-2, respectively). The concentration of arsenic and 
selenium was quantified as areal density a and expressed in units of µg cm-2. Analysis of the image 
was performed using SMAK MicroAnalysis toolkit (https://www.sams-xrays.com/smak). 
5.2.9. Calculations and statistical analysis 
Hepato-somatic index and condition factor (K-factor) were used as the physiological 
indicators of energy status of fish and calculated as follows: HSI = weight of liver (g)/ weight of 
the fish (g)] and condition factor (K) =  100 X weight of the fish (g)/ length (cm)3. SigmaPlot 
(version 12.5, Systat Software, Inc. USA) was used for statistical analysis and preparation of 
graphs, except for the analysis and graphing of the X-ray fluorescence imaging (XFI) data. The 
data are presented as mean ± standard error of mean (S.E.M.). Interactive effects of SeMet and As 
were analyzed by two-way analysis of variance (2-WAY ANOVA). Pairwise multiple comparison 
(post hoc) with Holm-Sidak correction was performed to determine the effect of different 
treatments. The assumptions of ANOVA, such as normality of distribution and heteroscedasticity, 
were verified using Shapiro-Wilk and Brown-Forsythe test, respectively. Data was subjected to 
logarithmic transformation when the assumption of normality was violated. A p-value of ≤ 0.05 
was considered to be significant while comparing different treatments. A Pearson correlation 
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analysis was conducted to assess the relationship between hepatic arsenic accumulation, lipid 
peroxidation and the activities of enzymatic antioxidants. For the correlation plots of XFI data, the 
error in both abscissa and ordinate axis were accounted to minimize the sum of square of the 
perpendicular distance from each point to the line. A custom designed program was used for the 
computation and graphing of the XFI data (MacDonald et al., 2015).  
5.3. Results 
5.3.1. Fish morphometrics [Hepato-somatic index (HSI) and condition factor (K-factor)] 
 No fish mortality was recorded in any of the treatments during the experimental exposure 
period. The interaction between arsenite and selenomethionine had a statistically significant effect 
on the fish HSI (F2,31 = 6.82; p = 0.003; Table 5.1). Supplementing the diet with arsenite, alone or 
in combination with high selenomethionine reduced the HSI by 50 %, (p < 0.001), while the 
reduction in HSI in fish treated with arsenite and medium SeMet was about 30 % relative to the 
control (p <0.001). The diet supplemented with only high selenomethionine also had a deleterious 
effect and reduced the HSI by 20 %, when compared to the control (p = 0.003); however, the fish 
fed with medium SeMet diet demonstrated an increase in the HSI by the same proportion (20 %) 
relative to the control (p = 0.008). No significant interaction between arsenite and selenomethionine 
was recorded for K-factor (F2,37 = 1.12; p = 0.339; Table 5.1); however, a significant decrease, 
relative to the control, was observed only in the fish treated with arsenite only diet (p = 0.031; 
Table 5.1). 
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Table 5.1. Physiological indicators of health of juvenile rainbow trout exposed to different 
dietary treatments of arsenite and/or selenomethionine (SeMet). 
Treatments HSI Condition factor (K) 
Control 0.025 ± 0.0011a 1.38 ± 0.088A 
Arsenite only 0.013 ± 0.0006b 1.17 ± 0.023B 
Medium SeMet 0.030 ± 0.0014c 1.35 ± 0.049A 
High SeMet 0.020 ± 0.0010d 1.29 ± 0.019A 
Arsenite + Med SeMet 0.017 ± 0.0009bd 1.22 ± 0.050A 
Arsenite + High SeMet 0.013 ± 0.0004b 1.21 ± 0.057A 
Values are mean ± SEM, n = 5 - 8. HSI = hepatosomatic index. Values with different alphabetic 
superscripts represent statistical difference among the treatments for a particular parameter (p < 
0.001). Similar superscripts represent no statistical difference (p > 0.05), as determined by 2-
WAY ANOVA and post hoc analysis. 
 
5.3.2. Hepatic thiol redox balance 
 A statistically significant interaction between arsenite and selenomethionine was recorded 
for hepatic GSSG and thiol ratio (GSH:GSSG), but not for GSH. However, there was a significant 
simple-main effect of the treatments on the GSH (Fig. 5.1). Exposure to arsenite only diet 
significantly reduced GSH content by 2.3 folds, whereas it increased GSSG level by 1.5-fold. As 
a result, there was a significant reduction in the GSH:GSSG ratio, relative to the control (p < 0.001; 
Fig. 5.1). The hepatic concentrations of thiols and their relative ratio did not differ significantly 
from the control when fish were fed with the diet supplemented with medium or high 
selenomethionine only (p > 0.05; Fig. 5.1). However, the GSH and GSH:GSSG ratio were 
significantly reduced, in comparison to the control, when the diets were supplemented with arsenite 
and selenomethionine (p < 0.001; Fig. 5.1). Supplementing the arsenite diet with medium 
selenomethionine reduced GSH and GSH:GSSG ratio by 1.7 and 2.2-folds, respectively relative to 
control (p < 0.001), whereas the reduction in GSH and GSH:GSSG in fish fed with arsenite + high 
selenomethionine diet was 3 and 4-folds, respectively (p < 0.001; Fig. 5.1). 
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5.3.3. Hepatic lipid peroxidation (LPO) 
 There was a significant effect of the interaction between arsenite and selenomethionine on 
the hepatic lipid peroxidation (F2,30 = 7.423; p = 0.002). The hepatic MDA level in fish fed with 
dietary arsenite, alone or in combination with medium selenomethionine, was 2.5 to 3-folds higher 
than the control (p < 0.001; Fig. 5.2). The hepatic lipid peroxidation following the treatment with 
arsenite + high selenomethionine was even higher than in fish treated with arsenite only diet. The 
hepatic MDA levels following treatment with arsenite + high selenomethionine were 5-folds and 
2-folds greater than in control and arsenite only treatment group, respectively (p < 0.001; Fig. 5.2). 
A Pearson correlation analysis also revealed that the degree of lipid peroxidation was higher with 
increased accumulation of arsenic in the hepatic tissue (r = 0.306; p = 0.039; Table 5.2). However, 
no change in the hepatic MDA levels, relative to control, was observed in fish treated exclusively 
with medium selenomethionine and high selenomethionine dietary treatments (p > 0.90; Fig. 5.2). 
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Figure 5.1: Concentration of reduced (GSH) and oxidized (GSSG) glutathione, and their ratio 
(GSH:GSSG) in the liver of rainbow trout exposed to various treatments. Data are presented as 
mean ± SEM (n = 6). For GSH and GSSG the statistical significance is denoted with small letters, 
and capital letters respectively. The bars with different letters are statistically different (p < 0.05). 
For GSH:GSSG, an asterisk (*) represents statistically significant difference in comparison to the 
control group and the data-points without an asterisk are statistically similar to each other (p < 
0.05). 
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Figure 5.2: Concentration of hepatic malondialdehyde (MDA) measured as a biomarker of lipid 
peroxidation (LPO) exposed to different dietary treatments of arsenite and/or selenomethionine 
(SeMet). Data are presented as mean ± SEM (n = 6 – 8). The experimental treatments with different 
alphabetical notations are significantly different (p < 0.005) from each other, while the treatments 
with common alphabetical notations have no significant difference among them, as determined by 
2-WAY ANOVA and post hoc analysis. 
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5.3.4. Hepatic antioxidative enzymes 
 The effects of dietary treatments on the activities of the hepatic antioxidative enzymes 
(CAT, SOD, and GPx) are illustrated in the Fig. 5.3. There was no interactive effect of dietary 
arsenite and selenomethionine on the CAT activity (F2,31 = 0.05; p = 0.95). However, the simple-
main effects revealed that exposure to arsenite, alone or in combination with medium or high 
selenomethionine resulted in a significant increase (~50%) in the CAT activity, in comparison to 
the control (p < 0.001; Fig. 5.3 A). A two-tailed Pearson correlation analysis revealed a strong 
correlation between CAT activity and hepatic arsenic accumulation (r = 0.532; p = 0.001; Table 
5.2).  In contrast, no significant change in CAT activity was recorded in fish treated exclusively 
with medium and high selenomethionine only diets (p > 0.1; Fig. 5.3 A).  
 Similar to the CAT activity, there was no interactive effect of arsenite and selenomethionine 
on the activity of the hepatic SOD enzyme (F2,32 = 0.469; p = 0.63), although exposure to arsenite 
only diet led to a 1.5-fold increase in the activity of SOD in contrast to the control (p < 0.001; Fig. 
5.3 B). Dietary exposure to both, arsenite + medium selenomethionine, and arsenite + high 
selenomethionine diets resulted in more than 2-folds increase in the SOD activity when compared 
to the control (p < 0.001, Fig. 5.3 B). A significant correlation was also revealed between SOD 
activity and hepatic concentration of arsenic (r = 0.733; p = 0.002; Table 3). However, no change 
in the activity of hepatic SOD, in contrast to the control, was observed when fish were fed with 
medium and high selenomethionine only diets (p > 0.5; Fig. 5.3 A). 
 An interactive effect of dietary arsenite and selenomethionine on hepatic GPx was revealed 
by the 2-Way ANOVA test (F2,26 = 3.95; p = 0.032). No effect on the GPx activity was recorded 
due to medium and high selenomethionine only diets in comparison to the control (p > 0.1; Fig. 
5.3 C). Dietary exposure to arsenite alone led to a significant increase (36 %) in the hepatic GPx 
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activity, in contrast to the control (p = 0.035; Fig. 5.3 C). Interestingly, dietary exposure to arsenite 
+ high selenomethionine resulted in an increase in the hepatic GPx activity, which was 112 % and 
56 % higher than the control and arsenite only treatment groups, respectively (p < 0.001; Fig. 5.3 
C). Similarly, dietary exposure to arsenite + medium selenomethionine resulted in the GPx activity 
that was 77 % and 30 % higher than the fish fed with control and arsenite only diets, respectively 
(p < 0.001; Fig. 5.3 C). Moreover, the GPx activity following treatment with arsenite + high 
selenomethionine was also statistically higher than the fish fed with arsenite + medium 
selenomethionine diet (p = 0.04; Fig. 5.3 C). Similar to CAT and SOD, the activity of GPx enzyme 
was also strongly correlated with the accumulation of arsenic in liver tissue (r = 0.397; p = 0.27; 
Table 5.2). 
Table 5.2. Pearson correlation coefficient of analyzed hepatic anti-oxidative enzymes or lipid 
peroxidation and hepatic arsenic (As) concentration. 
Enzymatic anti-oxidant Pearson correlation 
coefficient (r) 
p - value 
Catalase (CAT) 0.532 0.001 
Superoxide dismutase (SOD) 0.490 0.002 
Glutathione peroxidase (GPx) 0.397 0.027 
Lipid peroxidation (LPO) 0.306 0.039 
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Figure 5.3: Changes in the hepatic activities of (A.) catalase (CAT), (B.) superoxide dismutase (SOD), and (C.) glutathione peroxidase 
(GPx) exposed to different dietary treatments of arsenite and/or selenomethionine (SeMet). Data are presented as mean ± SEM (n = 5 
– 8).  In each figure panel (A, B, or C), experimental treatments with different alphabetical notations are significantly different (p < 
0.005) from each other, while the treatments with common alphabetical notations have no significant difference among them, as 
determined by 2-WAY ANOVA and post hoc analysis. 
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5.3.5. Accumulation of arsenic and selenium in hepatic, renal, and muscle tissue 
 A significant interaction between dietary arsenite and selenomethionine existed for the 
accumulation of arsenic in liver (F2,33 = 7.99; p = 0.001), but not in kidney (F2,31 = 2.90; p = 0.07) 
and muscle (F2,33 = 2.353; p = 0.11). Following the treatment with arsenite only diet, a significant 
accumulation of arsenic was observed in all the tissues (p < 0.001) with a maximum (38 folds) 
increase in the liver, followed by a modest increase in the kidney and muscle (3 and 2-folds, 
respectively), relative to the control (Fig. 5.4 A-C). The range of arsenic concentrations observed 
in all of the tissues from selenomethionine only dietary treatments (medium or arsenite) was similar 
(0.3 – 1.5 µg g-1 tissue), and significantly higher than their respective controls (p < 0.007; Fig. 5.4). 
The concentration of arsenic in kidney and muscle from selenomethionine only dietary treatments 
(medium or high) was also statistically similar to the arsenite only treatment group (p > 0.08; Fig. 
5.4 B, C). Although the hepatic concentration of arsenic in medium or high selenomethionine 
dietary groups was statistically higher than the control (p > 0.007), it was significantly lower than 
the hepatic arsenic levels observed in the arsenite only treatment (p > 0.001; Fig. 5.4A). The dietary 
treatment of arsenite and medium or high selenomethionine also resulted in significantly higher 
arsenic levels in all the tissues, in comparison to the control (p < 0.001; Fig 5.4 A-C). Interestingly, 
the arsenic accumulation in muscle following treatment with arsenite + high selenomethionine diet 
was twice as high as the arsenic concentration in muscle from arsenite only dietary treatment (p = 
0.039; Fig. 5.4 C). 
 An interactive effect of dietary arsenite and selenomethionine on selenium accumulation 
was revealed by 2-Way ANOVA in the liver (F2,33 = 9.69; p < 0.001) and muscle (F2,31 = 9.123; p 
< 0.001), but not in the kidney (F2,31 = 0.894; p = 0.419). The selenium accumulation in all of the 
tissues following treatment with arsenite only was significantly lower than the control (p < 0.001; 
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Fig. 5.5). There was a 4-fold and 6-fold increase in the hepatic Se concentration, relative to the 
control, following treatment with medium and high selenomethionine only diets, respectively (p < 
0.001; Fig. 5.5 A). Although the concentration of selenium in renal and muscle tissue also increased 
after treatment with selenomethionine only diets (both medium and high), the selenium 
accumulation between the two treatment groups was not statistically different (p > 0.367; Fig. 5.5 
B, C). Presence of arsenite in the diet supplemented with medium selenomethionine did not change 
the selenium accumulation pattern relative to that in the medium selenomethionine only treatment. 
However, a similar 2-fold decrease in the Se accumulation was recorded in the liver and kidney 
following treatment with arsenite + high selenomethionine in comparison to the high 
selenomethionine only diet (p < 0.001; Fig. 5.5 A and B).
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Figure 5.4: Concentration of arsenic in the liver (A) kidney (B), and muscle (C) in rainbow trout exposed to dietary treatments with 
arsenite and/or selenomethionine. Values are mean ± SEM (n = 6-8). In each figure panel (A, B, or C), experimental treatments with 
different alphabetical notations are significantly different (p < 0.005) from each other, while the treatments with common alphabetical 
notations have no significant difference among them, as determined by 2-WAY ANOVA and post hoc analysis.  
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Figure 5.5: Concentration of selenium in liver (A.) kidney (B.), and muscle (C) in rainbow trout exposed to dietary treatments with 
arsenite and/or selenomethionine (SeMet). Values are mean ± SEM (n = 6-8). In each figure panel (A, B, or C), experimental treatments 
with different alphabetical notations are significantly different (p < 0.005) from each other, while the treatments with common 
alphabetical notations have no significant difference among them, as determined by 2-WAY ANOVA and post hoc analysis.
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5.3.6. X-ray fluorescence imaging (XFI) of the fish telencephalon 
 The images from the representative brain sections showing the spatial distribution of 
arsenic and selenium in the telencephalic pallium are presented in the Fig. 5.6  5.8. The control 
showed no detectable amount of arsenic or selenium in the brain (Fig. 5.6 B). Following treatment 
with arsenite only diet, arsenic was detected in few randomly distributed hotspots within the 
pallium of the rainbow trout brain; however, selenium was below the limit of detection (Fig. 5.6 
C). Supplementation of the diet with selenomethionine, alone or in combination with arsenite, 
resulted in uptake of both arsenic and selenium which were highly co-localized along the 
telencephalic ventricle (Fig. 5.7 and 5.8). In addition to the spatial co-localization, the 
concentration of arsenic and selenium also exhibited a high degree of correlation (R2 > 0.90; Fig. 
5.9). Following treatment with medium selenomethionine only diet, arsenic and selenium existed 
in equimolar ratio in their regions of maximum accumulation (hotspots), and their spatial densities 
ranged between 0.01 and 0.02 µg cm-2.  However, in fish fed with high selenomethionine only diet, 
the concentration of arsenic exceeded selenium by 3  5 folds. 
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Figure 5.6: (A.) Transverse section of a fish brain embedded in OCT solution highlighting the 
telencephalic ventricle (TV) region in orange colour. The black rectangle indicates the region of 
the telencephalon scanned for the purpose of XFI. (B.) X-ray fluorescence images of the 
telencephalic region of the fish brain demonstrating the spatial localization of sulfur (top), arsenic 
(bottom-left) and selenium (bottom-right) in fish exposed to control diet (C.) X-ray fluorescence 
images of the telencephalic region of the fish brain demonstrating the spatial localization of sulfur 
(top), arsenic (middle) and selenium (bottom) in fish exposed to only arsenite supplemented diet. 
Each section was imaged with a step size of 5 µm and dwell time of 0.6 s. The concentration of 
arsenic and selenium are illustrated as areal density (µg cm-2). The distribution of sulfur is presented 
to illustrate the area of telencephalon that was scanned.
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Figure 5.7: X-ray fluorescence images of the telencephalic region of the fish brain demonstrating the spatial localization of arsenic (top) 
and selenium (bottom) in fish exposed to diets supplemented with medium selenomethionine (left) or high selenomethionine (right) only. 
Each section was imaged with a step size of 5 µm and dwell time of 0.6 s. The concentration of arsenic and selenium are illustrated as 
areal density ranges (µg cm-2). 
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Figure 5.8: X-ray fluorescence images of the telencephalic region of the brain demonstrating the 
spatial localization of arsenic (top) and selenium (bottom) in fish exposed to dietary arsenite 
supplemented with medium selenomethionine (left) or high selenomethionine (right). Each section 
was imaged with a step size of 5 µm and dwell time of 0.6 s. The concentration of arsenic and 
selenium are illustrated as areal density ranges (µg cm-2). 
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Figure 5.9: Correlation plots of arsenic vs. selenium for the representative images from the 
treatments, (A.) medium selenomethionine only, (B.) high selenomethionine only, (C.) arsenite + 
medium selenomethionine, and (D.) arsenite + high selenomethionine. The straight lines represent 
the lines of best fit and were obtained from the linear regression analysis of the XFI data. The 
correlation coefficient (R2) of the data are mentioned in the respective graphical illustration.  
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5.4. Discussion 
 To the best of our knowledge, this is the first study to investigate the interaction between 
dietary arsenite and selenomethionine in any aquatic animal. Our main objective was to examine 
the modulatory effects of environmentally relevant doses of dietary selenomethionine on arsenite 
induced oxidative stress and its tissue-level accumulation in freshwater fish. The measured dietary 
selenium concentration (1.2 ± 0.7 µg g-1) in the control diet was within the physiologically 
optimum range for dietary selenium requirement (0.1  4.7 µg g-1 dry wt.) in rainbow trout 
(Hodson and Hilton, 1983). The measured selenium concentration in the diets supplemented with 
medium and high levels of  selenomethionine was in the range of 12  14 and 46  48 µg g-1 dry 
wt., respectively (Table. 5.3).  Similar concentrations of selenium have also been reported in the 
aquatic food chain of the selenium contaminated sites in North American (Hamilton, 2004). 
Similarly, the macroinvertebrates living in the arsenic contaminated freshwater habitats have been 
reported to accumulate arsenic similar to the dietary concentrations used in this experiment (78 – 
88 µg g-1 dry wt) (Phillips, 1990). 
Table 5.3. Measured selenium and arsenic concentrations in different diets (µg g-1 feed dry 
weight).  
Treatments Se (µg g-1) As (µg g-1) 
Control 1.2 ± 0.7a 3.4 ± 0.8A 
Arsenite only 1.3 ± 0.9a 88.4 ± 2.7B 
Medium SeMet 12.2 ± 1.9b 2.8 ± 0.6A 
High SeMet 46.1 ± 3.1c 3.3 ± 0.9A 
Arsenite + Med SeMet 13.7 ± 1.2b 78.4 ± 3.0B 
Arsenite + High SeMet 47.8 ± 2.1c 81.6 ± 3.3B 
Values are mean ± SEM, n = 3 for the selenium and arsenic in the diets. Values with different 
alphabetic superscripts represent statistical difference in the concentration of a particular element 
between different treatments (p < 0.001). Similar superscripts represent no statistical difference 
(p > 0.05), as determined by 1-WAY ANOVA and post hoc analysis. 
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 The HSI and K-factor are one of the most commonly used general biomarkers of stress and 
environmental pollution at the tissue-level (Al-Ghais, 2013; Chellappa et al., 1995). Under normal 
physiological conditions, fish converts the excess dietary energy in liver and adipose tissue in the 
form of glycogen and fat reserves (Enes et al., 2009). However, when under chronic stress, such 
as exposure to aquatic pollutants, the energy needed to maintain homeostasis may exceed the 
assimilated dietary energy. As a result, a fish may use its hepatic glycogen reserves to compensate 
for the dietary energy deficit, which in the long run reduces the mass of the liver. The reduced liver 
weight, in proportion to the total weight of the body, is reflected by a decreased HSI. In addition, 
a fish may also utilize its muscular fat deposits to meet the energetic cost of homeostasis, and result 
in a decreased K-factor. In the present study, we observed that chronic exposure to dietary arsenite, 
alone or in combination with medium or high selenomethionine, reduced the HSI (Table 5.1), and 
was therefore energetically stressful to the fish. It should also be noted that the there was a slight 
but modest decrease in the HSI due to chronic exposure to high dose of selenomethionine alone, 
which alludes to the mild toxic nature of the high dose of selenomethionine used in this study. The 
K-factor, in contrast, seemed to be a less sensitive indicator and reflected chronic stress only when 
fish were fed with diet supplemented with arsenite alone. 
 Cells have evolved an efficient anti-oxidative strategy to mitigate the deleterious effects of 
ROS that are generated during aerobic respiration; however, exposure to a toxic dose of trace 
elements, such as arsenic and selenium, can increase the rate of ROS production and overwhelm 
the anti-oxidative machinery. Reduced form of glutathione (GSH) is a part of cellular anti-
oxidative machinery that readily neutralizes ROS by donating its electron, and during this process 
itself becomes oxidized to glutathione disulfide (GSSG). Since the cellular concentrations of GSH 
and GSSG are coupled with each other, a decrease in the concentration of GSH relative to GSSG 
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(reduced GSH:GSSG ratio) is often used as an indicator of oxidative stress. Previous literature 
indicates that toxicity due to chronic arsenite exposure is highly correlated with the reduced GSH 
levels in the tissues (Adeyemi et al., 2015; Sarkar et al., 2014; Xu et al., 2017). Therefore, 
maintenance of cellular GSH pool is of critical importance for defending against arsenite-induced 
toxicity. The cellular pool of GSH can be maintained by a combination of 3 processes (Chung and 
Maines, 1981; Jamwal and Niyogi, 2017; Richie et al., 2011): (i) the de novo synthesis of GSH, 
catalyzed by γ-glutamyl-cysteine ligase (ii) recycling of GSSG to GSH by glutathione reductase 
enzyme, and (iii) alleviation of oxidative stress by other anti-oxidants so that GSH is spared. Under 
chronic arsenite exposure, the hepatic thiol ratio can be reduced if the rate of oxidation of GSH 
overwhelms the GSSG recycling, or if the de novo synthesis of GSH is compromised. In the present 
study, a sharp decline in the hepatic GSH:GSSG ratio (Fig. 1) and a concomitant increase in the 
lipid peroxidation (Fig. 2) following the treatment with arsenite, alone or in combination with 
selenomethionine (medium or high), suggests increased cellular ROS accumulation. Although ours 
is the first study to provide a direct evidence of hepatic oxidative stress in response to dietary 
arsenite in a fish, previous experiments with waterborne arsenite have also reported hepatotoxicity 
in fish due to impaired redox homeostasis (Adeyemi et al., 2015; Greani et al., 2017a; Sarkar et 
al., 2014). In addition to generation of ROS, the arsenites, or the trivalent from of arsenic, also 
have strong affinity for the sulfhydryl groups (Shen et al., 2013). It is important to note here that 
the presence of a sulfhydryl group lends GSH its biological activity; therefore, binding of arsenite 
to this active group can inhibit the functional capacity of GSH and impair cellular redox balance. 
Moreover, the metabolic reduction of inorganic arsenic occurs only in the presence of the thiol 
compounds which can further reduce the cellular GSH concentration (Aposhian et al., 2004; 
Watanabe and Hirano, 2013). Therefore, exposure to the toxic doses of arsenic is expected to 
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contribute to the reduced GSH:GSSG ratio through a combination of processes involving its 
metabolism, generation of ROS,  and direct binding with GSH.  
We also observed a partial recovery of hepatic GSH:GSSG ratio with arsenite + medium 
selenomethionine dietary treatment (Fig. 5.1). It is known from previous studies that selenium, at 
optimal doses, can upregulate de novo synthesis of GSH (Chung and Maines, 1981; Jamwal and 
Niyogi, 2017; Richie et al., 2011). A modest increase in the hepatic GSH concentration with a 
dietary combination of arsenite and medium selenomethionine could be a result of selenium-
dependent upregulation of GSH synthesis (Fig. 5.1). A similar increase in the thiol ratio and GSH 
concentration during short-term (24 h) exposure to low doses of selenomethionine has also been 
observed previously with rainbow trout hepatocytes (Jamwal et al., 2016; Jamwal and Niyogi, 
2017). It should, however, be noted that the increase in the thiol ratio, in the present study, was not 
sufficient to prevent hepatic lipid peroxidation which was still elevated, as reflected by the MDA 
levels in the arsenite + medium selenomethionine treatment group (Fig. 5.2). Moreover, the dietary 
treatment of arsenite and high selenomethionine resulted in hepatic lipid peroxidation which was 
even higher than the arsenite only treatment group. This increase in lipid peroxidation was also 
accompanied by low GSH concentration and reduced thiol ratio in the trout liver. Based on an 
earlier estimate, long-term exposure to selenium exceeding 13 µg g-1 diet could be toxic to rainbow 
trout (Hodson and Hilton, 1983). Previous studies also demonstrated that both organic and 
inorganic forms of selenium, beyond a certain threshold concentration, can induce oxidative stress 
in fish (J.-H. Kim and Kang, 2015; Kupsco and Schlenk, 2014; Thomas and Janz, 2016). Even 
though we did not observe any detrimental changes in oxidative stress parameters exclusively due 
to high selenomethionine exposure, it is possible that dietary exposure to arsenite and 
selenomethionine was more toxic than their individual effects. Previously, Decker (2015) has also 
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reported no change in the hepatic thiol contents and lipid preoxidation when rainbow trout were 
chronically exposed to similar high dose (~ 37 µg g-1 diet) of dietary selenomethionine as used in 
the present study. However, a significant reduction in the HSI due to high dietary selenomethionine 
(Table 5.1) in the present study suggests that the high dose of selenomethionine, in isolation, 
involved high metabolic costs but did not impair cellular redox homeostatic machinery. It is 
possible that combination of high selenomethionine with arsenite overwhelmed the liver redox 
homeostatic machinery and resulted in higher lipid peroxidation. Although there are no precedents 
demonstrating the additive effects of arsenite and selenomethionine on lipid peroxidation, 
mammalian literature suggests that they both can potentiate each other’s toxicity through 
metabolic interactions (Kraus and Ganther, 1989; Levander, 1977; Styblo and Thomas, 2001; 
Thomas et al., 2001; Walton et al., 2003). 
In addition to the GSH, the cellular redox homeostatic machinery also consists of anti-
oxidative enzymes such as SOD, CAT, and GPx. Although the primary function of these enzymes 
is to protect against metabolically produced ROS (Benzie, 2000), they can also be induced in 
response to an external perturbation that causes increased production of oxyradical (Gül et al., 
2004). Therefore, increase in the activities of these enzymatic antioxidants are also used as 
effective biomarkers of exposure to environmental pollutants. The enzyme SOD converts toxic 
superoxide ions (O2•−) into H2O and H2O2, whereas CAT and GPx catalyze the conversion of H2O2 
into non-toxic H2O and O2 (Chelikani et al., 2004; Fukai and Ushio-Fukai, 2011; Mills, 1957). In 
the current study, the activities of all 3 antioxidative enzymes (SOD, CAT, and GPx) were 
upregulated in response to dietary arsenite treatment (Fig. 5.3). These results, in combination with 
previously discussed increase in lipid peroxidation and decreased GSH:GSSG ratio, suggest a 
compensatory response to the heightened oxidative stress caused by arsenite only dietary 
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treatment. Increase in the activities of anti-oxidative enzymes in response to arsenite exposure 
have also been observed in many other fish species, which is a defensive response to cope with the 
arsenite-induced oxidative stress  (Bhattacharya and Bhattacharya, 2007; Greani et al., 2017a; J. 
H. Kim and Kang, 2015; Sarkar et al., 2017). Although the cellular compensatory responses may 
enable an organism to survive a chronic stress, upregulation of antioxidative enzymes is also 
energetically expensive and may become unsustainable over a long term (Sokolova et al., 2012). 
An increase in the energetic burden of such compensatory response is also reflected as a significant 
reduction of HSI and K-factor, in the present study with fish exposed to arsenite alone. Consistent 
with our findings from thiol ratio and lipid peroxidation assays, the combination of arsenite with 
selenomethionine also resulted in significant upregulation of the activities of the enzymes, in 
comparison to the control. Therefore, a marked increase in the hepatic lipid peroxidation, despite 
the upregulated activities of anti-oxidative enzymes suggest that the combination of arsenite and 
selenomethionine could have overwhelmed the hepatic anti-oxidative response mechanism. It 
should also be noted that the activities of SOD and GPx, following the treatment with arsenite + 
high selenomethionine was even higher than the arsenite only group, further suggesting an additive 
interaction between arsenic and selenomethionine at the dose levels used in the present study. 
Biochemical and physiological responses to an environmental pollutant is highly 
dependent on its uptake and tissue burden, which is influenced by factors such as chemical 
speciation, water quality, exposure route, and temperature. Therefore, tissue-level accumulation 
of toxic element, and not merely its environmental presence, is a better indicator of hazardous 
exposure (McGeer et al., 2003). Presently, there is no consensus on how arsenite and 
selenomethionine may interact within a biological system, and a lack of understanding of the 
tissue-level accumulation of arsenic and selenium in their toxicological studies could be one of the 
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major reasons behind it. In the present study, we observed that chronic exposure to dietary arsenite, 
alone or in combination with selenomethionine, resulted in maximum accumulation of arsenic in 
the liver, followed by the kidney and muscle (Fig. 5.4). Similar tissue-specific pattern of arsenic 
accumulation was also reported in previous studies where fish were chronically exposed to arsenite 
(Jankong et al., 2007; J. H. Kim and Kang, 2015). Interestingly, supplementing the diet with 
selenomethionine also facilitated accumulation of arsenic in tissues even from the diets with only 
background level of arsenic (diets not supplemented with arsenite). In contrast, supplementation 
of arsenite in the diet dimnished the tissues-level accumulation of Se (Fig. 5). Selenium has been 
demonstrated to diminish the depuration rate of arsenic by interfering with As(III)-
methyltransferase, inhibting the complete metabolic methylation of arsenic in rats, and thus 
exacerbating the overall toxicity of arsenic (Levander, 1977; Styblo and Thomas, 2001; Thomas 
et al., 2001; Walton et al., 2003). In the present study, we also observed that the accumulation of 
arsenic was highly correlated with increased oxidative stress and its detrimental effects (Table 
5.2). Thus, it is likely that presence of selenomethionine increased the accumulation of arsenic and 
its toxicity via similar processes. This is the first study to demonstrate the modulatory effects of 
selenomethionine on tissue-specific accumulation of arsenic, and further investigations to 
determine the chemical speciation of arsenic and selenium in the tissues will be required to unravel 
the underlying mechanisms. It is important to note that even though the tissue-specific 
concentration of selenium was reduced in the presence of dietary arsenite, it was notably higher 
than the control levels. Therefore, deficiency of selenium cannot be attributed to the increased lipid 
peroxidation observed following dietary treatment with arsenite and selenomethionine. 
Brain is the primary organ that regulates the functions of all other vital organs in 
vertebrates, including fish. Although the complexity and size may differ, the vertebrate brain is 
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composed of distinct anatomical regions with highly specialized functions, and accumulation of 
toxic metals in specific brain regions can impair their associated roles. Previous research has 
established that metals and metalloids can have preferential distribution pattern in both mammalian 
and fish brain (MacDonald et al., 2015; Tarohda et al., 2004). In the current study, we used X-ray 
fluorescence imaging (XFI) to understand the distribution pattern of arsenic and selenium in the 
telencephalon of the rainbow trout brain (Fig. 5.6 A). Telencephalon of a fish is part of frontal 
cerebellum, and is involved in a large variety of critical behavioural and learning functions (Gómez 
et al., 2011; Rodriguez et al., 2005). In the present study, we recorded arsenic deposition in fish 
brain following chronic exposure to arsenic, which is consistent with previous findings (Bonnineau 
et al., 2016; Li et al., 2017). Arsenic is known to cross blood-brain barrier through 
aquaglyceroporins and glucose transporter (GLUT1) (Hamdi et al., 2009; Liu et al., 2006a), and 
has detrimental effects on neuronal development, locomotion and behavioural functions 
(Baldissarelli et al., 2012; Li et al., 2009). Interestingly, supplementation of diets with medium or 
high doses of selenomethionine resulted in increased uptake of both arsenic and selenium in fish 
brain, even when the diets did not contain supplemented arsenite (Fig 5.7). Moreover, arsenic and 
selenium also demonstrated high degree of spatial co-localization and correlation among their 
concentrations in the telencephalic ventricle region (Fig 5.7  5.9), which is a region of high 
neuronal proliferation in vertebrate brain (Barbosa et al., 2016). Intravenous injections of arsenite 
and selenite were also shown to result in increased co-localization of arsenic and selenium in 
multiple organs including liver and brain of hamster (Ponomarenko et al., 2017). However, this 
co-localization of arsenic and selenium was found to occur due to the formation of seleno bis-(S-
glutathionyl) arsenium ion, which was rapidly excreted out of the hamster’s body through bile. In 
contrast, our results suggest that the presence of selenomethionine in diet above the physiological 
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requirement of fish (> 3 µg g-1 diet) does not facilitate arsenic depuration, and instead leads to 
increased bioavailability and retention of arsenite in the fish brain. The apparent discrepancy 
between these two studies might have occurred due to the differences in chemical speciation of 
selenium (selenite vs. selenomethoinine), exposure route (intravenous injection vs. dietary 
exposure), exposure duration (30 minutes vs. 30 days) and/or test organisms (rat vs. fish). 
Nevertheless, our results from the brain tissue are also consistent with increased accumulation of 
arsenic in the liver, kidney, and muscle tissue in rainbow trout in the presence of dietary 
selenomethionine.  
Since we observed a high correlation between hepatic arsenic deposition and oxidative 
stress, it is possible that higher accumulation of arsenic in brain during co-exposure with selenium, 
can cause adverse effects on fish behaviour and cognitive functions. Our results also provide a 
prima facie evidence that use of selenomethionine as a therapeutic agent against environmental 
arsenic toxicity should be exercised with high caution, especially because of accumulation of 
arsenic and selenium in the regions of high neuronal proliferation. Further investigation are also 
needed to understand the mechanisms responsible for this complex arsenic-selenium inter-
relationship. 
5.5. Conclusion 
The present study demonstrated that supplementation of diet with selenomethionine, above 
the physiological requirements (> 3 µg g-1) , resulted in increased retention of arsenic in liver, 
kidney, brain, and muscle tissues. Exposure to a dietary combination of arsenite (~ 80 µg g-1 diet) 
with high selenomethionine (~40 µg g-1 diet) overwhelmed the hepatic anti-oxidative machinery 
and caused higher toxic effects. Selenomethionine was also able to increase the uptake and 
retention of arsenic in the neuronal proliferation zones of the telencephalon, which could also have 
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detrimental effects on the behavioural and cognitive functions of the fish. Although mammalian 
studies have demonstrated antagonistic effects between arsenic and selenium previously, 
synergistic or additive interaction between these two elements, as demonstrated in this study and 
few other mammalian studies, suggest that methylated forms of selenium can potentiate the 
toxicity of arsenite, rather than ameliorating it. 
  
 151 
 
 
 
 
 
Chapter 6: General discussion 
6.1. Introduction 
 Since the industrial revolution, anthropogenic activities have increased the rate of soil 
erosion and removal of minerals from natural deposits. The rate of deposition of metals and 
minerals into aquatic habitats in many parts of the world has exceeded their natural ability to 
recycle, hence causing the concentration of metals to reach toxic levels. For example, selenium, 
which is otherwise an essential metalloid in low doses, has reached toxic concentrations in many 
parts of the world because of effluents from coal and metal mining industry. In the recent years, 
there has been an increasing concern about the health and ecological consequences of 
environmental pollution from metals. Organisms living in natural habitats are often exposed to a 
combination of metals and metalloids which modulate each other’s toxic effect. Selenium is one 
such element that is known to co-exist with a variety of other elements and influence their toxicity. 
The overall objective of this study was to address a major knowledge gap in the field of 
environmental toxicology and understand the mechanistic underpinnings of how selenium 
modulates arsenite or cadmium-induced oxidative stress in freshwater fish, rainbow trout 
(Oncorhynchus mykiss). In vitro and in vivo experiments were conducted to understand the 
interactions at both cellular (Chapters 2 & 3) and organismal (Chapters 4 & 5) levels. For 
investigation at the cellular level, the hepatocytes of rainbow trout in primary culture were used to 
investigate the interactions between selenium and arsenite or cadmium. In the in vitro experiments, 
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I used selenite and selenomethionine as inorganic and organic forms of selenium to understand the 
chemical species-dependent effects. The investigations at the organismal level were conducted by 
exposing the fish to Artemia based diet supplemented with selenomethionine in combination with 
cadmium or arsenic for 30 days. The significant findings from the present research project are 
summarized in Figure 6.1.
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Figure 6.1: An overview of the significant findings of the present research project.
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6.2. Interactions between selenium and cadmium (Chapters 2 and 4) 
6.2.1. Interactive effects of selenium on cadmium-induced oxidative stress 
A series of in vitro and in vivo experiments were conducted to characterize the hepatic 
pathways by which different chemical species [inorganic (selenite) vs. organic (selenomethionine)] 
and exposure doses of selenium modulated cadmium-induced oxidative stress at the cellular and 
organismal level. The results from in vitro experiments with hepatocytes of rainbow trout have 
shown that both, selenite and selenomethionine can antagonize cadmium-induced oxidative stress 
by enzymatic and non-enzymatic antioxidative pathways which include increased cellular thiol 
status (GSH:GSSH) and upregulated activities of anti-oxidative enzymes (CAT, SOD, and GPx), 
respectively. A combination of enzymatic and non-enzymatic pathways resulted in an overall 
reduction of intracellular ROS production and increased viability of hepatocytes (Chapter 2). 
However, the protective effects of selenium against cadmium-toxicity were observed only at 
relatively low to medium concentrations (25 – 50 µM), and a combination of 500 µM selenium 
with 100 µM cadmium elicited additive toxic effects.  
Similar to the cadmium-selenium mechanistic interactions in the hepatocytes, my study has 
also demonstrated that selenium-cadmium antagonistic interaction also occurs at the organismal 
level (Chapter 4). Exposure to only cadmium (~ 40 µg g-1 diet) supplemented diet resulted in 
reduced hepatic thiol ratio and increased activities of antioxidative enzymes in rainbow trout. 
However, medium dose of dietary selenomethionine (~10 µg g-1 diet) in combination with 
cadmium restored thiol ratio and alleviated the heightened response of enzymatic antioxidative 
machinery. Increase in the activities of antioxidative enzymes in response to sub-lethal exposure 
to cadmium was likely a compensatory cellular mechanism to cope with the oxidative stress, which 
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is consistent with previous studies (Almeida et al., 2002; Basha and Rani, 2003; Cuypers et al., 
2010; Nair et al., 2015). Hepatosomatic index (HSI) and condition (K) factor were used as the 
indirect measures of the energy status and general well-being of the fish (Chellappa et al., 1995). 
Upregulated activities of hepatic antioxidative enzymes in response to dietary cadmium was 
concomitant with reduced HSI and K-factor, suggesting that the exposure to cadmium was 
energetically taxing to the fish, and compromised the growth rate. On the contrary, a dietary 
combination of a medium dose of selenomethionine and cadmium improved HSI and K-factor, and 
therefore reduced the energetic burden of cadmium toxicity. No antagonistic interactions with 
cadmium were observed with the higher dose of dietary selenomethionine  (~40 µg g-1 diet). In 
addition to the biochemical mechanisms, I also investigated the modulatory effect of dietary 
selenomethionine on the tissue-level accumulation of cadmium. 
6.2.2. Modulation of tissue-specific distribution of cadmium by selenium (Chapter 4) 
Exposure to dietary cadmium increased cadmium levels in kidney, followed by liver and 
muscle (Chapter 4). Although a dietary combination of cadmium and selenomethionine (both 
medium and high doses) reduced the overall cadmium burden in liver and kidney, the accumulation 
of cadmium in hepatic tissue of rainbow trout was still significantly higher in comparison to the 
control. Interestingly, despite the reduced hepatic cadmium levels due to selenomethionine 
treatment, cadmium-induced oxidative stress was ameliorated only by a medium dose of 
selenomethionine. This suggests that the hepatic oxidative stress was not dependent only on the 
cadmium accumulation. A dietary combination of cadmium with high selenomethionine resulted 
in higher hepatic selenium accumulation in comparison to the cadmium and medium 
selenomethionine treatment. Since selenium beyond a threshold level can also cause oxidative 
stress (Kupsco and Schlenk, 2014; Thomas and Janz, 2016), it is possible that higher accumulation 
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of both cadmium and selenium in the liver following the dietary treatment with cadmium and high 
selenomethionine could have contributed towards hepatic oxidative stress in an addtive manner. 
These results are consistent with the findings from my in vitro experiments where a high 
concentration of selenium had additive effects with cadmium and resulted in higher cytotoxicity. 
Therefore, the tissue levels of both selenium and cadmium appeared to have contributed towards 
oxidative stress. 
Overall, the results support my original hypothesis that selenium will modulate cadmium 
induced toxicity by ameliorating oxidative stress in a dose specific manner, with antagonistic 
interactions at low to intermediate exposure levels and additive/synergistic effects at higher doses. 
6.3. Interactions between selenium and arsenite (Chapters 3 and 5) 
6.3.1. Interactive effects of selenium on arsenite-induced oxidative stress 
Experiments on hepatocytes of rainbow trout in primary culture and a 30-days feeding trial 
were conducted to unravel the mechanisms by which selenium modulates the arsenite-induced 
oxidative stress in freshwater fish (Chapters 3 and 5). Using a series of in vitro experiments, which 
also involved a suite of pharmacological exposures, I have shown that selenite and 
selenomethionine mediate their protective effects against arsenite-induced oxidative stress through 
separate biochemical pathways (Chapter 3); however, the protective effects were only partial. 
Selenite ameliorated arsenite-induced oxidative stress primarily by upregulating the enzymatic 
antioxidants (especially SOD), whereas selenomethionine exerted its antioxidative response 
essentially by upregulating the non-enzymatic antioxidative pathway that involves GSH. The 
primary function of enzymatic and non-enzymatic antioxidative pathways was to prevent oxidative 
stress by scavenging of arsenite-induced ROS. In addition to chemical species-specific effects, both 
selenite and selenomethionine also showed a dose-specific effect against arsenite (100 µM) 
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toxicity. Selenite alleviated arsenite-induced reduction in cell viability at 10 – 20 µM concentration 
level, while selenomethionine was most effective at 10 µM against arsenite. Moreover, selenite 
was more protective than selenomethionine against arsenite toxicity. 
While the in vitro experiments revealed an antagonistic interaction between arsenite and 
selenium in fish hepatocytes, a dietary combination of medium (~10 µg g-1 diet) or high dose (40 
µg g-1 diet) of selenomethionine with arsenite (~80 µg g-1 diet) resulted in increased toxic effects 
and overwhelmed the hepatic anti-oxidative machinery (Chapter 5). Diet supplemented with 
medium selenomethionine and arsenite marginally improved the hepatic redox potential, and it was 
not sufficient to alleviate the degree of arsenite-induced lipid peroxidation which was still high in 
comparison to the control treatment group. The lipid peroxidation assay also revealed that chronic 
exposure to arsenite in combination with high selenomethionine was more toxic than treatment 
with arsenite or high selenomethionine exclusively. The combination of arsenite and 
selenomethionine also elicited a compensatory response in the form of upregulated the activities 
of antioxidative enzymes (CAT, SOD, GPx) to cope with the increased oxidative stress 
(Bhattacharya and Bhattacharya, 2007; Greani et al., 2017b; J.-H. Kim and Kang, 2015; Sarkar et 
al., 2017). Similar to the results from selenium and cadmium experiments, the compensatory 
upregulation of enzymes was also correlated with reduced HSI and K-factor, suggesting poor 
energy status and compromised growth performance of the fish. 
6.3.2. Modulation of tissue-specific distribution of arsenic by selenium (Chapter 5) 
In my study, I observed that supplementing the diet with selenomethionine increased the 
accumulation of arsenic in tissues. In contrast, the presence of arsenite in the diet reduced tissues-
level accumulation of selenium (Chapter 5). These results are in agreement with previous 
mammalian studies that demonstrated that selenium could reduce the depuration rate of arsenic 
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through metabolic interactions (Levander, 1977; Styblo and Thomas, 2001; Thomas et al., 2001; 
Walton et al., 2003). Interestingly, hepatic arsenic (not selenium) concentration was also highly 
correlated with oxidative stress and lipid peroxidation (Table 5.2). Therefore, it is possible that the 
increased oxidative insult in the hepatic tissues of the fish fed with a combination of arsenite and 
selenomethionine is due to a selenium mediated increase in arsenic accumulation.  
I have also used synchrotron-based X-ray fluorescence imaging (XFI) to understand the 
distribution pattern of arsenic and selenium in the telencephalon of the rainbow trout brain (Chapter 
5). Arsenic is known to cross the blood-brain barrier (Hamdi et al., 2009; Liu et al., 2006b); 
however, the effects of dietary selenium on the accumulation pattern of arsenic in the brain have 
not been investigated previously. I did not observe any measurable quantities of selenium or arsenic 
in the brains of the fish fed with control diet (no supplementation with arsenic or 
selenomethionine). However, supplementation of the diet with selenomethionine above the 
physiologically essential dose of selenium (> 3µg g-1 diet) increased the retention of arsenic in the 
fish telencephalon. Moreover, arsenic and selenium in the brain were also highly co-localized in 
the ventricle region of the telencephalon, which is the region of high neuronal proliferation. 
Interestingly, when the feed was supplemented with medium selenomethionine, arsenic and 
selenium were present in an equimolar ratio at the accumulation hotspots of the brain. Also, 
supplementing the feed with high selenomethionine increased the arsenic concentration in the 
brain, which exceeded selenium by 3 – 5 folds. These results are consistent with the selenium-
dependent increased accumulation of arsenic in liver, kidney, and muscle tissues. 
Overall, arsenite toxicity in fish occurs by disruption of redox homeostasis, which can be 
partially ameliorated by selenite and selenomethionine via enzymatic and non-enzymatic 
antioxidative pathways, respectively (Chapter 3). However, the interaction between arsenite and 
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selenium can be influenced by the metabolic interactions at systemic level, and selenium may 
actually exacerbate the toxic effects of arsenite under environmentally relevant exposure scenarios 
(Chapter 5). In conclusion, my research provides novel insights into the biochemical basis of how 
selenium can influence the biological effects of toxic trace elements, such as cadmium and arsenic, 
by interacting with them at cellular and systemic levels in a dose and chemical species dependent 
manner.  
6.4. Future research perspectives and recommendations 
Arsenic, cadmium, and selenium are all priority aquatic pollutants and often co-exist in 
aquatic habitats. Therefore, the understanding of their interactive effects on the health of aquatic 
animals is important and can be used to develop better regulatory guidelines. My research has 
provided novel and important mechanistic information on the interactive effects of selenium on 
cadmium and arsenic toxicity in freshwater fish. However, the molecular mechanisms involved in 
uptake of arsenic or cadmium in the presence of selenium still remain unresolved. For example, 
selenium was found to antagonize tissue level accumulation of cadmium which was also 
concomitant with reduced oxidative stress. Since, uptake of cadmium is highly dependent on ion 
transport channels such as DMT1 and L-type Ca+2 channel (Kwong and Niyogi, 2009), the effects 
of selenium on ion-transport channel mediated uptake of cadmium can be investigated. Similarly, 
intestinal uptake of arsenic in mammals has been shown to depend on  glucose transporters, 
aquaporins, and phosphate transporters (Calatayud et al., 2012). Investigations are also required to 
understand how selenium, beyond a physiologically essential concentration, causes increased 
uptake of arsenic in various tissues.  
In my research, co-localization of selenium and arsenic in brain tissues (Chapter 5) 
suggested formation of biological complex. It has been shown that arsenic and selenium, in the 
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presence of GSH, can form metabolic intermediates in the blood (Gailer, 2007; Korbas et al., 2008). 
It is possible that similar metabolic intermediates are formed in fish which need further 
investigation. Techniques such as synchrotron based X-ray absorption spectroscopy can detect 
novel biological complexation in the biological samples (Gailer et al., 2000). Also, selenium is 
being proposed as a therapeutic agent against arsenic toxicity. However, I have provided evidence 
suggesting that selenium may accentuate arsenic toxicity. Therefore, more research is needed to 
understand the metabolic relationship between arsenic and selenium. 
Exposure to toxic metals and metalloids is known to cause genotoxicity in fish (Barbosa et 
al., 2010). However, the mutagenic assays have revealed that most of these metals and metalloids 
are not redox reactive at environmentally relevant concentrations and therefore cannot cause 
genetic mutations (Bertin and Averbeck, 2006; Valverde et al., 2001). More recently, the 
deleterious effects of environmentally toxic trace elements have been linked with the epigenetic 
changes and not with genetic mutations (Nye et al., 2014). On the other hand, selenium is known 
to modulate one-carbon metabolism and DNA methylation pattern, and prevent epigenomic 
aberrations in mammals (Speckmann et al., 2017). Therefore, evaluation of the protective role of 
selenium against epigenetic interferences from arsenic and cadmium could be an interesting 
prospect which has not been studied in any aquatic animal so far. 
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APPENDIX1
Synchrotron-based X-ray fluorescence imaging (XFI) and its biological applications 
The X-ray fluorescence imaging (XFI) is one of the most popular synchrotron-based 
techniques that is used to quantify and determine the distribution of multiple elements 
simultaneously in a biological sample with a high rate of precision (Fahrni, 2007; Paunesku et al., 
2006). X-ray fluorescence imaging involves the use of high energy photons in the hard X-ray region 
(>1 keV)  to remove the electrons of metals, as photoelectrons, from their inner core electronic 
states (Fig. 1.4 a). An electron from the higher energy shell then loses energy in the form of a 
photon to replace the space in the core-shell that was vacated due to the removal of the 
photoelectron (Fig. 1.4 b). The energy of the photon emitted during this process is equal to the 
difference in binding energies of the two shells involved in the transition (Fig. 1.4 b) (Fahrni, 2007; 
Jones, 1988; Paunesku et al., 2006). This energy is characteristic for each element and is also 
known as the ‘fluorescence’ (Jones, 1988). The synchrotron-based XAS provides an excellent 
alternative to other analytical techniques that require extensive extraction and processing of tissues 
(B’Hymer and Caruso, 2006; Lakshmi Priya and Geetha, 2011). Due to minimal handling and 
processing requirements, the structural and histological integrity of the tissue can be maintained, 
and the spatial distribution of elements can be determined. This is particularly useful for 
determination of the distribution of multiple elements in delicate and structurally heterogeneous 
tissues, such as the brain (Surowka et al., 2015). The XFI has also been successfully used to 
determine the spatial distribution of elements in structurally heterogeneous tissues of fish. For 
example, distribution of mercury in the lens and photoreceptors of eye was determined in the eye 
                                                 
1 This chapter includes supplementary data and general introduction to X-ray fluorescence imaging 
technique. The figure number is presented as Cx.Sy format, where ‘Cx’ is the chapter number and ‘Sy’ indicates 
individual figure. Tables are presented as Cx.Ay format where ‘Cx’ indicates the chapter number and ‘Ay’ is the 
individual table number. 
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of the fish exposed to methylmercury (0.5 µM) for 48 h (Korbas et al., 2013). Similarly, the effect 
of maternal transfer of selenium was studied by visualizing the deposition of selenium in various 
regions of larvae obtained from zebrafish females fed with selenomethionine spiked diet for 25 
days (Choudhury et al., 2015). In my research, I have used XFI to determine the spatial deposition 
of arsenic and selenium in the telencephalic region of the fish brain in response to the interactions 
between dietary arsenite and selenomethionine. Telencephalon is a highly specialized region of 
brain that is responsible for various behavioral and cognitive functions (Gómez et al., 2011; 
Rodriguez et al., 2005), and the spatial distribution of arsenic or selenium in the telencephalon has 
not been investigated before. 
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Figure C1 S1: A schematic diagram using Bohr’s atomic model to illustrate the principle of X-
ray fluorescence. (a.) High energy X-ray beam excites the electron from the core-shell; (b.) an 
electron from the higher-shell replaces the place vacated by the ejected core-shell electron and 
emits an X-ray of a characteristic wavelength whose energy is equal to the difference in binding 
energies of the two shells involved in the transition (Figure modified from Fahrni, 2007). 
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Figure C3.S1: Changes in the viability of rainbow trout hepatocytes when exposed to 25 µM – 
500 µM arsenite (As). Data are presented as mean ± S.E.M. (n = 4), where n represents the number 
of true independent measurements, each performed with cells isolated from a different fish. Mean 
values with different letters are statistically significant (p<0.05). 
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Figure C3.S2: Changes in the viability of rainbow trout hepatocytes when exposed to 100µM 
arsenite (As), alone or in combination with different concentrations (50µM – 1000µM) of (A) 
selenomethionine, or (B) selenite. Data are presented as mean ± S.E.M. (n = 4), where n represents 
the number of true independent measurements, each performed with cells isolated from a different 
fish. Mean values with different letters are statistically significant (p<0.05). 
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Figure C3.S3: Changes in the viability of rainbow trout hepatocytes when exposed to 0.5 mM 
concentration of ATA (CAT inhibitor), BSO (GSH inhibitor), DETC (SOD inhibitor), or MS 
(GPx inhibitor) for 24 h. Data are presented as mean ± S.E.M. (n = 5), where n represents the 
number of true independent measurements, each performed with cells isolated from a different 
fish. Mean values with different letters are statistically significant (p<0.05). 
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Table C3.A1: Changes in activities of anti-oxidative enzymes in rainbow trout hepatocytes upon 
exposure to 0.5 mM concentration of ATA (CAT inhibitor), DETC (SOD inhibitor), or MS (GPx 
inhibitor) for 24 h. Data are presented as mean ± S.E.M. (n = 5), where n represents the number of 
true independent measurements, each performed with cells isolated from a different fish. The 
effects of the pharmacological inhibitors on the treated cells, with respect to the control treatments, 
were evaluated by t-test. The mean values with asterisk (*) differ significantly from the control 
treatments (p<0.05). 
Treatment Change in the activity of enzymes (% of control) 
ATA (0.5 mM) 63.34 ± 6.2* 
DETC (0.5 mM) 52.7 ± 9.0* 
MS (0.5 mM) 57.3 ± 7.6* 
 
